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GENERAL INTRODUCTION 
Dissertation Organization 
This dissertation is written in an alternate thesis format, as permitted by 
Graduate College. It includes a research objective, a background and literature review, 
a rationale, five manuscripts to be published, a general discussion, a general summary, 
a list of references cited in the general introduction, literature review, rationale and 
general discussion, and acknowledgements. 
This dissertation contains the experimental results obtained by the author during 
his graduate study under the supervision of his major professor. Dr. Walter H. Hsu. 
Research Objectives 
The purpose of this research was to study the a-adrenergic effects of natural 
catecholamines acting on myometrial contractility in vitro using the longitudinal layer 
and to identify and characterize myometrial a-adrenoceptors (ARs) using radioligand 
binding assays in sows in the estrous cycle and during pregnancy. 
The myometrial contractility was monitored following the administration of the 
AR agonist and antagonist. Since Ca^"" is a major signal for triggering contraction of 
smooth muscles, including myometrium, the objective of this research was also to 
determine whether natural catecholamine-induced myometrial contractions are 
mediated through an increase in Ca^'" influx or release from intracellular stores. 
(7,- and Oj-ARs were characterized and quantified in porcine myometrium to understand 
the relationship between the density of a-ARs and myometrial contractility and 
between the density of a-ARs and different reproductive stages during the estrous 
cycle and pregnancy. 
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Background and Literature Review 
The objective of this section is to provide concise informational background for 
the study of a-adrenergic influences of myometrial contractility in the sow. 
Anatomy of the Uterus 
The uterus, one of the essential organs for reproduction and gestation, is a 
hollow muscular organ which is continuous with the oviducts cranially and opens into 
the vagina caudally. It consists of body, horns and neck (cervix). The uterine horn in 
the pig is bicornuate type, which is long and convoluted (Mossman, 1977). In this 
type, two cornua always join at their cervical ends to form the body, which opens by a 
single cervical canal into the vagina. The uterine horns are remarkable for their length 
in pigs. In the nongravid state, each is about one meter long; at the height of 
pregnancy this may easily be doubled in length (Dyce et at., 1 987; Hafez, 1 987). The 
horns lie cranial to the pelvic inlet midway between dorsal roof and ventral floor of the 
abdomen and are suspended by extensive broad ligaments. The broad ligaments, 
which contain much smooth muscle, enlarge considerably during pregnancy, allowing 
and supporting the horns to sink to the abdominal cavity. 
The wall of the uterus has three distinct layers: endometrium, myometrium and 
perimetrium. Perimetrium or tunica serosa, the outmost layer, is a thin serous 
membrane, which is the extension of the peritoneum. The innermost layer is the 
endometrium or tunica mucosa, consisting of the epithelium of the lumen, the uterine 
glands and the connective tissues. The myometrium or tunica m.uscuiaris is located 
between the perimetrium and the endometrium. The myometrium consists of two main 
3 
layers of smooth muscle, the outer thinner longitudinal layer and the inner thicker 
circular layer with respect to the uterine lumen. The outer longitudinal layer, an 
extension of the smooth muscle present in the mesometrium, is continuous throughout 
the length of the uterus. The inner circular layer is apposed to the endometrium and 
separated from the outer layer by a vascular layer (pars vasculosa). 
The smooth muscle bundles of the longitudinal layer are arranged parallel to the 
long axis of the uterus, and upon contracting tend to shorten the uterus cephalo-
caudally. Because of the continuity of the myometrium with the more fibrous cervix 
which is secured by the broad ligament, contraction of the longitudinal muscle layer 
tends to pull the ovarian end of the uterus caudally. In the gravid uterus at term, such 
contraction may assist in the dilation of the cervix. In the circular layer, the bundles 
are arranged concentrically around the long axis. Contraction in this layer serves to 
constrict the uterine lumen (Finn and Porter, 1975). 
The ovary does not apparently influence the length of the uterus until the 
prepubertal gilt is about 100 days of age (Wu and Dziuk, 1988). The uterus grows 
gradually until puberty, then it doubles in length and weight at the first estrus. 
Embryos cause growth of the uterus during pregnancy beginning at day 18, continuing 
until about day 30 of pregnancy (Wu et al., 1988). From day 18 to 30 the uterus 
doubles in length but grows relatively little during the remainder of gestation. Growth 
of the uterus is stimulated by each embryo and is limited to that section of the uterus 
occupied by an embryo. The length of each pregnant uterine horn is dependent on the 
number of fetuses within that horn, independent of the number in the opposite horn 
(Dziuk, 1991). 
The uterine wall makes a slow but constant gain in weight throughout 
pregnancy (McDonald, 1989). There is no noticeable difference in the thickness 
between the longitudinal layer and circular layer of the myometrium in different phases 
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of the estrous cycle in pigs (Thilander and Rodriguez-Martinez, 1989a). In the early 
pregnancy, the longitudinal layer is separated from the thicker circular layer by the 
connective tissue. As the pregnancy proceeds, the thickness of the longitudinal layer 
decreases. In contrast, the thickness of the circular layer does not vary throughout 
pregnancy (Thilander and Rodriguez-Martinez, 1989b). The myometrial layers in the 
parturient pig have the same thickness as in the pregnant myometrium (Thilander and 
Rodriguez-Martinez, 1990). The thickness of both layers in the placental regions is less 
than in the nonplacental ones (Thilander and Rodriguez-Martinez, 1989b and 1990). 
The typical porcine myometrial cells are elongated spindle shaped, and 
irregularly outlined with numerous cytoplasmic projections. The nucleus is centrally 
located, elongated and oriented longitudinally to the cell. The intercellular space 
between the muscle cells is chiefly occupied by collagen fibers and fibroblasts. The 
cell membranes of different cells are in close proximity to each other. The cell size in 
pregnancy is larger than in the non-pregnant state as pregnancy proceeds. Moreover, 
the average cell diameter in the placental regions is greater than in the non-placental 
regions (Thilander and Rodriguez-Martinez, 1989a, 1989b and 1990). 
The ultrastructure of the porcine myometrium at well-defined stages of the 
estrous cycle, pregnancy and parturition has been studied (Thilander and Rodriguez-
Martinez, 1989a, 1989b and 1990). In general, the basic ultrastructure of porcine 
myometrial cells in pregnant sows resembles that of non-pregnant ones. However, the 
density of gap junctions begins to increase and the size of gap junctions becomes 
larger two days before parturition. In contrast, gap junctions are few and small 
throughout the rest of gestation and the estrous cycle. Gap junctions are intercellular 
channels that link cells to their neighbors and allow the passage of inorganic ions and 
sm.all molecules (Peracchia, 1980; Revel et 3l., 1985; Spray and Bennett, 19S5). The 
development of myometrial gap junction is physiologically regulated by steroid 
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hormones (Garfield et a/., 1980). Estrogens promote and progesterone suppresses the 
formation of gap junctions. Steroid hormones are thought to control genomic 
mechanisms and synthesis of connexin 43 proteins, the major components of the gap 
junction. Estrogens, particularly estradiol, stimulate the synthesis of gap junction by 
interacting with its receptors and stimulating the specific genome responsible for 
coding for the gap junction protein (Garfield, 1994). The increased gap junctions of the 
myometrium prior to and during parturition may provide low resistance pathways 
between muscle ceils, allow a rapid and synchronized spread of action potentials 
leading to well-coordinated contractions (Verhoeff et al.. 1986). 
The uterus receives its blood and nerve supply through the broad ligaments. 
The middle uterine artery provides the main blood supply to the uterus in the pig. In 
addition, there is a cranial supply from a branch of the ovarian artery and a caudal 
supply from a cranial branch of the vaginal artery (Dei Campo and Ginther, 1973). 
The medial uterine artery arises from the umbilical artery, which is given off 
from the ventral wall of the internal iliac artery, one of the terminal branches of the 
abdominal aorta (Nunez and Getty, 1969). The medial uterine artery has a tortuous 
cranioventrai course in the medial side of the broad ligaments. It usually divides into 
two main branches, i. e., cranial and caudal branches, in the middle part of the cranial 
third of the ligament. The cranial branch of the uterine artery divides several times and 
supplies the cranial half of the uterine horns. The caudal branch forms an arch in the 
mesometrium several centimeters from and parallel to the uterine horn. The branches 
to the uterine horn are interconnected at the mesometrial attachment, forming a series 
of loops which extends the length of the horn. The arterial arch terminates in a 
prominent anastomosis with the uterine branch of the vaginal artery. A network of 
these anastomotic vessels supplies blood to the uterine body and the cervix. 
The utero-ovarian artery, originating from the abdominal aorta, mainly supplies 
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blood to the ovary, ovarian bursa and oviduct. Some of its branches anastomose with 
the cranial branches of the medial uterine artery and supply blood to the tips of the 
uterus. 
The main venous drainages of the uterus are the medial uterine vein and utero-
ovarian vein (Nunez and Getty, 1970; Del Campo and Ginther, 1973). The medial 
uterine vein courses parallel to the satellite artery embedded in the broad ligament of 
the uterus. It drains into the common iliac vein of caudal vena cava. The utero-ovarian 
vein drains a plexus, near the ovary. It, enclosed with ovary artery, courses in the 
anterior border of the broad ligament. Then it drains into the common iliac artery or 
caudal vena cava. 
The distribution of adrenergic and cholinergic nerves in the porcine myometrium 
during the estrous cycle, pregnancy and parturition has been studied using 
histochemical methods and electromicroscopy (Thilander, 1989; Thilander and 
Rodriguez-Martinez, 1989a, 1989b, 1989c and 1990). Both adrenergic and cholinergic 
nerves are present in longitudinal and circular layers of porcine myometrium. 
Adrenergic nerves are present both in vascular and in non-vascular smooth muscles, 
whereas the cholinergic nerves mostly accompany the blood vessels. 
The distribution of uterine adrenergic nerves in cycling (Thilander and Rodriguez-
Martinez, 1989c) and pregnant pigs (Thilander, 1989), but not in immature pigs 
(Lakomy et at., 1983), differs from the pattern reported in other species (Owman and 
Sjoberg, 1966 and 1972; Rosengren and Sjoberg; 1967; Garfield, 1986). in 
lagomorpha (guinea pigs and rabbits) and carnivores (cats and dogs), the adrenergic 
nerves are evenly distributed throughout the uterine horns, while the pigs present very 
scanty innervation, except the cervix. The cervix has a rich innervation. In the rat, the 
adrenergic nerves predominantly innervate blood vessels, whereas in the porcine 
myometrium these nerves are also seen in synapsis with groups or bundles of non-
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vascular muscle cells (Thilander, 1989). 
Histochemical microscopy in pigs (Thilander, 1989), guinea pigs (Bell and 
Malcolm, 1978; Thorbert, 1978), rabbits (Rosengren and Sjoberg, 1968), humans 
(Nakanishi eta!., 1969; Thorbert etal., 1979) and sheep (Sigger ef a/., 1986;Renegar 
and Rexroad, 1990) revealed that the fluorescence intensity and the diameter of 
adrenergic nerves decreases as pregnancy proceeds, which is consistent with the 
ultrastructural investigations. This decrease is more pronounced in placental regions 
than in non-placental regions (Thilander, 1989). 
Concerning the nerve-muscle relationship, there is a low density of nerves to 
myometrial smooth muscle cells as compared to richly innervated smooth muscle such 
as rat vas deferens and urinary bladder. In the latter, each muscle cell is closely related 
to a nerve axon whereas in the myometrium nerve fibers are associated with groups or 
bundles of muscle cells (Silva, 1967; Adham and Schenk, 1969). 
As previously indicated the cholinergic innervation of the porcine myometrium is 
mostly associated with blood vessels (Thilander, 1989). The circular muscle layer has 
a more dense nerve network than the longitudinal one. The cervix has the richest 
innervation. This pattern is unaffected throughout the estrous cycle and pregnancy. 
The estrous cycle and ovarian steroids in the pig 
The information concerning this part is mainly reviewed from the following 
references; Anderson, 1987; Catchpole, 1991;Dziuk, 1991; Evans, 1989: Flood, 
1991; Hafez, 1987; Jainudeen and Hafez, 1987; McDonald, 1989; Pineda, 1989; 
Stabenfeldt and Edqvist, 1993. 
Puberty of the gilt is usually attained by the age of 6 to 7 months. The 
domestic female pig is polytocous and nonseasonally polyestrous with estrus occurring 
at intervals normally about 21 days (ranges: 1 9 to 23 days). The period of pregnancy 
8 
starts with fertilization and ends with parturition. The average length of gestation in 
sows is 114 days (range: 112 to 116 days). 
Classically, the estrous cycle consists of four phases, including proestrus, 
estrus, metestrus and diestrus. Proestrus is the period of rapid follicles growth under 
gonadotropic stinnulation that precedes the onset of estrus. It lasts about 2 days. 
Proestrus is associated with progressively declining levels of progesterone due to the 
regression of the corpus luteum (CD from the preceding cycle. At this stage, the 
fennale pig is exposed and behaviorally (e.g., restlessness, nnounting of other animals, 
lordosis response) responds to progressively increasing levels of estrogens secreted by 
the developing follicles. 
Estrus, the period of sexual receptivity, lasts about 2 to 3 days (an average of 
40 to 60 h). Ovulation occurs spontaneously and usually between 36 to 42 h after the 
onset of estrus or about 6 h before the end of estrus. It is conventional to designate 
the first day of estrus as day 0 of the estrous cycle. Proestrus and the portion of the 
estrual period prior to ovulation form the follicular phase of the estrous cycle. 
Metestrus lasts 1 or 2 days, which is the period of early CL development. The 
onset of metestrus is usually defined as beginning with the end of estrus. During this 
phase, the reproductive system switches from estrogens to progesterone dominance. 
Diestrus is the period of mature luteal activity. It begins about 4 days after 
ovulation and ends with regression of the CL. It is the phase that the reproductive 
organs are under the dominant influence of progesterone. This phase is the longest 
phase of the cycle for all of the domestic species, including pigs. Metestrus and 
diestrus form the luteal phase of the estrous cycle. 
The physiologic and behavioral changes are cyclic and repeated over time, 
unless normally interrupted by pregnancy, or by a variety of pathologic conditions, such 
as the development of follicular cysts. 
9 
Anestrus is a stage of sexual quiescence characterized by the lack of estrous 
behavior. Anestrus is a normal stage of the reproductive function in the prepuberal and 
in aged animals. Anestrus is also normal for the pregnant animal of all species, in 
fact, pregnancy is the most common cause of anestrus in polyestrous species, such as 
pigs. 
During the luteal and early follicular phases of the cycle, the follicles are small, 
i.e., 2 to 5 mm in diameter. About 10 to 20 follicles approach preovulatory size (8 to 
11 mm), while the number of smaller follicles declines (< 5 mm) during the proestrous 
and estrous phases. During the luteal phase of the cycle, which occurs between days 
5 and 1 6, the number of follicles with 2 to 5 mm in diameter increases. During days 7 
to 12, the CL are fully formed, functional, meaty, distinct, encapsulated, and endowed 
with a good blood supply. Day 12 is critical in the life of the CL of the sow. If viable 
embryos are present in the uterus, then the CL will continue their function. If viable 
embryos are not present, these CL will initiate irreversible regression. Luteolysis 
becomes apparent macroscopically by days 15, in which progesterone production is 
falling. By day 16 the CL have lost most of their vascularity, shrinkage in size has 
begun. By day 18 (proestrous phase), an increase occurs primarily in the growth of 
preovulatory follicles {> 8 mm in diameter). The waning CL are evident by their white 
color (corpora albicantia) and soft texture which signals the end of their function. 
The major steroid hormones involved in female reproductive processes are 
progesterone and estrogens. In addition, they may modify the density of ARs in 
myometrium in the estrous cycle and during pregnancy. Therefore, the following 
information of endocrinology will be restricted to these two ovarian steroid hormones. 
Ovarian steroid-secreting activity of the CL is indicated by concentrations of 
progesterone and estrogens, which change dramatically and quite predictably 
throughout the estrous cycle. The synthesis of progesterone in the CL is controlled by 
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luteinizing hormone (LH) in the nonpregnant animals. Estradiol-17;? and estrone are the 
estrogens which are produced by the theca interna and granulosa cells of the ovary in 
the pig. In addition, the placenta is the main site producing estrone, a metabolite of 
estradiol-1 7)9. Although the adrenal cortex also produces estrogens, under normal 
conditions, quantities are insufficient to replace the normal ovarian production of 
estrogens. 
Progesterone levels are low at estrus (day 0). Following ovulation at mid-estrus, 
the follicular remnants luteinize resulting in the formation of progesterone-producing 
CL. Plasma progesterone levels begin to increase abruptly and are followed by a 
precipitous decline, which is coincidental with luteolysis, 1 5 to 18 days after estrus. 
These progesterone levels in peripheral venous blood correspond to those patterns in 
ovarian venous blood throughout the cycle, and follow a pattern similar to the 
morphologic development and decline of the CL as well as ultrastructural changes in 
luteal cells. 
Estrogens, primarily estrone in peripheral plasma begin to increase coincidentally 
with the decline and disappearance of progesterone between day 1 5 and 20 of the 
estrous cycle. Peak values of circulating estrogens occur about 24 h before the onset 
of behavioral estrus. This reflects rapid growth and maturation of graafian follicles 
during the late proestrous phase of the cycle. Soon after ovulation, estrogen levels 
decline and remain low during the luteal phase of the cycle. 
The growth and maturation of ovarian follicles are dependent on secretion of 
adenohypophyseal gonadotropins, follicular stimulating hormone (FSH) and LH, from 
the anterior pituitary. FSH promotes ovarian growth and follicular maturation. FSH m 
synergy with LH facilitates follicular growth and estrogen production. LH is also 
important for the ovulatory process and the luteinization of the granulosa cells, which 
results in the formation of the CL. Rising blood levels of estrogen suppress the 
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pituitary release of FSH and facilitate release of LH. As estrogen levels rise, a surge of 
LH occurs at the onset of estrus triggering ovulation. Ovulation usually occurs about 
24 h after the LH surge. Then LH levels decline to low levels during the remainder of 
the cycle. 
The release of FSH and LH is controlled by gonadotropin-releasing hormone 
(GnRH), which is secreted from the median eminence and transported to the anterior 
pituitary by a portal system of capillaries. The secretion of gonadotropin is influenced 
by GnRH in two ways. The first way is to vary the frequency or amplitude of the pulse 
release of GnRH which is essential for the maintenance of LH and FSH secretion by the 
anterior pituitary. The second way to influence FSH and LH secretion is to change the 
sensitivity of the anterior pituitary to the pulses of GnRH through the modulatory 
effects of estrogen and progesterone. In general, increasing concentrations of estrogen 
cause an increase in sensitivity to GnRH and result in an increased release of 
gonadotropins. However, progesterone has an opposite effect. 
The placenta, like the CL, is a transient endocrine organ. It secretes steroid 
hormones, such as estrogens and progesterone, which are released into the fetal as 
well as the maternal circulation. The placenta of the sow is not capable of 
synthesizing sufficient amounts of progesterone using acetate and cholesterol derived 
from the maternal circulation to maintain pregnancy. Therefore, CL are essential for 
maintenance of pregnancy to term in the pig. In addition, the placenta relies on fetai 
Cortisol to induce activity of the placental enzymes to synthesize estrogens from 
progesterone (Jainudeen and Hafez, 1987). Hence, during the latter half of gestation, 
a high rate of estrogen production occurs in the placenta of farm animals, including 
sows. 
If the pig is pregnant, the CL will be m.aintained beyond day 15. Plasma 
progesterone levels associated with the first 14 days of the estrous cycle and 
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pregnancy are identical (Bazer and First, 1983). However, after that time plasma 
progesterone levels decrease from 30 - 40 ng/ml on day 1 2 to 14 of pregnancy to 10 
25 ng/ml on day 25 of pregnancy (Guthrie et al., 1974; Robertson and King, 1974; 
Knight et al., 1977). Then the levels remain fairly constant until about day 100 of 
pregnancy. After that, the progesterone concentrations start a pre-parturition decline 
to an average level of 5 ng/ml on the day of parturition. A further sharp decline to less 
than 1 ng/ml was observed within 24 h after farrowing (Robertson and King, 1974). 
The feto-placental unit is the major source of estrogen production during 
pregnancy. Starting at day 1 2 of the gestation the blastocysts undergo a rapid growth 
consistent with production of estrogens, mainly estradiol-1 7;ff. The maternal 
concentration of estrone sulfate is present as early as day 16 and reaches a peak near 
day 30, then declines at day 35 of pregnancy. The feto-placental unit is assumed to 
be the source of estrone sulfate because of the positive relationship between the 
number of fetuses and concentration of estrone sulfate in maternal plasma. This 
increase in estrogen concentrations from blastocysts may prevent uterine luteolytic 
action by suppressing RGFj^ secretion into uterine venous system, because estrogen 
administration to nonpregnant pigs during the luteal phase prolongs the CL life span. 
Therefore, the importance of estrogen secretion from the blastocysts is to maintain the 
luteal function during critical phases of early pregnancy. 
The concentrations of estrone and estradiol-1 7/? begin to rise again around days 
80 of gestation and then fall to basal levels after delivery of conceptuses (Robertson 
and King, 1974). This indicates that the rise in estrogens is associated with fetal 
maturity and is primarily of placental origin. 
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Catecholamines 
The term catecholamine (CAT) designates the compounds which are derivatives 
of phenylethylamine, hydrooxylated in positions 3 and 4 of the aromatic ring (Euler, 
1972) (Fig. 1). Dopamine is the biosynthetic precursor of epinephrine (EPI) and 
norepinephrine (NE). It acts essentially as a neurotransmitter in the central nervous 
system (CNS). NE is the neurotransmitter of sympathetic nerves. EPI is the only CAT 
in which the action is essentially hormonal which is mainly produced by the adrenal 
medulla, but is also found in the CNS. 
Four steps are involved in the biosynthesis of CATs from tyrosine (Fig. 2). They 
include: 1) hydroxylation of the phenolic ring; 2) decarboxylation of the lateral chain; 3) 
hydroxylation of the lateral chain; and 4) N-methylation. All of the enzymes involved in 
the biosynthesis of CATs are soluble and are present in the cytosol of the chromaffin 
cells, with the exception of dopamine y?-hydroxylase, which is found only in granules. 
Tyrosine is the normal precursor of CATs. Its source is essentially in dietary intake, 
but it is also derived from the hydroxylation of phenylalanine. Tyrosine is transformed 
into DOPA (3, 4-dihydroxyphenylaianine) by the action of tyrosine hydroxylase. The 
transformation of tyrosine into DOPA is the essential limiting step in the biosynthesis of 
CATs, since the activity of tyrosine hydroxylase in the adrenal medulla is 200 times 
less than DOPA-decarboxylase and dopamine yff-hydroxylase (Hanoune, 1990). Because 
tyrosine hydroxylation is the key step in the synthesis of DOPA, two forms of the 
enzyme exist. One is not phosphorylated which is only slightly active, and the other, 
phosphoryiated and very active. The phosphorylation step is under the control of a 
cAMP-dependent protein kinase. The activity of tyrosine hydroxylase is inhibited by a 
variety of compounds, particularly derivatives of tyrosine, such as a-methyltyrosine, 
and 3-iodotyrosine and its metabolites. Dopamine, ME and EPI also exert a negative 
feedback on the activity of this enzyme (Hanoune, 1990). 
Fig. 1. The biosynthesis of catecholamines. The cofactors are; 1: Fe^*-reduced 
pteridin; 2. pyridoxal phosphate; 3. ascorbic acid; and 4. S-adenosylmethionine. 
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Dopamine decarboxylase transforms DOPA into dopamine, which is 
competitively inhibited by several analogs, such as a-methyl DOPA. Hydroxylation of 
dopamine to NE is catalyzed by dopamine ^-hydroxylase, in the presence of Ca^', 
ascorbic acid, and molecular oxygen. Dopamine yS-hydroxylase is present in secretory 
granules associated with chromogranins, the function of which is unknown (Ganong, 
1991). 
The cytoplasmic enzyme, phenylethanolamine N-methyl transferase (PIMMT), 
which is found in appreciable quantities only in the adrenal medullary cell and some 
neurons of the brain, catalyzes the conversion of NE to EPI. In these cells, NE 
apparently leaves the vesicles, is converted to EPI, and then enters other storage 
vesicles. NE is also stored in granules in adrenergic nerve terminals. 
In the granulated vesicles, EPI and NE are bound to adenosine triphosphate 
(ATP) and associated with proteins chromogranins and essential ions, including Ca^', 
Mg^"^ and ascorbates. The principal protein components are chromogranins (especially 
chromogranin A), dopamine /^-hydroxylase and the precursors of Met- and Leu-
enkephalin (Lewis et a!., 1982; Viveros and Wilson, 1983). The CATs are held in the 
granulated vesicles by an active transport system, dependent on ATP and Mg^', and 
inhibited by reserpine. 
The CATs are released from autonomic neurons and adrenal medullary cells by 
exocytosis. The process of exocytosis is initiated by acetylcholine released from the 
preganglionic neurons that innervate the secretory cells. Acetylcholine increases the 
permeability of the cells, and the Ca^'^ that enters the cells from the extracellular fluid 
triggers exocytosis. The membrane of the granule becomes touching with the plasma 
membrane, and all of its contents, including CATs, ATP, chromogranins and dopamine 
^-hydroxylase, release into the blood because they are not membrane-bound. The 
storage vesicle is not reutilized, but rather is probably degraded. The synthesis of new 
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storage vesicles is necessary for an efficient synthesis. 
The release of NE by the sympathetic neuronal terminals occurs in response to 
an action potential, along with an influx of Ca^*. The secretion of EPI is increased by 
physiological or psychological stimuli, including hypoglycemia, physical exercise, 
hypoxia, anxiety, etc. 
EPI and NE are degraded to biologically inactive products by oxidation and 
methylation (Fig. 2). Degradation essentially involves two enzymes, monoamine 
oxidase (MAO) and catechol-O-methyltransferase (COMT). COMT catalyzes the 
methylation of the hydroxyl group in position 3 and MAO catalyzes the oxidative 
deamination of the aliphatic chain. COMT is especially abundant in the liver and 
kidney, where the major portion of circulating CATs is degraded, but is not found in 
nerve endings. MAO is primarily located in the external membrane of mitochondria. It 
is distributed to all tissues, being particularly plentiful in the nerve endings where CATs 
are secreted. 
Most circulating EPI and NE are 0-methylated to metanephrine and 
normetanephrine (Fig. 2A). The 0-methylated derivatives that are not excreted are 
largely oxidized to 3-methoxy 4-hydroxy-mandelic acid (VMA). Small amounts of 0-
methylated derivatives are conjugated to sulfates and glucuronides. 
On the other hand, in the noradrenergic nerve endings (Fig. 2B), some of the 
NE, is being constantly converted by MAO to physiologically inactive deaminated 
derivatives, 3,4-dihydroxymandelic acid (DOMA) and its corresponding glycol, 3,4-
dihydroxyphenylglycol (DOPEG). These compounds enter the circulation and may 
subsequently be converted to their corresponding O-methyl derivatives, VMA and 3-
methyoxy 4-hydroxyphenylglycol (MOPEG), respectively. 
After the release of NE from nervs terminals into the synaptic cleft, it is also 
inactivated by specialized transport systems, that mediate either neuronal uptake or 
Fig. 2. A. Metabolism of circulating epinephrine and norepinephrine. Most of the 
conjugates are glucuronides and sulfates. 8. Metabolism of norepinephrine in 
noradrenergic nerve endings. Epinephrine in nerve endings is presumably 
cataboiized in the same pathway (From Ganong, 1991). 
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extranuronal uptake (Iversen, 1973). In neuronal uptake (uptake-1), the released NE is 
taken up into the adrenergic nerve terminals of the CNS and the peripheral autonomic 
nervous system, and involves an active transport system. Many drugs, including 
cocaine, desipramine, imipramine and amitryptiline, potentiate nerve stimulation by 
inhibiting this process. Extraneuronal uptake (uptake-2) occurs in various extraneural 
peripheral tissues (smooth muscles, heart, certain gland tissues). Physiologically, this 
uptake leads to a rapid intracellular degradation of CATs by COMT, in contrast with the 
"uptake-storage" of uptake-1. This process is inhibited by corticosterone, 
metepinephrine and normetepinephrine. 
Classification of adrenoceptors 
Adrenoceptors (ARs) are found in nearly all peripheral tissues and some neurons 
of CNS. They mediate the central and peripheral actions of the EPI and NE. Several 
types of neuronal varicosities have prejunctional (or presynaptic) ARs serving as auto-
or heteroceptors that inhibit nerve evoked release of neurotransmitters. 
The ARs were originally classified as a and 0 subtypes, based on the relative 
rank order of potency of six sympathomimetic amines, including EPI, NE and 
isoproterenol, on physiological response (Ahlquist, 1948). EPI was most potent in 
causing vasoconstriction, pupil dilation, uterine contraction, etc, and was designated as 
a-adrenergic. in contrast, isoproterenol was most potent in causing vasorelaxation, 
myocardial stimulation, bronchodilation and uterine relaxation, and was designated as 
)ff-adrenergic. It also was realized that both a- and ;?-ARs were present in the same 
tissue, such as uterus. This scheme, with modifications, still remains intact. 
o-ARs were first subclassified based on their anatomical locations, as either a--
ARs that wsrs postsynaptic and mediated effector organ release (e.g. NE) or Oj-ARs 
that were presynaptic and regulated a negative feedback mechanism of 
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neurotransmitter release danger, 1974). The terms pre- and post-synaptic refer to the 
localization of the receptor sites with respect to the nerve terminal and effector organ. 
That is, postsynaptic receptors are located extraneuronally in the effector organ, 
whereas presynaptic receptors are situated on the membrane of the postganglionic 
neuron. However, this anatomical classification was confused by the existence of a--
ARs in non-presynaptic locations, such as platelets and vascular smooth muscles 
(Berthelsen and Pettinger, 1977). 
A functional classification of a-ARs was recommended on the basis of the type 
of function mediated by the receptor subtype (Berthelsen and Pettinger, 1977). a,-ARs 
were proposed to mediate excitatory responses. Conversely, Oj-ARs were thought to 
mediate inhibitory responses in nature. However, NE-induced vasoconstriction could 
be inhibited by both a selective a,-AR antagonist, prazosin (PRZ) and a selective Oj-AR 
antagonist, yohimbine (YOH) (Drew and Whiting, 1979). This indicated that the 
postsynaptic excitatory response was mediated not only by a,-ARs but also Oj-ARs. 
Later, a pharmacological subclassification is used to designate a,- and a--ARs. 
This is based on the relative activity and affinity of specific agonists and antagonists, 
respectively (Starke, 1981). For instance, a-ARs that are activated by either 
methoxamine or phenylephrine, and that are antagonized by low concentrations of PRZ 
in a dose-dependent manner, are subclassified as a,-ARs. In contrast, the ARs which 
are activated by either xyiazine, clonidine or medetomidine, and the induced effect can 
be blocked competitively by either idazoxan, rauwoiscine (RAU) or YOH, are designated 
as Os-ARs. 
It has been suggested that the ARs be divided into three families, the cr.-ARs, 
the O2-ARS and ;9-ARs (Bylund, 1988). The rationale for this classification is based on 
three lines for evidence (Bylund, 1988; Bylund et al., 1994). First, the difference in 
affinity of selective drugs is 3 to 4 orders of magnitude between major subtypes (e.g.. 
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o,, Oj, and y?). However the affinity ratios among subtypes of each of these major 
groups are generally only 10 to 100. Second, second-messenger signalling pathways 
are different for each of these three major types. Finally, the predicted amino acid 
sequences of the ARs are more consistent with three rather than two major types 
(Bylund, 1992). Because the classification of a-ARs in this research did not use the 
method of molecular cloning, the foregoing brief review will not focus on that part. 
Heteroqeneitv of a,-Adrenoceptors Although PRZ is a potent and highly selective a -
AR antagonist, there is 100-fold range in the ability of PRZ to antagonize different a -
AR-mediated responses (Agrawal eta!., 1984; Medgett and Langer, 1984; Flavahan 
and Vanhoutte, 1986). The wide range in PRZ affinity suggested the presence of two 
subtypes of Oi-AR with a high affinity for PRZ (/Cg < 0.4 nM) and the other one with a 
lower affinity to PRZ [K^ < 1.6 nM) (Medgett and Langer, 1984). 
Several a,-AR antagonists, such as phentolamine, WB 4101, chlorethyl-
clonidine (CEC), (-I-)-niguldipine and 5-methylurapidil were also used to distinguish a--
AR subtypes. Phentolamine and WB 4101 produced biphasic displacement of specific 
[^H]PRZ binding in rat cerebral cortex, while other orAR antagonists, 
dihydroergocryptine and indoramin exhibited monophasic displacement. This 
suggested that phentolamine and WB 4101 could distinguish between high and low 
affinity of Oi-AR binding sites in rat cerebral cortex (Morrow eta!., 1985). Further 
studies confirmed these findings and designated the cr^-ARs with subnanomolar affinity 
for WB 4101 as 0,^ and the a,-ARs with low affinity as 0,3 (Morrow and Creese, 
1986). 
Chlorethylclonidine (CEC), an irreversible alkylating derivative of clonidine, 
inactivated only approximately half of the o.-ARs in the rat cerebral cortex, but did not 
inactivate the a,-ARs in the rat hippocampus (Johnson and Minneman, 1387). 
However, all of the OrARs in both brain regions were sensitive to another alkylating 
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drug, phenoxybenzamine. This indicated that CEC could differentiate between a,-AR 
subtypes and that these subtypes had a differential distribution within different regions 
of the brain (Johnson and Minneman, 1987). Further studies showed that CEC 
inactivated nearly all of the o,-ARs in rat liver and spleen, but very few of the a,-ARs m 
the rat vas deferens (Han et a!., 1987). Those O t-ARs that were insensitive to CEC 
with high affinity sites for WB 4101, were designated as a,a subtype. In contrast, 
those receptors which were sensitive to CEC with low affinity for WB 4101, were 
designated as gtib subtype (Han et a!., 1987). 
Other a,-AR antagonists, including benoxathian, 5-methyl-urapidil, 
(+ )niguldipine and oxymetazoline also have a higher selectivity for the subtype than 
the cr,g subtype, in contrast, spiperone is a selective Oig-AR antagonist. 
A third distinct subtype of a-i-AR (a,c) was cloned from a bovine brain cDNA 
library (Schwinn eta!., 1990). The pharmacology of bovine a.c-AR resembles that of 
the Oia-AR. It possesses high affinity for PRZ. However, several ligands bind to o-c-
ARs with much higher affinities than Oi^-ARs. For instance, WB 4101 is 4-fold more 
selective for the a,c-ARs than for the ai^-ARs. Natural CATs, EPI and NE bind to the 
£7,c-AR with lower affinities relative to the a,A-AR. Bovine a^^-AR may also be 
differentiated by its sensitivity to CEC. CEC pretreatment only inactivated part of the 
a,c-AR binding sites. Therefore, it is suggested that the sensitivity of CEC to the 
bovine ct,c-AR is between a-^-ARs (insensitive) and the a,B-ARs (sensitive). 
Heterogeneity of Oi-Adrenoceptors The o^-ARs have been subclassified mainly by 
functional and radioligand binding studies, although several distinct a^-AR proteins have 
been cloned and expressed. 
initially the subclassification of aj-ARs was based on the ability of PRZ to inhibit 
the binding of I^HIPRZ or ['H]rauwolscine (I'HjRAUi lo tissue homogenates from a 
variety of isolated tissues or tumor cell lines (Bylund, 1985; Nahorski et a!., 1985; 
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Petrash and Bylund, 1986). The Oj'ARs in the neonatal lung rat kidney and the 
NG108-15 ceil (a neuroblastoma x glioma hybrid cell line) having a high affinity for PRZ 
and ARC 239 were designated as Ojb subtype (Bylund et al., 1988). In contrast, the 
Oj-ARs in human platelets or in the HT29 cell (a human colonic adenocarcinoma cell 
line) having a low affinity for PRZ and ARC 239 were designated as subtype. 
Further studies showed that this subclassification scheme was not a result of species 
differences because both subtypes were detected in human brain cortex (Petrash and 
Bylund, 1986) and rat brain cortex (Kawahara and Bylund, 1985). 
Although this subclassification is based mainly on data from radioligand binding 
studies, important functional studies on the inhibition of Oj-AR-mediated attenuation of 
cAMP production with PRZ have confirmed the existence of and a^g-subtypes in 
HT29 and NG108-15 cells, respectively (Bylund and Ray-Prenger, 1989). 
Furthermore, several ligands have been shown to have selective actions for 
these two Oj-AR subtypes. For instances, benoxathian, BRL 44408 (Young et a!., 
1989), oxymetazoline, RX 821001 (Niddam eta!., 1990), and WB 4101 are relatively 
selective for O ja-ARs. In contrast, ARC 239, chlorpromazine, imiloxan, PRZ and 
spirocatrine are relatively selective for Ojg-ARs (Michel et a!., 1990). However, EPI and 
NE do not distinguish between Oja- and ajs-ARs (Bylund et a!., 1994). 
Two additional subtypes, e.g. and 020 have been identified by the correlation 
of the affinity for a variety of a-AR antagonists to compete for [^H]RAU binding sites. 
The Ojc-AR has been found in a cell l ine derived from opossum kidney (Murphy and 
Bylund, 1988), in native opossum kidney (Blaxall et al., 1991) and in Y79 cells (a 
human retinoblastoma cell line) (Gleason and Hieble, 1992). 
The a2c-AR has similar characteristics to those of the ajs-AR (e.g. a relative high 
affinity for PRZ), but the ratio of the affinities of PRZ and YOH is intermediate between 
those of the OJA- and the O jb-ARs (Murphy and Bylund, 1988). Moreover, the principal 
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characteristics of the Ojc'AR are a very high affinity for RAU and WB 4101, and a 
higher PRZ/oxymetazoline affinity ratio (Hieble and Ruffolo, 1995). 
A fourth subtype, designated as has been found in bovine pineal gland 
(Simonneaux et a!., 1 991), rat submaxillary gland (Michel et a!., 1 989) and RINm5F 
cells (a rat pancreatic islet tumor cell line) (Remaury and Paris, 1992). This subtype 
has similar characteristics to cT ja-AR (e.g. a low affinity for PRZ, spiroxatrine and ARC 
239), but has lower affinity for idazoxan, RAU and YOH than the other subtypes. 
Several other tissues, including adipose tissues from rat, rabbit and hamster, 
and rabbit jejunal enterocytes, possess an Oj-AR having low affinity for RAU and YOH. 
It is likely that these tissues represent additional examples of the Ojo-subtype (Hieble 
and Ruffolo, 1995). 
In the study of subclassification of presynaptic Oj-ARs, the radioligand binding 
techniques may not correspond precisely to any of the Oj-AR subtypes. The reason for 
this is not certain, but it is possible that the nerve terminals of sympathetic neurons are 
unable to provide sufficient amounts of plasma membrane proteins to perform 
radioligand binding assays. Therefore, functional studies, such as presynaptic Oj-AR-
mediated inhibition of neurotransmitter release are used to subclassify presynaptic a.-
ARs (Ruffolo and Hieble, 1994). In general, the presynaptic 02-ARs are considered as 
Oja/Ojd subtype because of their low affinity to PRZ. 
Heterogeneity of ^-Adrenoceptors All three y?-AR subtypes 3"^ /ffj) have been 
identified by functional and pharmacological studies and molecular cloning, and can be 
activated by EPl and NE (Bylund et a!., 1994). EPI and NE have differential affinities 
for yff-AR subtypes. EPI and NE have equal potency at yff,-ARs. At yS'^-ARs, however, 
EPI selectivity is up to 100-fold greater than NE (Lands et at., 1 967a and 1967b). In 
contrast to p,- and P2-AR3, NE is more potent than EPI as a ^3-AR agonist to mediate 
biologic response (Bylund et a!., 1994). 
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;?i-ARs are mainly present in heart and adipose tissues to increase heart rate and 
force of contraction, and lipolysis, respectively. yS^^ARs mediate smooth muscle 
relaxations, including airways, most blood vessels and uterus (Lands eta!., 1967a). 
The avian /ff-AR of turkey erythrocyte has many similarities but also some 
significant differences, when compared to mammalian y9,-ARs (Neve eta!., 1986). This 
atypical ^ff-AR has unusually low affinity to the yff-AR antagonist propranolol. Based on 
the identification of selective agonists, such as BRL 37344, and the expression of a 
recombinant receptor, it is classified as a ySj-AR (Emorine etaL, 1989). The primary 
actions mediated by the ;?3-ARs are lipolysis in white adipose tissue, thermogenesis in 
brown adipose tissue (Arch etaL, 1984), inhibition-of glycogen synthesis in skeletal 
muscle (Challis etaL, 1988) and inhibition of contractile activity in gastrointestinal 
smooth muscle (Bond and Clark, 1988). 
Adrenoceptors, both a and appear to belong to a superfamily of membrane 
receptors that transmit information into the interior of ceils through coupling to 
guanine-nucleotide-binding, regulatory proteins (G-proteins) (Gilman, 1987; Lefkowitz 
and Caron, 1988; Birnbaumer, 1990; Summers and McMartin; 1993). However, the 
signaling mechanisms of the a- and /?-AR classes are distinct. All subtypes of /?-ARs 
are coupled by G, to link to the activation of adenylyl cyclase (AC) resulting in the 
generation of the second messenger cyclic 3',5' adenosine monophosphate (cAMP). 
Oi-ARs produce changes in cellular activity by increasing intracellular levels of free 
Ca^'". They do this by coupling with phospholipase C through G,, which initiates the 
hydrolysis of a membrane phospholipid, phosphatidylinositol bisphosphate, to produce 
two second messengers, diacylglycerol, which activates protein kinase C, and inositol 
1,4,5,-trisphosphate ( IP3) ,  which acts on a specific intracellular receptor to release 
sequestered Ca^"^ (Berridage and Irvine, 1989). The a2-Ans are coupled by pertussis-
sensitive (PTX-sensitive) G-proteins to AC or alternatively to ion channels. Thus, they 
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alter cellular activity either by reducing intracellular levels of cAMP or by directly 
modifying activity of ion channels such as the Na'^/H'^ antiport, or Ca^* channels, or K* 
channels (Bylund, 1988). 
The adrenoceptors in the myometrium and the influence of ovarian steroids It has 
been demonstrated that all four main subtypes (a., Oj, y?,, of ARs are present in 
the myometrium of various species of mammals. It has also been suggested that 
ovarian steroids, estrogen and progesterone, modify the densities of myometrial a- and 
;9-ARs in different stages of the estrous cycle and during pregnancy. Moreover, there 
are marked species differences with regard to the effect of ovarian steroids on the AR 
patterns in myometrium. 
Using radioligand binding assays of [^Hlprazosin ([^H]PRZ) and [^Hlrauwolscine 
((^H]RAU), it has been demonstrated that a, - and Oj-ARs are present in the 
myometrium of different species, including humans (Bottari et al.. 1983a and 1983b), 
rats (Maitier and Legrand, 1985; Legrand et al., 1993), guinea pigs (Arkinstall and 
Jones, 1988; Arkinstall et a!., 1989; Haynes et al., 1993), rabbits (Falkay, 1990) and 
ewes (Vass-Lopez et al., 1990b). 
Ovarian steroids, estrogens and progesterone modify the densities of myometrial 
a-ARs and the densities vary with stages in the estrous cycle and pregnancy. In 
general, the density of a,-ARs is not affected by the ovarian steroids in rabbits 
(Hoffman et aL, 1981) or ewes (Vass-Lopez et a!., 1 990b), and it does not change in 
the menstruous cycle or pregnancy in women (Bottari etai., 1983c and 1985). 
However, its density during pregnancy is 40% higher than that during an estrous cycle 
in guinea pigs (Arkinstall etal., 1989). 
The changes of myometrial Oj^ARs under the influence of ovarian steroids are 
more variable than those of cr,-ARs in the different species. In rabbits (Hoffman et al., 
1981; Jacobson et aL, 1 987; Riemer et aL, 1987) and humans (Bottari et aL, 1 983c 
and 1985) the myometrial o^-AR density increases when the circulating estrogens are 
high. However, its density decreases in ewes (Vass-Lopez et a!., 1990a and 1990b) 
and sows (Rexroad and Guthrie, 1983) in the same endocrine environment. In ewes, 
the myometrial Oj-AR concentration is high (Rexroad, 1981; Vass-Lopez et a!.. 1990a 
and 1990b) in the progesterone-treated ewe, and during pregnancy which is a high 
progesterone environment. In contrast, in humans (Bottari eta!., 1983c and 1985) and 
rabbits (Williams et a!., 1976) the a^-AR density is decreased in the same endocrine 
environment. Moreover, the density of myometrial Oj-ARs increases greatly in mid-
pregnancy, then decreases abruptly at the end of pregnancy in rats and guinea pigs 
(Kyozuka eta!., 1988; Legrand eta!., 1993), whereas the Oj'AR concentration 
increases in rabbits at term (Jacobson etal., 1987). 
Although Oz-ARs were reported to be present in the porcine myometrium, the 
studied used [^Hldihydroergocryptine, a non-selective a-AR antagonist (Rexroad and 
Guthrie, 1983). [^H]Dihydroergocryptine is unable to characterize the myometrial 02-
ARs as specifically as the selective o^-ligand, such as [^H]RAU. 
Both and /ffj-ARs have been identified in the myometrium of rats 
(Abrahamsson etal., 1988; Maltier and Legrand, 1988), guinea pigs (Abrahamsson et 
aL. 1988), sheep (Crankshaw and Ruzycky, 1984) and humans (Abrahamsson et a!.. 
1988). 
The density of yff-ARs is also influenced by the ovarian steroids. The number of 
myometrial /Sj'ARs is increased by estrogen and/or progesterone treatment in guinea 
pigs (Hatjis etal., 1988). However, in the rabbit myometrium the ^,-AR does not 
change with the same treatments (Roberts et a!., 1 977a and 1 977b). At term, the 
density of /Jj-ARs in myometrium is controversial. It has been reported that the number 
of ^Sj-AR does not change at parturition in humans (Dattel et a!., 1986), rats (Cohen-
Tannoudji et aL, 1 991), or in antiprogesterone-treated rat at term (El Alj et a!., 1 989). 
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However, during the last weeks of human pregnancy (39 to 40 weeks) (Breuiller et a/., 
1987) or in the rabbit at term (Vallieres et a!., 1 978), the density of ;S-AR decrease in 
both the longitudinal and circular layers of the myometrium. This reduction in the 
number of correlates with the disappearance of ^-AR-mediated AC response 
(Litime et al., 1989) and occurs at the time when the progesterone-estrogen ratio is the 
lowest in myometrial tissues (Ferre et a!., 1978). 
Uterine Contraction 
The contraction of smooth muscles, including myometrium can be stimulated by 
membrane depolarization (e.g. High K"" solution) or agonists (NE, oxytocin, 
prostaglandins and acetylcholine). The primary result of the stimulation is an increase 
in the intracellular Ca^"^ concentration ([Ca^"^],) from 140 nM to 500 - 700 nM (Williams 
and Fay, 1986). Ca^"^ enters the sarcoplasm from the extracellular space via voltage 
dependent Ca^"" channels (VDCCs) or receptor operated Ca^" channels. Ca^" also 
enters the sarcoplasm from the sarcoplasmic reticulum (SR) via IP3 receptors or 
ryanodine receptors (Allen and Walsh, 1994). The VDCCs are the primary source of 
activator Ca^* ions in myometrium (Kosterin et a!., 1994). 
As a sequence of the elevated [Ca^"],, Ca^"^ binds to calmodulin to form a Ca**-
calmodulin complex (Fig. 3). The Ca^"'-calmodu!in complex activates myosin light chain 
kinase (MLCK) (Barany and Barany, 1990; Higashi et a!., 1983). The active form of 
MLCK leads to phosphorylation of MLC which results in an increase in the actin-
activated myosin Mg-ATPase. This phosphorylation triggers the cycling of myosin 
crossbridges along the actin filaments. The development of force or contraction of the 
muscle can occur with hydrolysis of ATP (Marston, 1989). 
Relaxation of the muscle follows the restoration of [Ca^*], by extrusion of Ca-" 
from the cell by a sarcolemmal Ca^'^-ATPase pump (Carafoli, 1987, Strehler, 1991) or 
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31 
the Na'"-Ca^"" exchanger (Grover eta!., 1981), or pumping Ca^" into SR by Ca^*-
ATPase pump in the SR membrane (Wuytack et at, 1989). Phosphorylated MLCK 
showed a marked decrease in its affinity for Ca^'^-calmodulin, leading to a reduction in 
phosphorylation of MLC, causing uterine relaxation (Higashi et a!., 1983). Relaxation 
also occurs as a result of the dephosphorylation of MLCs by myosin light chain 
phosphatase (Haeberle et a!., 1985). 
The uterus has spontaneous contractile activity. This means that the 
myometrium generates electrical activity spontaneously in vitro and in vivo without any 
hormonal or neural influence, but hormones can alter this activity (Marshall, 1980). For 
instance, estrogens promote the spontaneous contractions. 
The basis of the myogenic mechanism is the spontaneous depolarization of 
pacemaker cells in the myometrium. However, unlike cardiac muscle, the pacemaker 
cells in the myometrium are not anatomically fixed or defined {Wray, 1993). The 
spontaneous activity is accompanied by cyclic phosphorylation and dephosphorylation 
of MLC (Janis et a!., 1980). During spontaneous force development, phosphorylation 
increases from 0.35 mol phosphate/mol light chain to 0.8 mol/mol, while during 
spontaneous relaxation the phosphate content decreases to 0.35 mol/mol (Janis et a!., 
1 981; Barany et al., 1985). 
It is generally believed that a decrease in [Ca^"'], is coupled with relaxation 
(Barany and Barany, 1990). The decrease in [Ca~*], may be accomplished by inhibiting 
Ca^" influx or by stimulating the Ca^" efflux and sequestration. The VDCC blockers, 
such as verapamil cause a decrease in smooth muscle contraction by inhibiting specific 
Ca^"^ channels. /ff-AR agonists are coupled to AC via G,-protein, to increase cAMP 
levels. The increased cytoplasmic cAMP concentration activates the cAMP-dependent 
protein kinase (protein kinase A). The increased activity of protein kinase A leads to 
phosphorylation of membrane proteins resulting in a decreased Ca** entry into and 
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increased Ca^* efflux and sequestration in myometrial cells (Do Khac, 1986; Anwer et 
a!., 1990). These events decrease intracellular and subsequently lower the 
activity of and calmodulin and MLCK. 
Natural CATs, EPI and NE activate c7-ARs to produce nnyometrial contraction, 
and stimulate ;S-AR to cause relaxations (Alquist, 1948). it is also well established that 
a relative preponderance of myometrial a- and /S-ARs can be induced by changes in 
plasma concentrations of ovarian steroids, estrogens and progesterone, such as those 
which occur during pregnancy or different stages of the estrous cycle (Marshall, 1970). 
In general, the excitatory, a-AR-mediated responses to CATs in myometrium are 
enhanced under conditions of estrogen dominance in rats (Diamond and Brody, 1966), 
rabbits (Miller and Marshall, 1965) and humans (Bottari et a!., 1985). In contrast, the 
inhibitory, yff-AR-mediated responses are more prominent under the influence of 
progesterone. 
The increased contractile activity of the estrogen-dominated uterus probably 
arises from an estrogen-induced increase in the membrane potential (changing from -35 
mV in ovariectomized rat to -50 mV) which facilitates spontaneous depolarization by 
pacemaker cells (Marshall, 1980). Estrogens also induce hypertrophy of myometrial 
cells and stimulate the synthesis of the contractile proteins actin and myosin, metabolic 
enzymes and ATP through synthesis of specific RNA and protein (McKerns, 1977). 
Moreover, the increased contractility from estrogens may also result from the 
stimulation of gap junction formation, which enhances conduction and synchrony 
between cells (Sims et aL, 1982). Therefore, the influence of estrogens on the 
myometrium includes membrane, metabolic, and structural changes which promote 
excitation and contraction. 
The mechanism by which progesterone decreases myometrial excitability is not 
completely clear (Riemer and Roberts, 1986). Progesterone produces hyperpolarization 
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in myometrium from -50 mV to about -65 mV (Marshall, 1980). The hyperpolarizing 
effect would be expected to reduce excitability and impulse conduction. Progesterone 
produces the formation of a high-affinity state /S-ARs and increases the density of 
myometrial ;?-ARs, consistent with its role in decreasing uterine activity (Wray, 1993). 
Although both (7,-ARs and Oj-ARs are present in the myometrium and the 
density of Oj-ARs is more than that of Oi-ARs in rabbits {Hoffman et a/., 1981), rats 
{Maltier and Legrand, 1 985), sheep (Rexroad, 1981; Vass-Lopez et a/., 1990a and 
1990b), humans (Bottari eta!., 1985) and pigs (Rexroad and Guthrie, 1983), it is 
generally believed that a,-ARs, but not Oj-ARs mediate increases in myometrial 
contractility (Hoffman eta!., 1981; Digges, 1982; Wray, 1993). The general 
conclusion that o,-ARs mediate an increase in myometrial contractility may be due to 
the fact that the majority of the data concerning the adrenergic influence on 
myometrial contractility has been collected from rodents (Digges, 1982). o.-AR-
mediated contraction on the myometrium is linked to phosphoinositide breakdown and 
IP3 via Gj, protein (Breuiller et a/., 1991). 
There is recent evidence that Oj-ARs can mediate myometrial contractility. 
Xylazine, an c/j-AR agonist, induces an increase in intrauterine pressure in cycling cows 
(LeBlanc et at., 1984a and 1984b; Rodriguez-Martinez et a!., 1987), dogs (Wheaton et 
a/., 1989), goats (Perez eta!., 1994) and sheep (Marnet et a!., 1987). Xylazine also 
increases electromyographic activity in the pregnant ewe (Jansen et a!., 1984). 
Intravenous perfusion of the Oj-AR antagonist, YOH suppresses the spontaneous 
uterine electromyographic activity at the end of gestation or during labor in the ewe, 
but the Oi-AR antagonist, PRZ does not modify the uterine activity (Prud'Homme et a!., 
1988). In addition, xylazine causes a dose-dependent increase in myometrial 
contractil ity in vitro in tissues from cycling pigs (Ko er a!.. 1990a) and cows (Ko et a!., 
1990b). The effect of xylazine is antagonized by YOH, but not by PRZ. These findings 
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indicate that at least in ruminants and pigs the Oj-ARs may play a role in the regulation 
of myometrial contractility. Moreover, even o-.-ARs are present in the myometrium in 
pigs (Rexroad and Guthrie, 1983) and ewes (Vass-Lopez ef a/., 1990b), its role in 
myometrial contractility in these species is still not clear. 
The mechanism that explains how the Oj-AR mediates myometrial contractility is 
not known. Oz-AR activation can produce an inhibition of AC. This 02-AR-mediated 
inhibition of AC is regulated by G proteins that act to couple a-AR activation to a 
reduction in the catalytic activity of AC. The inhibition of AC is abolished by pertussis 
toxin which inactivates G, protein via ADP-ribosylation of the o-subunit. Inhibition of 
a2-AR-mediated responses by pertussis toxin has been used as evidence for the critical 
role of an inhibition of AC (Nichols, 1991). 
G proteins participate in the regulation of Ca^"" influx in vasoconstriction 
(Nichols eta!., 1988 and 1989). Cj-AR-mediated vasoconstriction is completely 
inhibited in rats pretreated with pertussis toxin. In addition, Oj-AR-mediated 
vasoconstriction results from Ca^^ influx through activation of VDCCs in the rat 
saphenous vein (Cheung, 1985). These results may indicate that Oj-AR-mediated 
vasoconstriction, which is dependent on Ca^"^ influx via VDCC, involves a pertussis-
toxin-sensitive G protein. However, the relationship between the inhibition of AC in 
vascular smooth muscle produced by CTj-AR agonists and the Ca^"' influx is still 
unknown. 
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RATIONALE 
Natural catecholamines (CATs) epinephrine (EPI) and norepinephrine (NE) 
potentially modulate uterine contractions through adrenoceptors (ARs), in which a-
action is excitatory and y?-action is inhibitory. All four main types (a,, cr^, of 
ARs have been demonstrated in myometrium by using functional and radioligand 
binding studies in different species of animals. However, information is lacking on the 
effects of natural CATs on myometrial contractil ity in sows and the distribution of a-
ARs in porcine myometrium. 
Compared with in vivo studies, the use of isolated tissue preparations in vitro 
greatly reduces the problems related to the distribution and metabolism of agonists and 
eliminates complication, such as feedback effects. Isolated porcine longitudinal 
myometrium can be used to determine the response of specific drugs on myometrial 
contractil ity. In addition, specific agonists and antagonists can be used to classify and 
characterize the specific receptors in the myometrium. Radioligand probes can aid in 
identifying the receptor sites. With this technique, the receptors can be quantified, 
their specificity can be defined, and the kinetics of their interactions with radioligands 
can be examined. Furthermore, alterations in the density or characteristics of receptors 
in various physiological states, such as during the estrous cycle and during pregnancy 
can be directly examined. Because the density of receptors and the nature of the 
functions which translate external signals into cell responses determine the efficiency 
of the stimulus response mechanism (Kenakin, 1984), the results from radioligand 
binding assays can be used to compare and correlate the effect of specific a-ARs on 
porcine myometrial contractility. 
Previous studies from our laboratory suggested that xylazine, an £y2-An agonist, 
induced a dose-dependent increase in the amplitude of bovine and porcine myometrial 
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contractions (Ko et a/., 1990a and 1990b). These effects were blocked by yohimbine 
(YOH) and idazoxan, aj-AR antagonists, but not by prazosin (PRZ), an a,-AR 
antagonist. These results indicate that o^-ARs in bovine and porcine myometrium 
mediate uterine contractions. 
Although Oj-ARs are the dominant subtype in porcine myometrium and the 
longitudinal layer of porcine myometrium is primarily innervated by sympathetic nerves, 
the effects of natural CATs on cr-ARs in porcine myometrial contractility are not weil 
understood. Hence, in section one we examined whether natural CATs, EPI and NE, 
mediated myometrial contractions and whether the effect of EPI and NE was mediated 
by c/,- or Oj-ARs. Ca^"*" is a major signal for triggering contraction of smooth muscles, 
including myometrium (Kosterin et a!., 1994), and the increase in [Ca^*] can be due to 
an increase in Ca^^ entry through channels and/or an increase in Ca^* release 
from intracellular stores. Hence, we also studied if either or both components are 
involved in the CAT-induced contractions. 
The effect of CATs on the uterus is closely related to the concentrations of 
ovarian steroids. Generally, it is believed that estrogens promote uterine contraction 
and progesterone increases relaxations. The plasma concentrations of ovarian steroids, 
estrogens and progesterone, in sows vary in the estrous cycle (Ford and Christenson, 
1979; Thilander and Rodriguez-Martinez, 1989a) and during pregnancy (Ford et a!., 
1984; Thilander and Rodriguez-Martinez, 1989b and 1990). In section two we studied 
and compared the effect of natural CATs and the role of extracellular Ca^* on 
myometrial contractility in the different phases of the estrous cycle and during various 
stages of pregnancy. From the results of the above experiments we concluded that 
the effects of EPI and NE on myometrial contractil ity were mediated predominantly by 
i72-AR3. 
The use of [^Hlprazosin and [^H]rauwolscine has identified myometrial a,- and 
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aj-ARs, respectively, in different species of animals. Ovarian steroids may modify the 
density of myometrial o-ARs. In section three of the research, we characterized and 
quantified the o,- and ctj'ARs in porcine myometrium in the estrous cycle and during 
pregnancy. We correlated the relationship between the density of a^- and o^-ARs and 
the potency of CATs on myometrial contractility. Since Oj-ARs have four subtypes 
{a2A' 02B' O2C ^ the cells or tissues, we also attempted to characterize the 
predominant (72-AR subtype in the porcine myometrium. 
From the results of section three we concluded that the Oj'AR in porcine 
myometrium is the OjA-subtype. Therefore, in section four we tested if the o^^-AR 
antagonist, WB 4101, blocked the effect of EPI-induced increase in myometrial 
contractility. We also correlated the relationship of the affinities of three Oj-AR 
antagonists, PRZ, WB 4101 and YOH, in porcine myometrium between functional 
experiments and radioligand binding assays. 
Although orARs are also present in porcine myometrium in small amounts, the 
activity of Oi-AR on contractions is not clear. Therefore, in section five, we determined 
whether the a,-AR agonist methoxamine has any stimulatory effect on myometrial 
contractility, it is likely that methoxamine induced myometrial contractions by 
activating a,-, but not o,-ARs. 
The methodology and techniques described above provide an understanding of 
the effect of natural CATs on myometrial contractility and the distribution of specific <7-
ARs in cycling and pregnant sows. 
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Oj-ADRENOCEPTORS AND VOLTAGE-DEPENDENT CA^" CHANNELS MEDIATE 
EPINEPHRINE- AND NOREPINEPHRINE-INDUCED INCREASE IN PORCINE MYOMETRIAL 
CONTRACTILITY IN VITRO 
A paper submitted to Journal of Reproduction and Fertility. 
Chih-Huan Yang and Walter H. Hsu 
Abstract 
The adrenergic effect of epinephrine and norepinephrine on porcine myometrial 
contractility in vitro was investigated using longitudinally layered uterine strips from 
sows in the luteal phase of the estrous cycle. Epinephrine and norepinephrine alone 
(10'^ - 10"'' M) induced dose-dependent myometrial contractions and this effect was 
potentiated by pretreatment with propranolol. When uterine strips were pretreated 
with 10'® M propranolol both epinephrine (10 ® - 3 x 10"^ M) and norepinephrine (10 - -
10® M) caused a dose-dependent increase in myometrial contractility, with epinephrine 
being more potent than norepinephrine. In the presence of 10° M propranolol, higher 
doses of epinephrine (10 ® - 3 x 10'® M) and norepinephrine (3 x 10 ® - 3 x 10 " M) 
decreased the contractility progressively. This decreased contractility was reversed by 
a higher concentration of propranolol (3 x 10 ® M). The oj-adrenoceptor antagonist, 
yohimbine (3 x 10 ®, 10'^, 3 x 10'^ M), antagonized the effects of both epinephrine and 
norepinephrine in the same dose-dependent manner. In contrast, the o--adrenoceptor 
antagonist prazosin (10'^ M) did not block the epinephrine- or norepinephrine-induced 
increases in contractil ity. When uterine strips -.vera pretreated -.vith Ca^'-free Tyrcde's 
solution or 10'^ M verapamil, a voltage-dependent Ca^"^ channel blocker, the 
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epinephrine- and norepinephrine-induced myometrial contractility was greatly 
decreased. Moreover, this decreased contractility in Ca^"'-free medium was further 
inhibited by 10"^ M yohimbine, and to a less extent by 10^ M prazosin. These results 
suggest that: 1) epinephrine- and norepinephrine-induced increase in myometrial 
contractility in the luteal phase of the estrous cycle in the sow is mediated 
predominantly by oj'^drenoceptors and 2) this effect of epinephrine and norepinephrine 
is attributed primarily to an increase in Ca^"^ influx, through voltage-dependent 
channels and at least in part due to calcium release from intracellular stores. 
Introduction 
Myometrium is under adrenergic influence, since all four subtypes (a-, a-, P-J 
of adrenoreceptors (ARs) are present in the myometrium of various species of 
mammals (Bottari et al., 1985). Although yffj-ARs are predominantly responsible for 
myometrial relaxation (Bulbringn and Tomita, 1987), the o-AR subtype that mediates 
myometrial contractility remains controversial. Despite the fact that in humans (Bottari 
eta!., 1985), pigs (Rexroad and Guthrie, 1983), rabbits (Hoffman etaL, 1981), rats 
(Maltier and Legrand, 1985) and sheep (Rexroad, 1981; Vass-Lopez et a!., 1990), the 
densities of myometrial Oj-ARs are greater than a,-ARs, it is generally accepted that o.-
ARs mediate increases in myometrial contractility (Hoffman eta!., 1981; Digges, 1982; 
Wray, 1993). This conclusion may be biased because the majority of the the data 
concerning adrenergic influence on myometrial contractility has been collected from 
rodents. In rodents, a,-, but not a2-AR agonists, increase myometrial contractility 
(Maltier and Legrand, 1985; Digges, 1982; Kyozuka et a!., 1988). 
Evidence that Oj-ARs also mediate myometrial contractility is supported by 
studies with xylazine, an Oj-AR agonist. Xylazine induced an increase in intrauterine 
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pressure in cycling cows (LeBlanc ef 1984a; Rodriguez-Martinez et a!., 1987), dogs 
(Wheaton et aL, 1989), goats (Perez et aL, 1994) and sheep (Marnet et a!., 1987). 
This effect of xylazine is abolished by the aj-AR antagonist, yohimbine (YOH), but not 
by the a,-AR antagonist, prazosin (PRZ) (Rodriguez-Martinez et a!., 1987; Perez et a!.. 
1994). Xylazine also increases uterine electromyographic activity in the pregnant ewe 
(Jansen et a!., 1984). Intravenous perfusion of YOH suppresses the spontaneous 
uterine electromyographic activity at the end of gestation or during labor in the ewe, 
but PRZ does not modify uterine activity (Prud'Homme, 1988). In vitro xylazine causes 
a dose-dependent increase in myometrial contractility in both cycling cows and sows 
(Ko et aL, 1990a; Ko et aL, 1990b). This effect is antagonized by a^-AR antagonists, 
idazoxan and YOH in a dose-dependent manner, but not by PRZ (Ko et aL, 1 990a; Ko 
et aL. 1 990b). These findings suggest that 02-ARs play an important role in the 
regulation of uterine contractility. 
Oj-ARs are a dominant subtype over a,-ARs in the porcine myometrium (Rexroad 
and Guthrie, 1983), and the longitudinal myometrium is primarily innervated by 
sympathetic, but not parasympathetic nerves (Taneike et aL, 1994). The effect of 
natural catecholamines (CATs) on o,- and a2-ARs in porcine myometrial contractility is 
not well-understood. Therefore, the present study was designed to investigate the a-
adrenergic effect of the natural CATs epinephrine (EPI) and norepinephrine (NE) on 
porcine myometrial contractility in vitro in the luteal phase of the estrous cycle. We 
have used the myometrium of this phase as a model in other studies (Ko et aL. 1990b; 
Yu et aL, 1995), and the specimens are readily available at abattoirs. 
Ca^" is a major signal for triggering smooth muscle contraction. Myometrial a-
and y?-ARs may mediate an increase and a decrease in [Ca^*], respectively (Do Khac et 
aL, 1986; Nichols, 1991). In smooth muscle cells, activation of CrARs mobilizes Ca** 
from the sarcoplasmic reticulum and extracellular fluid in association with an increase 
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in the formation of 1,4,5-inositol triphosphate through activation of phosphoiipase C, 
while activation of 02-ARs increases cytosolic Ca^* concentration ([Ca^"] ) through 
opening voltage-dependent Ca^"" channels (VDCC) (Nichols, 1991). In this context, EPI 
and NE may increase [Ca^""], via mobilization of Ca^'" from both extra- and intracellular 
sources to induce myometrial contractions. Thus the experiments were also designed 
to determine whether EPI- and NE-induced myometrial contractions are mediated 
through an increase in Ca^"" release or influx. 
Materials and Methods 
Tissue preparation 
The uterine specimens were collected from a local abattoir. Only the mid-
portion of the uterine horns was used in the experiments. Specimens were determined 
to be in the luteal phase based on the presence of light red corpora lutea in the ovaries, 
and the absence of embryos (Arthur et a!., 1989). Tissues were stored in ice-cold 
Tyrode's solution (137 mM NaCI, 2 mM KCI, 1 mM CaClj, 0.4 mM MgCI^, 1 1 mM 
dextrose, and 12 mM NaHC03; pH 7.4) and transported to the laboratory. Upon 
arrival, the endometrium was removed from the uterus; the myometrium was stored in 
ice-cold Tyrode's solution aerated with 95% 02-5% CO^ and was used for experiments 
within 30 h. There were no changes in responsiveness to contractants during this 
period. 
Longitudinal uterine strips (10x2 mm') were ligated with silk threads at both 
ends and suspended vertically in a 10-ml double-jacketed glass bath containing 
Tyrode's solution at 37°C and aerated with 95% 02-5% CO,. One thread was 
attached to a fixed support while the other thread '.vas connected to a Grass FT03 
transducer (Grass Instrument Co., Quincy, MA) and myometrial contractions were 
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recorded isometrically with a 8-channel polygraph recorder (R411, Beckman 
Instruments Inc., Schiller Park, IL). The strips were equilibrated under a 2-g tension 
over 20 - 25 min before being exposed to 10 ® M carbachol (CARB) to determine their 
responsiveness to the contractant. Two three-minute exposures to CARB separated by 
a 15 min interval were performed with four 10-ml washes of Tyrode's solution used to 
remove CARB after the stimulation. The strips lost contractions within 1 5 min after 
the washout of CARB, and this quiescent state lasted > 25 min. The basal resting 
tension was readjusted to 2 g before the pretreatment drug was added. In NE 
experiments, no uptake blockers were used because neither the neuronal uptake-1 
blocker desimipramine (10 ' M) (Furchgott, 1972) nor the extraneuronal uptake-2 
blocker corticosterone acetate (10"^ M) (iversen and Salt, 1970) affects the NE effect 
on myometrial contractility (Yang and Hsu, unpublished results; n = 6 uteri). In the 
following experiments, EPI or NE was added at 10-min intervals in cumulative doses to 
attain a dose-response relationship. 
Experimental protocols 
A. EPI- and NE-induced myometrial contractility and the influence of propranolol 
(PROP). PRZ and YOH 
In experiments designed to observe the /?-AR-mediated effect from EPI or NE 
stimulation, a 10-min pretreatment with 10 ® M PROP was performed before each 
agonist was administered in cumulative doses. The control group did not receive 
PROP. The 10-min pretreatment was based on a preliminary experiment, in which /?-
AR antagonism by PROP reached a maximum in 10 min (n = 4 uteri). 
In another experiment, the Oi-AR antagonist PRZ (10 ® M) or the Oj-AR 
antagonist YOH (3 x 10'®, 10"^, or 3 x 10'^ M) was added with 10" M PROP to the 
organ bath for 10-min. The 10-min pretreatment was based on a preliminary 
experiment, in which a2-AR antagonism by YOH reached a maximum in 10 min (n = 4 
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uteri). After 10-min of pretreatment with the antagonists, EPI or NE was given in 
cumulative doses. Controls received only EPI or NE without an a-AR antagonist. 
Different strips from the same uterus were randomly assigned to all treatment 
groups in one trial, and each uterus was used for one trial only. 
B. Effect of Ca^'^-free medium and verapamil on the EPI- and NE-induced 
mvometrial contractilitv and the influence of PRZ and YOH 
Ca^^'-free Tyrode's solution was prepared by excluding CaClj. Ca'*-free groups 
were treated as follows: after the myometrial strips had been stimulated by CARB 
twice, and washed twice with 10 ml of Ca^^-free Tyrode's solution at 5-min intervals, 
another 10 ml of Ca^'^-free medium was applied with PROP to block jff-receptor-
mediated uterine relaxation. 
In a preliminary experiment, the Ca^"^ chelating agent EGTA (10 ' M) did not 
change EPI-induced myometrial contraction in a Ca^""-free medium (n = 6 uteri). Based 
on this result, EGTA was not used in the Ca^'^-free medium with the exception of one 
experiment. In this experiment, three treatments were assigned as follows: a. Ca^*-
free medium; b. 10"^ M verapamil in Ca^'^-containing medium; and c. Ca^'-containing 
medium (control group). Verapamil, a VDCC blocker, was used to block Ca^" influx. 
In addition, all groups had been pretreated with 10 ® M PROP before EPI or NE was 
adninistered. 
In a separate experiment, we determined whether the EPI (10 ° M)-induced 
myometrial contractions in Ca^^-free medium was mediated by a.- or o^-ARs by using 
10"^ M PRZ and/or 10'^ M YOH. 
Assessment of the contractile response 
The contractile response was assessed by the area under the contraction curve 
and was determined with the use of a scanning program (SigmaScan, Jandei, Corte 
Madera, CA). These values were expressed as a percentage of the response to 10 " M 
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CARB treatment for 10 min. In pilot studies many tissue strips lost contractions after a 
3-min but not a 10-min stimulation by 10® M CARB after several washouts using 
Tyrode's solution. To transform data for 3-min CARB treatment to those for 10-min 
treatment, an independent experiment was performed to obtain a regression line to fit 
the tissue strips' responses to a 10-min 10 ® M CARB stimulation. The tissue strips 
were stimulated by 10 ® M CARB twice. After the initial 3 min CARB treatment and 
subsequent 4 - 5 washes with 10 ml of Tyrode's solution each for a total of 1 5 min, 
the strips were stimulated again by 10® M CARB for 10 min. By using the 3 min and 
10 min areas that were produced by the second stimulation a regression line was 
calculated; 
Y (10 min) = 2.95 ' X (3 min) -f- 1.32, (n = 39). 
In this study, the contractile area produced by the second 3-min 10® M CARB 
stimulation was transformed to a 10-min area using the above formula and this 10 min 
area was defined as the 100% 10® M CARB contractile response for each individual 
strip. The contractile response of the tissue strip was calculated from the contractile 
area produced by agonist EPI or NE over 10 min at each cumulative dose and was 
expressed as a percentage of the response to 10 ® M CARB. 
Drugs 
The following drugs were used: carbachol chloride, (-)epinephrine bitartrate, (-) 
norepinephrine bitartrate, propranolol HCI, yohimbine HCI, EGTA (Sigma Chemical Co., 
St. Louis, MO), prazosin HCI (Pfizer Inc., Groton, CT), and verapamil HCI (Knoll 
Pharmaceutical Co., Whippany, NJ). Drugs were dissolved in distil led water, except for 
epinephrine and norepinephrine, which were dissolved in 0.1% (W/V) ascorbic acid in 
0.9% NaCI, and prazosin HCI, which was dissolved in 2% lactic acid to achieve a 
concentration of 1 mM. Drug-containing solutions were prepared by appropriate 
dilution of the stock solutions, which were stored at -20°C. 
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Data analyses 
The dose-response curves were produced by cumulative application of EPI and 
NE in approximately one-half log and one log increments in experiments A and B, 
respectively (van Rossum, 1963). The data were expressed as pDj (-log ECjc)-
Dissociation constants (/Cg) of YOH against the agonist were determined using 
the equation: = [B]/(CR - 1), where B is the concentration of the antagonist 
(Furchgott, 1972). The response to YOH (3 x 10 ® M) was used for this calculation 
because YOH at this dose caused a consistent antagonism on contractility. The 
concentration ratio (CR) is calculated as ECso'/ECsq, in which EC50 and EC50' values are 
the values for the agonist in the absence and presence of the antagonist, respectively. 
The dissociation constant of the antagonist was expressed as p/Cg (= -Log K^). In the 
y9-AR antagonism studies and experiment B, the contractile response was compared 
with the control group at the corresponding dose of the agonist. 
Data were expressed as mean ± SE and analyzed by analysis of variance 
(ANOVA). The conservative F value was used to establish significance for the 
treatment effect. The least significant difference test as used to determine the 
difference between means of end points for which the ANOVA indicated a significant 
(P < 0.05) F ratio. 
Results 
A. Effect of PROP. PRZ and YOH on EPI- and NE-induced increase in mvometrial 
contractility 
Both EPI (10'® - 3 X 10 ' M) and NE (10'^ - 10'® M) in the presence of 10 " M 
PROP produced a dose-depsndent increase in myometrial contractility (Figs. 1 and 2). 
The potency of EPI was significantly greater than that of NE (Table 1). Higher doses of 
Fig. 1. Representative tracings of the uterine contractile response for 3 x 1 0 ® M 
epinephrine (A) and 3 x 10 ® M norepinephrine (B) in the presence of 10"® M 
propranolol. Arrowheads show the administration of the agonist. 
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A. 
Epinephrine 
" 5 1 
B. 1 min 
Norepinephrine 
Fig. 2. Dose-response curves for epinephrine (EPI) and norepinephrine (NE) in the 
absence and presence of 10® M propranolol (PROP). Data are expressed as 
means ± SE (n = 6). Effects are shown in the presence of PROP (O: EPI; a: 
NE) and in the absence of PROP (•: EPI; •: NE). 
*P < 0.05, compared with that in the absence of PROP at the corresponding 
concentration of the same agonist. 
"P < 0.05, compared with EPI in the absence of PROP at the corresponding 
agonist concentration. 
% Cont rac t i le  Response 
(Carbachol lo"^ M = 100%) 
M 01 C» O K) 
0 0 0 0 0 0 0  
H * 
•H 
CH * •—I* 
Table 1. pDj values for epinephrine and norepinephrine in the control and 10 ® M 
prazosin treatment groups in the presence of 10 ® M propranolol 
Treatment Epinephrine Norepinephrine 
Control 7.81 ± 0.07' 7.38 ± 0.08 
Prazosin 7.59 ± 0.10' 7.11 ± 0.11 
"P < 0.05, comparing with norepinephrine in the same treatment. 
The data are expressed as mean ± SE (n = 6). 
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EPl (10'® - 3 X 10'® M) and NE (3 x 10 ® - 3 x 10'^ M) decreased the maximal 
contractility progressively. This decreased contractility was reversed by the addition of 
a higher concentration of PROP (3 x 10 ® M) (Fig. 3). 
In the absence of 10 ® M PROP, EPl and NE, at higher concentrations than that 
in the presence of PROP, caused progressive increases in myometrial contractility (Fig. 
2). The contractility reached maximum at 10"® M of EPl or NE. However, the 
magnitude of these responses was much smaller than that in the PROP-pretreated 
groups (Fig. 2). The effect of NE alone on myometrial contractility was greater than 
that of EPl, since NE concentrations (10 ® - 10'^ M) that initiated the contractions were 
lower than those of EPl (10'^ - 3 x 10 ® M). 
The aj-AR antagonist, YOH, blocked the effects of both EPl and NE in a dose-
dependent manner (Figs. 4A and 4B). The p/Cg values for YOH against EPl and NE were 
not significantly different from each other (Table 2). In the presence of 3 x 1 0^ M 
YOH, EPl (> 3 X 10 ® M) induced contractions with significantly smaller magnitude 
than other groups (Fig. 4A). This inhibition was reversed by 10 " M PROP (Fig. 5). 
However, this phenomenon was not observed in the NE group. Norepinephrine (NE) 
still induced myometrial contraction to attain approximately the same maximum effect 
as the control and other YOH treatment groups (Fig. 4B). 
The a,-AR antagonist, PRZ, even at a high concentration of 10 - M, failed to 
antagonize the effect of EPl or NE on myometrial contractility (Figs 6A and 6B). The 
pDj values of the PRZ group were not significantly different from those of control 
groups (Table 1). 
B. Effects of Ca^"^-free medium and verapamil on EPl- and NE-lnduced mvometrial 
contractility 
Soth EPl and NE (10 - 10 M) caused a doss'depsnderjt increase in mYomstrial 
contractility in the presence of 10 ® M PROP (Figs. 7A and 78). This effect of EPl and 
Fig. 3. Representative tracings of the uterine contractile response for epinephrine (EPI) 
in the presence of 10® M propranolol (PROP). The EPI-induced myometrial 
contractility was decreased progressively by the stimulation with high EPI 
concentrations (A, B and C), but was reversed by 3 x 10® M PROP (D). 
Cumulative doses of EPI were used. 
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EPI 3 X 10"= M 
B. 
EPI 10"^ M 
C. 
EPI 3 X 10"^ M 
4 g I 
1 mm 
PROP 3 X 10"° M 
Fig. 4. Effect of yohimbine (YOH) on epinephrine (A)- and norepinephrine (B)-induced 
increases in myometrial contractility. Ail strips had been pretreated with 10^ 
M propranolol for 10 min before the first dose of the agonist was applied. 
Data are expressed as means ± SE (n = 6). Effects are shown in the absence 
(o) and in the presence of YOH, 3x10® M, •; 10' M, a; 3 x 10" M, •. 
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Table 2. Dissociation constants (p/Cg) for yohimbine against the agonists acting on the 
CTz-adrenoceptors in porcine myometrium in the luteal phase of the estrous 
cycle. 
Agonist 
Epinephrine 
Norepinephrine 
Yohimbine 
8.42 ± 0.14 
8.26 ± 0.26 
'The data are expressed as mean ± SE (n = 6). 
The p/Cg values for yohimbine against epinephrine and norepinephrine are not 
significantly different each other (P > 0.05). 
Fig. 5. Representative tracings of the uterine contractile response for epinephrine (EPI) 
in the presence of 3 x 10'^ M yohimbine (YOH). The contractile responses 
were obtained by the cumulative doses (A - C). A higher concentration (10 ' 
M) of propranolol (PROP) further increased contractile response (D). 
Cumulative doses of EPI were used. The tissue strip had been pretreated with 
10 ® M PROP at the beginning of the experiment which was before panel A 
was obtained. Data shown are the representative of three experiments. 
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A. 
EPI 3 X 10"® M 
3. 
EPI 10"^ M 
g 
D. 
PRO? 10"^ M 
Fig. 6. Effect of prazosin (PRZ) on epinephrine (A)- and norepinephrine (B)-induced 
increase in nDyometrial contractility. Ail strips had been pretreated with 10 ' M 
PROP for 10 min before the first dose of the agonist was applied. Data are 
expressed as means ± SE (n = 6). Effects are shown in the absence (o) and 
in the presence of (•) of 10 ® M PRZ. 
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Fig. 7. Effects of Ca^^-free medium and 10"® M verapamil on epinephrine (A)- and 
norepinephine (B)-induced increase in myometrial contractility. Data are 
expressed as means ± SE (n = 6). 
'P < 0.05, compared with the control group at the corresponding agonist 
dose. 
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NE was significantly ininibited by Ca^'^-free Tyrcde's solution or 10'^ M verapamil (Figs. 
7A and 7B). 
In the free-Ca^"^ medium with 10'^ M EGTA, both 10 ' M PRZ and 10 ' M YOH 
significantly inhibited 10® M EPI-induced contractions (Fig. 8). The inhibitory effect of 
YOH was significantly greater than that of PRZ. The combination of 10 ' M PRZ and 
10 ' M YOH failed to cause greater antagonism of EPI-induced myometrial contractions 
than YOH alone. 
Discussion 
The results of the present study suggest that EPI- and NE-induced contractility 
of porcine longitudinal myometrium is mediated predominately by Oj-ARs, and 
minimally by Oi-ARs. These findings agree with those of others that the cr^-ARs 
present in the porcine myometrium in the luteal phase of the estrous cycle (Rexroad 
and Guthrie, 1983) mediate contractions. In addition, these results are consistent with 
a previous report that a xylazine-induced increase in porcine myometrial contractility is 
mediated by Oj-ARs (Ko etal., 1990a). This o^-AR function is mediated predominantly 
by Ca^"^ entry through VDCC and to a much lesser extent through Ca*" release from 
intracellular stores. In addition, results of the present study suggest that c7,-ARs also 
mediate EPI-induced Ca^"" release, but this effect is less potent than that mediated by 
CTj-ARs. 
In the present study, the magnitude of myometrial contractility induced by EPI 
and NE was lower in the absence than that in presence of yff-AR blockade. It is 
generally believed that myometrial relaxation is mediated by /ffj'ARs (Digges, 1 982; 
BGIbringn and Tomita, 1987). Unlike EPI, NE has little action on /ff^-ARs (Weinar, 
1985). Therefore, in the absence of PROP, EPI's action on myometrial contraction has 
Fig. 8. Effect of 10'^ M prazosin (PRZ) or/and 10"' M yohimbine (YOH) on 10^ M 
epinephrine-induced myometrial contraction in the Ca^"^-free medium with 10^ 
M EGTA. Data are expressed as mean ± SE (n = 6). 
'P < 0.05, compared with Ca^'^-containing medium group. 
"P < 0.05, compared with Ca^'"-free medium alone. 
"*P < 0.05, compared with Ca^^-free medium with 10'^ M PRZ treatment. 
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been reported to be less than that of NE. Since EPI is more potent than NE on the a-
ARs of most organs (Weiner, 1985), in the presence of 10® M PROP, the EPI-induced 
myometrial contractions were greater than those induced by NE. However, the CAT-
induced contractility decreased at higher concentrations (> 10® M). This decreased 
contractility was reversed by a higher dose of PROP (3 x 10 ® M) indicating that it was 
caused by yffj'AR-mediated relaxation. Overall, with regard to porcine myometrial 
contractility the a-excitatory effect dominated over the /^-inhibitory effect at higher 
concentrations of CAT (> 10 ® M). 
In the presence of PROP, the Oj-AR antagonist YOH competitively antagonized 
the EPI- and NE-induced increase in myometrial contractility in a dose-dependent 
manner. PRZ, the o,-AR antagonist, even at a high concentration of 10 ® M, failed to 
do so. Since EPI and NE act on the same qtj-ARs, the pK^ values of YOH against EPI 
and NE were not significantly different (Furchgott, 1972). These results suggest that 
02-, but not Oi-ARs, mediated the EPI- and NE-induced increase in porcine myometrial 
contractility. 
The antagonism by YOH at 3 x 10'^ M appeared to be a noncompetitive manner 
since high concentrations (> 3 x 10® M) of EPI did not overcome its inhibitory action 
(Bourne and Robert, 1995). However, the same effect did not occur in the NE-treated 
groups which was attributed to its lower potency in activating y?j-ARs. The EPl-
decreased contractility at 3 x 10' M YOH was reversed by a higher dose (10 ® M) of 
PROP indicating that the noncompetetive antagonism was attributable to ^,-AR-
mediated relaxation. 
Our results in the sow were different from those in the rat (Acritopoulou-
Fourcroy and iVIarcais-Collado, 1988) and rabbit (Hoffman et a!., 1981). In these latter 
species a.-AR antagonists abolish the myometrial contractility that is induced by EPI, 
NE or phenylephrine. Results of the present investigation, however, were consistent 
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with those reported in the cow (Ko et al., 1990b; LeBlanc et al.. 1984a; Rodreguez-
martinez eta!., 1987), sow (Ko eta!., 1990a), goat (Perez et at., 1994) and sheep 
(Marnet et al., 1987; Prud'Homme, 1988), suggesting that Oj-ARs play an important 
role in EPl- and NE-induced myometrial contractions in the sow. 
The Ca^^-free medium and VDCC blocker verapamil greatly inhibited the effect 
of EPl and NE on myometrial contractility. Hence, it is reasonable to suggest that a-r 
AR-mediated myometrial contraction is largely attributable to an increase in Ca** influx 
through VDCC and to lesser extent to an increase in release from intracellular stores. 
The Oi-AR-mediated increase in ICa^""], in smooth muscle is attributed to a release from 
intracellular stores followed by a Ca^"" influx through a capacitative mechanism 
(Nichols, 1991), suggesting that the EPl- and NE-induced increase in Ca^* release in 
porcine myometrium may be due to activation of Oi-ARs. 
In the present investigation, both PRZ and YOH blocked the contractile 
responses to a-adrenergic activation in Ca^'^-free medium, with the antagonism by YOH 
being greater than that by PRZ. These results suggest that the EPI-induced Ca^" 
release from intracellular stores is mainly due to activation of o^-ARs and to a lesser 
extent by ai-ARs present in the porcine myometrium. In blood vessels, the crj-AR-
mediated Ca^'^ release from intracellular stores evokes smooth muscle contractions 
(Daly et aL, 1990; Nielsen et a/., 1992). The mechanisms by which a.-AR mediates 
contraction of smooth muscle in Ca^"'-free medium are not clear. We found that a,-
ARs in porcine myometrium mediated Ca^"" release from intracellular stores (ZhuGe and 
Hsu, unpublished results). In addition, the Oj-AR-mediated contraction in the rabbit 
saphenous vein in Ca^'^-free medium occurs without an increase in resting [Ca^'l, 
indicating that the Oj-AR-mediated contraction may also involve an increase in the 
sensitivity of the contractile apparatus to Ca^"^ (Aburto st si., 1993). 
The ovarian steroid hormones may influence the density of a-ARs in 
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myometrium. In guinea pig (Arkinstaii and Jones, 1988), murine (Legrand et a!., 1993) 
and ovine (Vass-Lopez et a!.. 1990) myometrium, a higher density of aj-ARs is found 
when progesterone is the main circulating steroid. In contrast, the density of Oj-ARs in 
myometrium increases in a high estrogen environment in women (Bottari era/., 1985) 
and rabbits (Riemer et a!.. 1987). The density of ct,-ARs does not appear to be 
affected by ovarian steroid hormones (Germain et aL, 1994). However, the influence 
of ovarian steroid hormone on a,-AR density in the sow is unclear. Rexroad and 
Guthrie; 1983, used [^H]dihydroergocryptine (DHE), a non-selective a-AR antagonist, 
and [^HJPRZ to quantify myometrial a-ARs in cycling and early pregnant gilts. The 
results of that study suggested that the Oj-AR was the main receptor subtype because; 
1) YOH had a much greater affinity to compete for [^H]DHE binding sites than did PRZ, 
and 2) [^H]PRZ binding sites for a,-ARs were only present in small quantity. In 
addition, the density of Oj-ARs has been reported to be greater in the luteal phase than 
those at or near estrus (Rexroad and Guthrie, 1983). We have characterized and 
quantified myometrial cr,- and Oj-ARs using I^HIPRZ and l^H]rauwoiscine binding assays 
in the luteal phase of the estrous cycle of the sow. The ratio between Oj- and a--AR 
numbers was greater than 65 (Yang and Hsu, unpublished results). These findings that 
the Oj-AR was the dominant subtype supported those of the present study that a^-ARs 
are the primary mediators of EPI- and NE-induced myometrial contractions. The porcine 
myometrium in the luteal phase of the estrous cycle is exposed to low estrogens and 
high progesterone, and thus differs those of the follicular phase and the last trimester 
of the pregnancy, when exposure to estrogens is high (Thilander and Rodriguez-
Martinez, 1989a, 1989b, 1990). Therefore further study is needed to determine 
whether the number of Oj-ARs changes in porcine myometrium of the cycling or 
pregnant sow and whether these changes in aj-AR densities affect myometrial 
contractility. 
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Although the physiological function of Oj-ARs in porcine myometrium is not 
clear, the results of the present study suggest that cr^-ARs mediate an increase in 
myometrial contractility and thus may play an important role in the regulation of 
porcine myometrial contractions. Considering this characteristic, activation of these 
receptors with cTj-AR agonists may induce abortion (LeBlanc et a!., 1984b) or 
parturition {Koetal., 1989). 
In conclusion, the present work suggests that but not o.-ARs, mediate EPI-
and NE-induced increases in porcine myometrial contractility in the luteal phase of the 
estrous cycle. The results also suggest that activation of Oj-ARs increases porcine 
myometrial contractility primarily by increasing Ca^* entry through VDCC, and to a 
lesser extent by increasing Ca^"" release from intracellular stores. 
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THE C72-ADRENOCEPTOR-MEDIATED MYOMETRIAL CONTRACTILITY IN CYCLING AND 
PREGNANT SOWS 
A paper sumitted to Journal of Reproduction and Fertility. 
Abstract 
The adrenergic effect of epinephrine and norepinephrine on porcine myometrial 
contractility in vitro was studied using the longitudinal layer of uterine strips from sows 
in the estrous cycle and various stages of pregnancy. The uterine strips in the follicular 
phase presented spontaneous contraction throughout the experiments, and the 
contractions were decreased by the action of epinephrine and norepinephrine in the 
absence of propranoloL In the presence of propranolol, neither epinephrine nor 
norepinephrine increased myometrial contractility. However, epinephrine and 
norepinephrine induced dose-dependent myometrial contractions in other reproductive 
stages using the same treatment. The contraction to catecholamines were potentiated 
by pretreatment with 10 ® M propranolol. In the presence of 10 ® M propranolol, 
epinephrine and norepinephrine induced dose-dependent increases in contractility in the 
luteal phase of the estrous cycle and during pregnancy. Comparing pD^ values, the 
potency of epinephrine was greater than that of norepinephrine in all tested groups. 
The order of the potencies for epinephrine and norepinephrine was luteal phase 2: late 
pregnancy (days of gestation = 73 -79) > mid-pregnancy (days of gestation = 53 -
60) > early pregnancy (days of gestation = 39 - 40) > prepartum period (days of 
gestation = 111 - 113). These induced myometrial contractions were inhibiteri by the 
CTj-adrenoceptor antagonist yohimbine (10'® - 3 x 10'^ M) in a dose dependent manner, 
but not by prazosin (10® M). Contractions to epinephrine and norepinephrine on the 
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myometrium were greatly decreased in Ca^'^-free Tyrode's solution or by 10'^ M 
verapamil, a voltage-dependent Ca^'^ channel blocker, in all reproductive stages. The 
inhibition in the follicular phase of the estrous cycle and in the prepartum period was 
greater than in other tested reproductive stages. These results suggest that 
epinephrine and norepinephrine-induced increase in myometrial contractility in the 
cycling and pregnant sows is mediated predominantly by oj-adrenoceptors and that this 
effect of epinephrine and norepinephrine is attributed primarily to an increase in Ca^* 
influx, through voltage-dependent Ca^"^ channels. The present findings also 
demonstrated that the epinephrine- and norepinephrine-induced myometrial 
contractions were less in the follicular phase and the prepartum period, a period 
characterized by high estrogen exposure, than those in the luteal phase and other 
stages of pregnancy, a period characterized by high progesterone exposure. 
Introduction 
It has been well documented that activation of a- and ^ff^'adrenoceptors (ARs) 
causes myometrial contraction and relaxation, respectively (Ahlquist, 1962; Bulbringn 
and Tomita, 1987). Although both o,- and orj'ARs are present in the myometrium, their 
effect on contractility shows marked species differences. OrARs mediate myometrial 
contraction in humans (Bottari eta/., 1985) and rodents (Hoffman et al., 1981; Digges, 
1982; Maltier and Legrand, 1985; Kyozuka et al., 1988), despite a greater density of 
Oj-ARs than a,-ARs in these species. Oj-ARs mediate myometrial contractions in sows 
(Ko et a/., 1 990a; Yang and Hsu, 1995) and gtj-AR agonists such as xylazine also 
induce myometrial contractility in dogs (Wheaton eta/., 1989), goats (Perez et al., 
1994), sheep (Jansen at al., 1984) and cows (LeBlanc et al., 1984; Ko et al., 1990b). 
The contractile response of the uterus is modified by ovarian steroids, estrogens 
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and progesterone. It is generally believed that estrogens promote myometrial 
contractions whereas progesterone promotes relaxation (Miller and Marshall, 1965). 
Estrogen treatment in rabbits can increase myometrial contractility by increasing a.-
adrenergic sensitivity without altering receptor density (Riemer et a/.. 1987). However, 
this increased sensitivity is thought to be the result of an estrogen-mediated increase in 
the postreceptor effects of prostaglandins (Hurd et a!., 1991). Estrogen treatment also 
causes a dramatic increase in the number of Oj-ARs in the rabbit myometrium but this 
increase does not influence myometrial contractions (Riemer et a!., 1987). The plasma 
concentrations of estrogens and progesterone change during the estrous cycle and 
pregnancy in the sow (Ford and Christenson, 1979; Ford et a!., 1984; Thilander and 
Rodriguez-Martinez, 1989a, 1989b and 1990). However, it is not clear whether the 
changes in the endogenous steroid concentrations influence AR-mediated myometrial 
contractility. 
In the luteal phase of the estrous cycle, a phase in which progesterone is the 
dominant sex steroid, the Oj'Subtype is the major AR influencing myometrial 
contractility (Yang and Hsu, 1995). However, the role of ct-ARs on myometrial 
contractility in the follicular phase of the estrous cycle and during pregnancy is not 
well-understood. Therefore, the present study was undertaken to investigate the 
adrenergic effect of natural catecholamines on myometrial contractility and to 
determine which of the a-AR subtypes mediate myometrial contractility changes in the 
estrous cycle and during pregnancy. In addition, the study was also designed to 
investigate the role of extracellular Ca^"^ on the myometrial contractility in cycling and 
pregnant sows. 
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Materials and Methods 
Tissue preparation 
Porcine uterine specimens were collected from a local abattoir and a surgical 
laboratory. Specimens from the follicular phase and luteal phase of the estrous cycle 
and various stages of pregnancy were used. The crown-rump measurement of the 
fetus was used to estimate the days of the gestation and specimens were classified as 
early pregnancy (EPG; days of gestation = 39 - 40), mid-pregnancy (MPG; days of 
gestation = 53 - 60) and late pregnancy (LPG; days of gestation = 73 - 79) (Evans 
and Sack, 1973). Prepartum specimens were obtained from sows undergoing a C-
section at 111th - 11 3th day of the pregnancy according to the known breeding 
record. The uteri were visually inspected and classified as follicular phase if ovaries 
had follicles > 6 mm in diameter and no corpora lutea. Luteal phase was identified by 
ovaries with light red corpora lutea and the absence of embryos (Arthur et a!., 1989). 
Only the mid-portion of the uterine horns was used in the experiments. The tissues 
were stored in ice-cold Tyrode's solution and transported to the laboratory. Upon 
arrival, the endometrium and placenta were removed form the uterus; the myometrium 
was stored in ice-cold Tyrode's solution (137 mM NaCI, 2 mM KCI, 1 mM CaCU, 0.4 
mM MgCl2, 11 mM dextrose, and 12 mM NaHCHOj; pH 7.4) aerated with 95% 0;-5% 
CO2 and was used for experiments within 30 h. There were no changes in 
responsiveness to contractants during this period. 
The methods for studying porcine myometrial contractility were as previously 
described (Yang and Hsu, 1995). Longitudinal uterine strips (10x2 mm*) were 
suspended vertically in a 10-ml organ bath containing Tyrode's solution maintained at 
37°C and aerated with 95% 0^-5% CO2- Th6 contrsctioDS wsrs rscordsd isomstricslly 
on a multiple-channel recorder (R411, Beckman Instruments Inc., Schiller Park, IL) by a 
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transducer (Grass FT03, Grass Instrument Co., Quincy, MA). The strips were 
equilibrated under a 2-g tension for 20-25 min before being exposed to two 10 "^ M 
carbachol (CARB) treatments for 3 min each to determine their responsiveness to the 
contractant. Four washes with 10 ml of Tyrode's solution each were used to remove 
CARB after each 3-min stimulations. The interval between the two CARB stimulations 
was 15 min. With the exception of the follicular phase specimens, uterine strips lost 
contractions within 1 5 min after the washout of CARB. This quiescent state usually 
lasted > 25 min in the luteal phase specimens and > 45 min in the pregnancy 
specimens. The basal resting tension was readjusted to 2 g before the administration 
of the pretreatment drug. In the following experiments, epinephrine (EPI) or 
norepinephrine (NE) was added at a 10-min interval in cumulative doses to attain a 
dose-response relationship. 
Experimental protocols 
A. Effect of CARB on myometrial contractions during the estrous cvcle and pregnancy 
In pilot studies we noticed that many tissue strips lost contractions after a 3-
min but not a 10-min stimulation by 10° M CARB and subsequent Tyrode's solution 
washouts. The contractile pattern and response to 10 ® M CARB as characterized by 
the area under the contraction curve (AUCC) varied and was dependent on the phase 
repreductive stage. In addition, the AUCC which was induced by the stimultion with 
EPI or NE was measured for 10 min because it reached maximal response in 10 min. 
Therefore, an independent experiment was performed to obtain a regression line for 
each reproductive stage to fit the tissue responses to a 10-min 10'^ M CARB 
stimulation from the responses to a 3-min CARB stimulation. The tissue strips were 
stimulated by 10 ® M CARB twice. After the initial 3 min CARB treatment and 
subsequent 4 - 5 washes with 10 ml of Tyrode's solution each for a total of 1 5 .^nin. 
The strips were stimulated again by 10 ® M CARB for 10 min. By using the 3 min and 
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10 min areas that were produced by the second stimulation a regression line for each 
stage was calculated: 
Follicular phase (F) Y (10 min) = 2.70 • (3 min) -1- 1.10 (n = 25) 
Luteal phase (L) Y (1 0 min) = 2.95 * (3 min) 1.32 (n = 39) 
Early pregnancy (EPG) Y (10 min) = 3.42 * (3 min) -f- 1.08 (n = 30) 
Mid-pregnancy (MPG) Y (10 min) = 3.01 • (3 min) -t- 4.02 (n = 30) 
Late pregnancy (LPG) Y (10 min) = 3.42 * (3 min) + 0.84 (n = 30) 
Prepartum period (PPT) Y (1 0 min) = 2.26 * (3 min) -t- 5.65 (n = 11) 
Because the contractile responses to CARB among the different reproductive 
stages were different, the transformed 10-min AUCC to 10 ® M CARB stimulation in 
each stage was also different. Therefore, it was necessary to study the effect of 10-
M CARB on myometrial contractility in different phases of the estrous cycle and 
various stages of pregnancy. 
The mycmetial strips of different reproductive stages used in the following 
experiments B, C and D, and other related studies in our laboratory were used. The 
10-min AUCC to 10 ® M CARB stimulation for each strip was transformed from data 
obtained in the second 3-min 10 ® M CARB stimulation using the above formula. The 
transformed 10-min AUCCs of different reproductive stages were compared with each 
other. 
B. EPI- and NE-induced myometrial contractility in the follicular phase of the estrous 
cycle and the influence of propranolol (PROP! 
The myometrial strips in the follicular phase did not lose contractions after the 
strips were subjected to CARB stimulation and subsequent washouts with Tyrode's 
solution. Therefore, PROP was given until the spontaneous contractile activity had 
stabilized which usually took approximately 50 min. 
To observe the a- and yff-AR-mediated effect from EPI or NE stimulation, a 10-
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min pretreatment with 10® M PROP was applied before each agonist was administered 
in cumulative doses (3 x 10'® - 3 x 10'® M). The control group did not receive PROP. 
To observe the time effect on the myometrial contractions throughout the experiment, 
time control groups were also studied. These groups were treated in the same manner 
as the other groups except that no agonist was applied. 
C. EPI- and NE-induced mvometrial contractility in the luteal phase of the estrous cvcle 
and oreonancv and the influence of PROP, PRZ and YOH 
To exclude the )?-AR-mediated effect from EPI or NE stimulation, the p-AR 
antagonist 10 ® M PROP was added for 10 min before each agonist was administered in 
cumulative doses (3 x 10 ® - 3 x 10'® M) at 10 min intervals. The control group did not 
receive PROP. 
To characterize the o-AR-mediated contractions from EPI and NE stimulation, 
the CT,-AR antagonist PRZ (10® M) or the a^-AR antagonist YOH (10 ®, 3 x 10 ®, 10" or 
3 x 10"^ M) was added with 10 ® M PROP. The control group did not receive the 
antagonist. 
A 10-min pretreatment period for the antagonists was chosen because in the 
preliminary experiment (n = 4 animals) antagonism of ARs reached a maximum in 10 
min. Different strips from the same uterus were randomly assigned to all treatment 
groups in one trial, and each uterus was used for one trial only. 
D. Effect of Ca^"^-free medium and verapamil on EPI- and NE-induced mvometrial 
contractility 
Protocols for treatment with Ca^"^-free Tyrode's solution and Ca^'-free groups 
were performed as previously described (Yang and Hsu, 1995). 
The uterine strips were assigned to three treatments as follows: a. Ca""-free 
medium; b. verapamil (10'^ M) in Ca^^-containing medium; and c. Ca^^-containing 
medium (control group). Verapamil, a voltage-dependent Ca^* channel (VDCC) blocker. 
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was used to block influx. All groups were pretreated with lO'^ M PROP for 10 
min before EPI or NE was given. The uterine strips in the follicular phase lost their 
spontaneous contractions :< 30 min following treatment with Ca^*-free medium or 
verapamil. Propranolol (PROP) was given only after the disappearance of spontaneous 
contractions had occurred. 
Assessment of the contractile response 
Protocal for the determination of the contractile response was as previously 
described (Yang and Hsu., 1995). Briefly, the contractile response was assessed by 
the AUCC and was determined with the use of a scanning program (SigmaScan, 
Jandel, Corte Madrera, CA). The contractile response of the tissue strip was 
calculated from the AUCC produced by EPI or NE over 10 min at each cumulative dose 
and was expressed as a percentage of the response to 10 ® M CARB. 
Drugs 
The following drugs were used; carbachol chloride, {-)epinephrine bitartrate, (-) 
norepinephrine bitartrate, propranolol HCI and yohimbine HCI (Sigma Chemical Co., St. 
Louis, MO); prazosin HCI (Pfizer Inc., Groton, CT); verapamil HCI (Knoll Pharmaceutical 
Co., Whippany, NJ). Drugs were dissolved in distilled water, except for epinephrine 
and norepinephrine, which were dissolved in 0.1% (WA/) ascorbic acid in 0.9% NaCI, 
and prazosin HCI, which was dissolved in 2% lactic acid to achieve a concentration of 
1 mM. Drug-containing solutions were prepared before use by appropriate dilution of 
stock solutions and were stored at -20°C. 
Data analyses 
The purpose of the present study was to observe the changes in myometrial 
contractility in stages of the estrous cycle and pregnancy in response to EPI and NE. 
Hence, the data obtained from luteal phase specimens in the previous study (Yang and 
Hsu, 1995) were involved in this study for comparison. 
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Dose-response curves were produced by cumulative applications (van Rossum, 
1963) of EPI and NE in approximately one-half log increment in experiments B and C, 
and one log increment in experiment D. The data from experiment C were expressed 
as pDz (-log EC50). 
Dissociation constants (/Cg) of YOH against the agonist were determined using 
the equation: = [B]/(CR - 1), where B is the concentration of the antagonist 
(Furchgott, 1972). The response to YOH (3 x 10 ® M) was used to calculate 
because YOH at this dose caused an obvious and consistent antagonism on 
contractility. The concentration ratio (CR) is defined as ECso'/ECco, in which EC;; and 
ECso' values are the values for the agonist in the absence and presence of the 
antagonist, respectively. The dissociation constant of the antagonist was expressed as 
P/Cb (= -log K^). 
In experiment B, the contractile response of each treatment group in the 
follicular phase was compared at the corresponding dose of the agonist. In experiment 
D, the contractile response was compared with the control group at the corresponding 
dose of the agonist in the same phase. In addition, the contractile response at 10 " M 
of the agonist was compared among the different phases because this dose caused 
maximal myometrial contractility (Yang and Hsu, 1995). 
Data were expressed as mean ± SE and were analyzed by analysis of variance 
(AIMOVA). The conservative F value was used to establish significance for the 
treatment effect. The least significant difference test was used to determine the 
difference between means of end points for which the ANOVA indicated a significant 
(P < 0.05) F ratio. 
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Results 
A. Effect of CARB on mvometrial contractions during the estrous cycle and pregnancy 
The contractile responses of myometria! strips obtained during the estrous cycle 
and pregnancy to the 10-min CARB (10 ® M) stimulation were different. Their 10-min 
transformed AUCCs were significantly different (P < 0.05) among all groups except 
between luteal phase and late pregnancy (Table 1). The order of the transformed areas 
produced by the stimulation of 10 ® M CARB was EPG > MPG > L > LPG > PPT > F. 
B. EPI- and NE-induced myometrial contractility in the follicular phase of the estrous 
cycle and the influence of PROP 
The uterine strips showed spontaneous contractions in the time control groups 
in both absence and presence of 10® M PROP throughout the experiment (Figs. 1A and 
I B ) .  
In the absence of PROP, EPI (> 3 x 10 ® M) and NE (> 3 x 10 ' M) each 
progressively decreased myometrial contractility. The contractility was significantly 
different from those in PROP-pretreated groups (EPI, > 3 x 10® M; NE, > 3 x 10'^ M) 
and time control groups at the corresponding agonist concentrations (EPI, >3x10^ 
M; NE, > 3 X 10 ® M) (P < 0.05). In the presence of PROP, EPI and NE did not 
increase myometrial contractions when compared with the time controls. 
C. EPI- and NE-induced mvometrial contractility in the luteal phase and during 
pregnancy and the influence of PROP, PRZ and YOH 
Both EPI and NE in the presence of 10" M PROP produced dose-dependent 
increases in myometrial contractility in all 5 reproductive stages studied (Figs. 2A and 
3A). Higher doses of EPI and NE decreased the contractility progressively. The pD, of 
EPI was significantly greater than that of NE in the same stage (P < 0.05; Table 2). 
The rank order of the potencies (pDj) of EPI and NE in different stages was L > LPG > 
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Table 1. Effect of 10 ® M carbachol on the myometrial contractions in the estrous 
cycle and various stages of pregnancy 
Stage n' Mean ± SE° = 
Follicular phase (F) 68 14.55 ± 0.64 
Luteal phase (L) 250 18.20 ± 0.24 
Early pregnancy (EPG) 196 21.39 ± 0.43 
Mid-pregnancy (MPG) 204 19.40 ± 0.30 
Late pregnancy (LPG) 162 17.50 ± 0.39 
Prepartum (PPT) 145 16.05 ± 0.28 
°n is the number of animals. 
The data are expressed as areas in cm^. Data were transformed from areas of the 
second 3-min 10 ® M CARB stimulation to 10-min contractile areas using the formulas 
described in Materials and Methods. 
There are significantly (P < 0.05) different among ail groups except for L vs. LPG, 
which was not significantly different. 
Fig. 1. Effect of epinephrine (EPI) and norepinephrine (B) in the presence (o) and 
absence {•) of propranolol (PROP) in the follicular phase of the estrous cycle. 
The time control groups did not receive agonist in the presence (a) and 
absence (•) of PROP. Data are expressed as means ± SE (n = 5). The data 
of baseline contractile activity were obtained at 10 min before the agonist was 
given. 
'P < 0.05, comparing with that in the presence of PROP (o) at the 
corresponding agonist concentration. 
"P < 0.05, comparing v 'th that in the time control in the absence of PROP 
(•) at the corresponding agonist concentration. 
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Fig. 2. Dose-response curves for epinephrine in the luteal phase of the estrous cycle 
and the pregnancy in the presence (A) and absence (B) of propranolol (PROP) 
Uterine strips were obtained from sows in the luteal phase (o) of estrous 
cycle, and in early pregnancy (•), mid-pregnancy (A), late pregnancy (•) and 
prepartum period (•). Data are expressed as mean ± SE (n = 6). 
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Fig. 3. Dose-response curves for norepinephrine in the luteal phase of the estrous 
cycle and the pregnancy in the presence (A) and absence (B) of propranolol 
( P R O P ) .  U t e r i n e  s t r i p s  w e r e  o b t a i n e d  f r o m  s o w s  i n  t h e  l u t e a l  p h a s e  { o )  o f  
estrous cycle, and in early pregnancy (•), mid-pregnancy (a), late pregnancy 
(•) and prepartum period (•). Data are expressed as mean ± SE (n = 6). 
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Table 2. pDj values for epinephrine and norepinephrine in the presence of 10 ° M 
propranolol in the control and prazosin (10'° M)-treated groups in the luteal 
phase of estrous cycle and pregnancy 
Agonist 
Treatment Stage 
Epinephrine Norepinephrine 
Control 
L 7.81 0.07*'^ 7.38 
00 q
 
6
 
EPG 7.49 ± 0.15*'^ 6.95 4 - 0.06^ 
MPG 7.63 ± 0.04*-^ 7.06 ± 0.03 
LFG 7.72 0.13*-^ 7.34 0.13 
PPT 6.80 0.10' 6.33 ± 0.16 
Prazosin 
L 7.59 ± 0.10" 7.11 -r- 0.1 1 
EPG 7.16 
— 
0.11* 6.59 -u 0.14 
MPG 7.39 ± 0.08* 6.99 ± 0.20 
LPG 7.60 ± 0.15' IM -u 0.19 
PPT 6.70 0.12* 5.86 ± 0.20 
The data are expressed as mean ± SE (n = 6). 
'P < 0.05, compared with norepinephrine in the same stage treatment. 
"P < 0.05, compared with prepartum period (PPT) in the same agonist. 
^P < 0.05, compared with mid-pregnancy (MPG) in the same agonist. 
-P < 0.05, compared with early pregnancy (EPG) in the same agonist. 
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MPG > EPG > PPT (Table 2). 
In the absence of 10 ® M PROP, EPI and NE at concentrations of > 10^ M 
caused progressive increases in myometrial contractility (Figs. 2B and 3B). The 
prepartum specimens exhibited the smallest increase in contractility among the groups. 
The a^-AR antagonist, YOH, blocked the effects of both EPI and NE in a dose-
dependent manner in all 5 stages studied. The p/Cg values for YOH against EPI and NE 
were not significantly different among the five reproductive stages (Table 3). 
The ai-AR antagonist, PRZ, even at a high concentration of 10 ® M failed to 
antagonize the effect of EPI or NE on myometrial contractility. The pD; values from EPI 
or NE stimulation in the PRZ groups were not significantly different from those in 
control groups in all 5 stages (Table 2). 
D. Effect of Ca^"^-free medium and verapamil on the EPI- and NE-induced myometrial 
contractility 
Both EPI and NE (< 10"^ M) caused a dose-dependent increase in myometrial 
contractility in the presence of 10® M PROP (Figs. 4A and 5A). This effect of EPI and 
NE was greatly decreased by 10® M verapamil (Figs. 4B and 5B) or in the Ca^*-free 
Tyrode's solution (Figs. 4C and 5C). In the Ca^'^-free medium or with verapamil 
pretreatment the uterine strips from the follicular phase and prepartum period had a 
smaller contractile response to EPI and NE (10 ® M) than those from the luteal phase 
and other stages of pregnancy (P < 0.05). 
Discussion 
The results of the present study demonstrate that EPI- and NE-induced 
contractions of porcine longitudinal myometrium are mediated predominately by a-^-
ARs, and minimally by o,-ARs both in the luteal phase of the estrous cycle and during 
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Table 3. Dissociation constants Ip/Cg) for yohimbine against the agonists acting on the 
cr2-adrenoceptors in the estrous cycle and pregnancy 
Agonist Stage 
Yohimbine 
Epinephrine 
L 6 8.42 ± 0.14 
EPG 6 8.04 ±0.12 
MPG 6 8.1 1 ± 0.07 
LPG 6 7.90 ± 0.08 
PPT 5 8.09 ± 0.22 
Norepinephrine 
L 6 8.26 ± 0.26 
EPG 6 7.95 ± 0.07 
MPG 6 8.26 ± 0.10 
LPG 6 8.16 ± 0.12 
PPT 5 7.85 ± 0.09 
''n is the number of animals. 
'^The p/^g values for yohimbine against epinephrine and norepinephrine are not 
significantly different among the reproductive stages. 
Fig. 4. Effect of verapamil and Ca^"'-free medium on epinephrine (EPI)-induced 
increase in myometrial contractility. Effects are shown in Ca^^-containing 
medium (control group) (A), 10'^ M verapamil (B) and Ca^^'-free medium (C). 
Uteri w. e obtained from sows in the follicular phase (F) and the luteal phase 
(L) of the estrous cycle, and in early pregnancy (EPG), mid-pregnancy (MPG), 
late pregnancy (LPG) and prepartum period (PPT). Uterine strips had been 
pretreated with 10®M PROP. Data are expressed as mean ± SE (n = 6), and 
those for the statistics was at 10® M EPI were compared. 
T < 0.05, compared with LPG group. 
''P < 0.05, compared with L group. 
°P < 0.05, compared with LPG group. 
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Fig. 5. Effect of verapamil and Ca^^-free medium on norepinephrine (NE)-induced 
increase in myometrial contractility. Effects are shown in Ca^*-containing 
medium (control group) (A), 10"® M verapamil (B) and Ca^^-free medium (C). 
Uteri were obtained from sows in the follicular phase (F) and the luteal phase 
(L) of the estrous cycle, and in early pregnancy (EPG), mid-pregnancy (MPG), 
late pregnancy (LPG) and prepartum period (PPT). Uterine strips had been 
pretreated with 10® M PROP. Data are expressed as mean ± SE (n = 6), and 
those for the statistics was at 10® M NE were compared. 
"P < 0.05, compared with EPG group. 
"P < 0.05, compared with LPG group. 
'P < 0.05, compared with L group. 
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pregnancy. These findings are consistent with those of the previous report that 
xyiazine-induced increase in porcine myometrial contractility is mediated by Oj-ARs (Ko 
eta!., 1990a). In addition, this CTj-AR mediated contractility is primarily dependent on 
Ca^"^ influx through VDCC which is consistent with what has been reported for other 
smooth muscles (Wray, 1993). 
In the presence of PROP, EPI and NE induced an increase in myometrial 
contractility in a dose-dependent manner in all reproductive stages except the follicular 
phase. In response to higher doses of both EPI and NE, myometrial contractility 
decreases because more ;92-ARs have been activated by EPI and NE (Yang and Hsu, 
1995). The responses to EPI or NE on contractility were different among reproductive 
stages. In general, the responses to EPI and NE during all stages of the pregnancy 
were less than or equal to that in the luteal phase. Moreover, the least potency was 
observed in the prepartum period when compared with other pregnancy stages. 
In the absence of PROP, the inhibitory effect of EPI (> 3x10 ® M) and NE {> 3 
X 10"' M), on myometrial contractions in the follicular phase was attributed to the 
activation of myometrial ^Sj^ARs by EPI or NE (Yang and Hsu, 1995). In the presence 
of PROP, EPI and NE did not cause a significnat dose-dependent increase in myometrial 
contractility in the follicular phase, in which the tissue strips were exposed to high 
estrogens and presented spontaneous contractions throughout the experiment. 
The effect of estrogens on myometrial contractility is still controversial. In rat 
myometrium, estrogens exert an inhibitory effect on spontaneous contraction (Batra 
and Bengtsson, 1978), and on contractions that are evoked by the electrical 
stimulation (Osa and Ogasawara, 1984) or KCI-depolarization (Batra and Bengtsson, 
1978). In addition, both estradiol and diethylstilbestrol inhibit myometrial Ca'* channel 
activity in the cells isolated from pregnant rats (Yamamoto, 1995) and Ca''' influx is 
decreased by diethylstilbestrol in the rat myometrium (Batra and Bengtsson, 1978). 
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However, Ca^"" influx in myometrial strips and myometria! Ca^^ channel density 
increase in estrogen-dominated rats (Batra, 1987). Furthermore, Ca^"' influx through 
VDCC does not significantly change between estrogen- and estrogen followed by 
progesterone-dominated murine myometrium (Ruzycky et aL, 1987). The density of a-,-
ARs in porcine myometrium in the follicular phase, in which the circulating estrogens 
are high, is less than that in the luteal phase in which the circulating progesterone is 
high (Yang and Hsu, unpublished). The lack of myometrial contractile response to 
catecholamines in the follicular phase may be due, at least in part, to the relative low 
concentration of Oj'ARs in the follicular phase when compared with the luteal phase 
(Yang and Hsu, unpublished). 
CARB. a cholinergic agonist, mediates muscarinic Mj and M3 receptors via G 
and Gq protein signal transduction pathways, respectively, to cause myometrial 
contractions in guinea pigs (Eglen eta!., 1989; Leiber e? a/., 1990). In the present 
study, the contractile responses to CARB in the myometrium of the estrous cycle and 
during pregnancy were variable. Generally, the myometrium which was exposed to a 
high progesterone environment such as those in the luteal phase and during pregnancy, 
except at peripartum period, had a higher response to CARB stimulation when 
compared with those in the follicular phase and in the prepartum period when the 
tissues were exposed to the high estrogen environment. It is unclear why CARB 
produces variable contractile activity at different stages of the reproductive cycle. 
However, maximal contractile activity in progesterone-dominated myometrium is 
greater than that in estrogen-dominated myometrium in the guinea pig (Ruzycky and 
Crankshaw, 1988). This contractile difference is positively correlated with the density 
of muscarinic receptors in the myometrium. It is not clear if the different myometrial 
contractile responses to CARB stimulation in reproductive stages in the present study 
can be attributed to the density of muscarinic receptors. In addition, CARB-mediated 
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[^H]inositol phosphate accumulation and myometrial contractions in progesterone-
dominated myometrium is greater than that in the estradiol-dominated myometrium in 
rats (Ruzycky and Triggle, 1987). It may be necessary to delineate the relationship 
between myometrial contractility and the stimulation of inositol phospholipid turnover 
by CARB in the porcine myometrium. 
Nevertheless, the variable contractile responses to CARB in different 
reproductive stages does not influence the interpretation of the EPl- and NE-induced 
myometrial contractilities as each stage of the tissues had its own, independent 
transformation equation to derive the contractile response. Furthermore, in the present 
study, CARB-evoked myometrial contractile response was different from the EPl- or NE-
evoked response through Oj'ARs. 
Although the physiological role of Oj-ARs in porcine myometrium during 
pregnancy is not clear, Oj-ARs are known to mediate an increase in myometrial 
contractility. One of the major functions of the uterus during pregnancy is to provide a 
quiescent state to allow for fetal growth and development until parturition. The 
induced myometrial contractility may be influenced by other factors. For example, 
during pregnancy, the high circulating progesterone and the presence of myometrial p-
ARs promote uterine relaxations (Wray, 1993). We have confirmed that porcine 
myometrial /?-ARs reach a maximum mid-pregnancy (days of gestation = 56 - 60), at 
the same time that the circulating estrogens are low and progesterone concentrations 
are high (Thilander and Rodriguez-Martinez, 1989b). The maximum binding density 
(B,„„) of ;ff-ARs in porcine longitudinal layer in this stage is 359 ± 42 fmol/mg protein. 
Then the 6^3^ of yff-AR decreases progressively to 171 ± 19 fmol/mg protein in the 
prepartum period (Yang and Hsu, unpublished data), when the circulating estrogens are 
high (Ford eta!., 1984; Thilander and Rodriguez-Martinez, 1990). Furthermore, 
estrogens reduce myometrial /S-AR-mediated cAMP production leading to a decrease in 
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the myometrial relaxation in the rabbit (Riemer et at., 1988). These findings suggest 
that /ff-ARs during pregnancy are influenced by the ovarian steroids and increasing or 
decreasing /ff-AR-mediated relaxations may affect Oj-AR-mediated porcine myometrial 
contractility during pregnancy. 
In addition, the plasma estrogen concentrations increase prior to parturition in 
many species, including sows (Ford et at., 1984; Thilander and Rodriguez-Martinez, 
1990). The high estrogen levels stimulate the formation of gap junctions in 
myometrium, enhance uterine contractility through stimulation of prostaglandin 
production, and increase myometrial oxytocin receptors to facilitate labor (Garfield, 
1994). Therefore, the activity of myometrial aj'ARs may interact with other 
hormones, such as prostaglandin Fj, to cause myometrial contractions (Ko et a!., 1989) 
although the lower density of CTj'ARs in the prepartum period (Yang and Hsu, 
unpublished data) may be related to the decreased EPI- and NE-induced myometrial 
contractility. 
The results of the present study confirmed and extended our previous findings 
that a Ca^'^-free medium and a VDCC blocker, verapamil, greatly reduced the effect of 
EPI and NE on porcine myometrial contractility during the estrous cycle and pregnancy. 
These results suggested that the Oj-AR-mediated myometrial contractility 
predominantly depends on the Ca^"" influx via VDCC and at least in part, due to calcium 
release from intracellular stores (Yang and Hsu, 1995). The contractile responses to 
10 ® M of EPI and NE in the Ca^"^-free medium were different among the different 
reproductive stages which were consistent with contractile responses in the Ca'*-
containing medium. In general, the response was less in the tissues in the follicular 
phase and prepartum period which were exposed to the high estrogen environment 
than those in the luteal phase and other stages of pregnancy which were exposed to 
the high progesterone environment. 
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The density of cr^-ARs in the follicular phase is less than that in the luteal phase 
in the pig (Rexroad and Guthrie, 1983; Yang and Hsu, unpublished), and the density of 
a2-ARs decreases during preparturient period in guinea pigs (Arkinstall and Jones, 
1988) and rats (Legrand etal., 1993). In addition, as the pregnancy progresses in the 
sow, the thickness of the longitudinal layer decreases progressively (Thilander and 
Rodriguez-Martinez, 1989b). Therefore, it is also possible that the decreased density 
of Oj-ARs in the myometrium and the decreased thickness of myometrial strips reduces 
the contractile response in the Ca^'^-free medium. Future studies are needed to 
quantify the density of porcine myometrial Oj-ARs during the estrous cycle and 
pregnancy and to correlate the number of Oj-ARs with the myometrial contractility. 
Ovarian hormones influence the activity of the VDCC in rat myometrial cells 
(Rendtefa/., 1992; Yamamoto, 1995). Progesterone increases (Rendt er a/., 1992) 
and estrogens decrease (Yamamoto, 1995) the Ca^'^ channel activity. In contrast, the 
function of Ca^"^ influx through myometrial VDCC in estrogen-dominated rats is not 
altered significantly compared to the progesterone followed by estrogen-dominated rats 
(Ruzycky et a!., 1987), and estradiol does not inhibit myometrial VDCC activity in 
preparturient sows (ZhuGe and Hsu, unpublished). Hence, the mechanisms by which 
ovarian hormones influence Ca^'*' channel and myometrial contractility in porcine 
myometrium need further investigation. 
In conclusion, the results of the present study suggested that Oj-ARs mediate 
natural catecholamines EPl- and NE-induced increase in myometrial contractilities in the 
cycling and pregnant sows. The effect of EPl and NE is attributed primarily to an 
increase in Ca^"  ^ influx, through VDCC. This study also demonstrates that the EPl- and 
NE-induced myometrial contractions in the follicular phase and the prepartum period, 
which are exposed to high estrogens levels, were less than those in the luteal phase 
and other stages of pregnancy, which are exposed to high progesterone levels. 
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CHARACTERIZATION OF a,- AND a^-ADRENOCEPTORS IN PORCINE MYOMETRIUM 
A paper submitted to Journal of Pharmacology and Experimental Therapeutics. 
Chih-Huan Yang and Walter H. Hsu 
Abstract 
Binding of [^Hjprazosin and [^H]rauwolscine was used to identify porcine 
myometrial a,- and oj-adrenoceptors, respectively, during the estrous cycle and 
pregnancy. Binding of [^H]prazosin and I^H]rauwolscine to membrane proteins from the 
porcine myometrium was saturable with high affinities and was rapidly reversed by 10 ' 
M phentolamine. Saturation binding studies with [^HJprazosin showed that the density 
of a,-adrenoceptors was low throughout the reproductive stages tested; the order of 
the maximum density of binding sites in fmol/mg protein was luteal phase (23.6 
± 2.1) = early pregnancy (days of gestation = 37 - 40) (22.0 ± 1.3) > late 
pregnancy (days of gestation = 77 - 79) (20.0 ± 3.9) > mid-pregnancy (days of 
gestation = 57 - 60) (1 5.6 ± 3.4) > prepartum period (days of gestation = 111-
113) (11.3 ± 1.1) > follicular phase (7.5 ± 1.6). The density of a,-adrenoceptors 
accounted for 1 - 3% of total a-adrenoceptors, and the equilibrium dissociation 
constants (Kq) being 21.5 - 33.5 pM, which were not significantly different among the 
tested groups. The density of os-adrenoceptors varied in the different reproductive 
stages although the values (4.6 - 6.9 nM) were not changed significantly. The order 
of 8^3^ values in fmol/mg protein was early pregnancy (2,426 ± 430) = very late 
pregnancy (days of gestation S: 100) (2,392 ± 341) > late pregnancy (2,049 ±131) 
= mid-pregnancy (1,999 ± 318) > luteal phase (1,568 ± 135) = prepartum period 
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(1,507 ± 236) > follicular phase (265 ± 50). Therefore, the density of myometrial 
oj-adrenoceptors was higher in the tissues exposed to a high progesterone environment 
than the tissues exposed to a low progesterone environment. From the competition 
binding studies in myometrial membranes from luteal phase, the drug affinities, 
including idazoxan, oxymetazoline, prazosin, RX 821002, WB 4101 and yohimbine, 
were highly correlated when porcine myometrium was compared with known a-.e,-
subtype tissues or cells. In contrast, comparison of porcine myometrium with other 
known Oj-subtype, i.e., Ojb, Ojc- and tissues and ceils resulted in poor correlation. 
The present findings suggested that a.- and Oj-ARs are present in the porcine 
longitudinal myometrium during the estrous cycle and pregnancy. The a^-AR is the 
dominant o-AR in porcine myometrium and its density varies among the reproductive 
stages. Its density is high in progesterone-dominated stages, such as the luteal phase 
and pregnancy, and is low in estrogen-dominated stages, such as the follicular phase. 
In contrast, Oi-ARs are in low concentrations throughout the reproductive stages. 
Furthermore, porcine myometrial Oj-AR may be the Oja subtype based on the results of 
competition experiments. 
Introduction 
Using radioligand binding assays of [^Hlprazosin (PRZ) and ["H]rauwolscine 
(RAU), it has been demonstrated that o,- and oj-adrenoceptors (ARs) are present in the 
myometrium of different species, including humans (Bottari et a/., 1 983a and 1983b), 
rats (Maltier and Legrand, 1985; Legrand eta!., 1993), guinea pigs (Arkinstall and 
Jones, 1988; Arkinstall et a!., 1989; Haynes eta!., 1993), rabbits (Falkay, 1990), 
ewes (Vass-Lopez et aL, 1990b) and pigs (Taneike et a!., 199 5). The functions of a--
and aj-ARs to mediate myometrial contractions are species different, a,-ARs mediate 
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myometriai contractility in rats (Kyozuka etal., 1988), rabbits {Hoffman ef a/., 1981), 
guinea pigs (Hartley etal., 1983) and humans (Bottari etal., 1985) even tinrough the 
density of myometriai Oj-ARs in these species may exceed that of o,-ARs. In contrast, 
Oj-ARs mediate myometriai contractility in pigs (Ko eta!., 1990a; Yang and Hsu, 
1995a and 1995b), cows (LeBlanc et a!.. 1984a and 1 984b; and Ko et a!., 1 990b), 
goats (Perez et aL, 1994) and sheep (Prud'Homme, 1 988). 
The ovarian steroids, estrogens and progesterone modify the densities of 
myometriai a-ARs and these densities vary in the estrous cycle and pregnancy. The 
density of Oi-ARs is not affected by the ovarian steroids in rabbits (Hoffman et a!., 
1981) or ewes (Vass-Lopez et a!., 1990b), and does not change in the menstruous 
cycle or pregnancy in women (Bottari et a!., 1983c and 1985). However, the a -AR 
density is 40% higher during pregnancy when compared to that during the estrous 
cycle of guinea pigs (Arkinstall and Jones, 1989). 
The findings pertaining to myometriai Oj-ARs are more variable than those of a -
ARs in the different species. In rabbits (Hoffman et a!., 1981; Jacobson et a!., 1 987; 
Riemer et a/., 1987) and humans (Bottari et a!., 1983c and 1 985) the myometriai a--
AR density increases when plasma estrogen concentrations are high. However, the 
density decreases in ewes (Vass-Lopez et a!., 1990a and 1990b) and sows (Rexroad 
and Guthrie, 1983) in the same endocrine environment. In ewes, the myometriai a.-AR 
concentration is high (Rexroad, 1981; Vass-Lopez et a!., 1990a and 1990b) in the 
progesterone-treated ewe and during pregnancy which is in a high progesterone 
environment. In contrast, in humans (Bottari et a!., 1 983c and 1985) and rabbits 
(Williams et a!., 1 977) the Oj-AR density is decreased in the same endocrine 
environment. Moreover, the density of myometriai a^-ARs increases greatly in mid-
pregnancy, then decreases abruptly at the end of pregnancy in rats and guinea pigs 
(Kyozuka et a!., 1 988; Legrand et a!., 1 993), whereas the Oj-AR concentration 
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increases in rabbits at term (Jacobson et al., 1987). 
The presence of Oj-ARs in porcine myometrium has been reported using 
[^Hldihydroergocryptine (DHE), a non-selective a-AR antagonist (Rexroad and Guthrie, 
1983). The use of [^H]DHE is unable to quantify the a,-ARs in the myometrium, nor 
does it characterize the myometrial Oj-ARs specifically as the selective O2-AR ligand, 
such as l^H]RAU. Recently, although [^H]PRZ and (^H]RAU have demonstrated the 
presence of a,- and Oj-ARs in porcine myometrium, respectively, the study is limited to 
gilts in the follicular phase of the estrous cycle (Taneike et a!., 1995). 
The present study was undertaken to characterize and quantify a.- and 0;-ARs 
in the porcine myometrium in the estrous cycle and pregnancy using the same 
radioligands. The a^-ARs in myometrium may be heterogenous because both Oja" and 
CTjB^subtypes are present in rat myometrium (Legrand et a!., 1993). However, from the 
functional studies we have demonstrated that natural catecholamine-induced increase 
in porcine longitudinal myometrial contractility in the estrous cycle and during 
pregnancy is mediated predominantly by Oj-ARs (Yang and Hsu, 1995a and 1 995b), 
because this increased contractility is not inhibited by a-.- and O jb-AR antagonist, PRZ 
(< 10 ® M). Therefore, the present study was also to determine the Oj-AR subtype(s) 
in porcine myometrium. 
Materials and Methods 
Tissue preparation 
The uteri used in the study were obtained from a local packing plant and a 
surgical laboratory. The specimens from the follicular phase and luteal phase in the 
estrous cycle and various stages of pregnancy were used. The crown-rurnp 
measurement of the fetus was used to estimate the days of the gestation in the early 
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pregnancy (EPG; days of gestation = 37 - 40), mid-pregnancy (MPG; days of gestation 
= 57 - 60), late pregnancy {LPG; days of gestation = 77 - 79) and very late pregnancy 
(VLPG; days of gestation >100 days) (Evans and Sack, 1973). The prepartum 
specimens (PPT) were obtained from sows undergoing the C-section at 11 1 th - 113th 
day of the pregnancy according to the known breeding record. The uteri were 
determined to be in the follicular phase through visual inspection of ovaries containing 
follicles > 6 mm in diameter and without corpora lutea. In the luteal phase the ovaries 
had light red corpora lutea and the absence of embryos (Arthur et al., 1 989). Only the 
mid-portion of the uterine horns was used in the experiments. The tissues were stored 
in ice-cold Tyrode's solution (137 mM NaCI, 2 mM KCI, 1 mM CaClj, 0.4 mM MgCU, 
1 1 mM dextrose, and 12 mM NaHCOj,- pH 7.4) and transported to the laboratory. 
Upon arrival, the endometrium and placenta were removed from the uterus; the 
myometrium was maintained in ice-cold Tyrode's solution aerated with 95% 0;-5% 
COj. Only the longitudinal layer of myometrial tissues with serosa were minced into 
approximately 2 mm x 10 mm at 4°C. They were immersed in the hypotonic solution 
(10 mM Tris, 0.5 mM dithiothreitol, 1 mM Naj EDTA; pH 7.4) and stored at -80°C 
until assayed. 
Membrane preparation 
The minced, frozen myometrial tissues were thawed at room temperature, they 
were homogenized in ice-cold hypotonic solution for three times of 1 5 sec each with a 
Tissumizer® (SDT-1810, Tekmar Co., Cincinnati, OH) at 55 setting. The homogenate 
was centrifuged at 1,000 x g (J-6B Centrifuge, Beckman Instruments Inc., Palo Alto, 
CA) for 10 min at 4°C. The supernatant was collected and recentrifuged at 50,000 x 
g (J-21B Centrifuge, Beckman Instruments Inc., Palo Alto, CA) for 30 min at 4°C. The 
pellet was collected and resupended in 25 mM glycylglycina (pH 7.6) at 4°C. The 
protein concentration in this membrane suspension was determined as previously 
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described (Lowry et a!., 1951). 
Binding assays 
In saturation experiments of o,- and a^-ARs, one tissue sample from each six or 
seven reproductive stages was studied simultaneously with others using a latin square 
block design. In kinetic experiments for a,- and Oj-ARs and competition experiments 
for O2-ARS, only the tissue samples in the luteal phase of the estrous cycle were used. 
For a," and O2-AR saturation experiments, the total incubation volume was 400 
/yl. The total binding was determined with duplicate tubes containing 200 ij\ membrane 
protein suspension/tube, in which 1 mg/ml and 60 /vg/ml of protein suspensions were 
used for CT,- and aj-AR bindings based on the results of preliminary experiments, 
respectively. In these preliminary experiments, we found that there were only small 
amounts of Oi-ARs in myometrial membrane protein. In contrast, the aj-AR density 
were high in protein suspension. Therefore, in order to decrease non-specific bindings 
we used 1 mg/ml of membrane protein suspension for a,-ARs to increase their 
bindings; and used 60 //g/ml for Oj-AR binding (Bylund and Toews, 1993). The protein 
suspension was incubated with 100 //I [^H]PRZ at a final concentration of 0.02 - 1.0 
nM for 40 min at 30°C or with 100 /vl [^H]RAU at a final concentration of 0.05 - 2.0 
nM for 30 min at 22°C in 25 mM glycylglycine. Non-specific bindings were 
determined by incubation of membrane protein and respective radioligand with a 
parallel set containing 10'" M phentolamine. The specific binding was determined by 
subtracting non-specific binding from total binding. Approximate 85% of total binding 
at 0.1 nM [^H]PRZ and 90% at 0.5 nM [^HJRAU were obtained. 
In kinetic studies, 0.1 nM [^H]PRZ and 0.5 nM I^HIRAU were used in both 
association and dissociation experiments for a,- and cr^-ARs, respectively. For 
association experi.ments, 200 }j\ mem.brane suspension and the fixed concentration of 
radioligand were incubated with or without 10'^ M phentolamine (100 /vl) for various 
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times from 1 5 sec to 70 min. The nonspecific and specific bindings were proceeded as 
the same as in the saturation experiments. For dissociation experiments, 200 /vi 
membrane suspension was preincubated with the fixed radioligand (100 yui) for 40 mm 
and 30 min for CT,- and Oj-ARs, respectively. Then, a final concentration of 10 " M 
phentolamine (100 /yl) was added and incubated for various additional times from 1 to 
40 min. 
For competition experiments on Oj-ARs, duplicate tubes containing 200 ij\ 
membrane suspension, 100 ^J\ [^H]RAU at a final concentration of 0.5 nM, and 100 /vl 
of increasing concentrations of various unlabelled a-adrenergic agents including 
idazoxan and yohimbine (Oj-AR antagonists) (Timmermans, 1989), oxymetazoline (a.A-
AR agonist) (Bylund et aL, 1988), prazosin [a-,- and Oje-AR antagonists) (Bylund eta!., 
1988), RX 821002 (Oja^AR antagonist) (Uhlen and Wikberg, 1991) and WB 4101 (a--
and a2A'AR antagonist) (Ruffolo and Heible, 1994) were incubated for 30 min at 22°C. 
Other procedures were performed as for the a^-AR saturation experiments. 
The reaction of all experiments was terminated by adding 3.5 ml ice-cold buffer 
(50 mM Tris HCI, 0.5 mM MgClj; pH 7.5) rapidly into each tube. The bound 
radioactivity was separated from free radioligand by filtration through buffer-presoaked 
glass fiber filter (GF/B or GF/C, Whatman Inc., Clifton, NJ) using the 1 2-sample cell 
harvester (Millipore Corp., Bedford, MA). Filters and tubes were washed rapidly three 
times with 3.5 ml ice-cold buffer each. Air-dried filter was placed into a 20-ml plastic 
scintillation vial with 10 ml scintillation cocktail (ScintiVerse®, Fisher Scientific, Fair 
Lawn, NJ). The scintillation vials containing the filter were shaken overnight and the 
radioactivity was measured with a liquid scintillation analyzer (1600TR, PACKARD 
Instrument Co., Meriden, CT). 
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Drugs and Chemicals 
The following chemicals and drugs were used: [7-methoxy-^H]pra20sin (72.2 
Ci/mmol) and (methyl-^H]rauwolscine (86.2 Ci/mmol) (DuPont, NEN research product, 
Boston, MA); oxymetazoline HCI and yohimbine HCI (Sigma Chemical Co., St. Louis, 
MO); RX 821002 and WB 4101 HCI (Research Biochemicals Inc., Natick, MA); 
idazoxan (Reckitt & Colman Pharmaceutical Div., Kingston Upon Hull, England); 
phentolamine HCI (Ciba-Geigy Pharmaceutical Co., Summit, NJ); prazosin HCI (Pfizer 
Inc., Groton, CT). The radioligands were diluted with 25 mM glycylglycine in 
appropriate concentrations immediately before use. Drugs were prepared as 1 mM 
stock solutions by dissolving them in distilled water, except for prazosin HCI, which 
was dissolved in 2% lactic acid to achieve a concentration of 1 mM, and stored at -
20°C. The stock solutions were diluted with 25 mM glycylglycine to appropriate 
concentrations before use. 
Data analyses 
in kinetic studies, the data of association experiments were linearized by 
plotting the natural logarithm of the amount specifically bound at equilibrium state {B^^) 
divided by that amount minus the amount bound (S) at discrete times less than the 
equilibrium state. In [^.(./(S^-fi)], versus time (Limbird, 1986). The slope of this line is 
the pseudo-first order association rate constant or observed rate constant, (min '). 
The first order dissociation rate constant, k.. (min '), was determined by a plot of In 
versus time, where is the amount of radioligand bound just before the 
addition of 10'® M phentolamine and B is the amount bound at any time thereafter, 
which yields a regression line with the slope of -k.j. The association rate constant, k^. 
(M • min'M, is determined from = (/t^B-A-.-)/L, where L is the radioligand 
concentration. The equilibrium dissociation constant, K^, equals k,.!k,^ (Limbird, 
1986). 
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For saturation experiments, the maximal number of binding sites/mg of 
membrane protein (5^) and equilibrium dissociation constant (/<"•) were estimated by 
Rosenthal plot analysis (Rosenthal, 1949) from a computer-assisted linear regression of 
the data plotted as bound versus free ligand (Tallarida and Murray, 1986). The Hill 
coefficient (/?„) was obtained from the slope of log logit plot of saturation-binding 
curves (Bennett, 1978). 
For competition studies, the data were analyzed by a computer-assisted curve 
fitting to obtain IC50 (the concentration of competing adrenergic compound which 
inhibits 50% of specific binding) and Hill coefficient (n^). The inhibition constant {K) of 
the competing adrenergic agent was calculated from IC50, K = ICjo/d + L/Ko) (Cheng 
and Prusoff, 1973), where L is [^H]RAU concentration, which is 0.5 nM, and is the 
mean equilibrium dissociation constant, which is obtained from saturation experiments 
in the luteal phase of the estrous cycle, of 5.6 nM (Bennett, 1978). The Hill coefficient 
(/7h) was obtained from the slope of the log logit plot (Hill plot), which was plotted as 
log [%5^^/(1 00%-%5^3J] versus log (concentration of competing adrenergic 
compound). is the specific radioligand binding occurring in the absence of any 
competing agent. Binding occurring in the presence of a competing agent was 
expressed as percentage of (Bennett, 1978). 
Data were expressed as mean ± SE and analyzed by analysis of variance 
(ANOVA). The data for in different reproductive stages were analyzed using a 
randomized block factorial design. The conservative F value was used to establish 
significance for the treatment effect. The least significant difference test was used to 
determine the difference between means of end points for which the ANOVA indicated 
a significant (P < 0.05) F ratio. 
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Results 
Kinetic studies of f^HIPRZ and I^HIRAU bindings 
Specific binding of [^H]PRZ and [^H]RAU to porcine myometrial nnennbrane of 
50,000 X g fraction in the luteal phase of the estrous cycle was rapid. The association 
half life (f.^) were 4 and 3 min, respectively (Fig. 1A and 2A). It reached equilibrium in 
30 min and maintained at a steady state up to 70 min under our conditions. Both 
specific bindings of [^H]PRZ and [^H]RAU were reversed rapidly by 10 ' M 
phentolamine. The dissociation were 8.9 ± 0.9 and 12.3 ± 0.8 min, respectively 
(Figs. 1A and 2A). Using pseudo-first-order association and first-order dissociation 
kinetics, linear transformations of kinetic binding data yielded straight regression lines 
(Figs IB and 1C, and Figs. 2B and 2C), indicating each that radioligand binds to a 
single class of binding sites (Murphy and Bylund, 1988). 
Saturation studies of [^HIPRZ and [^HTRAU bindings 
The results of saturation binding experiments in porcine myometrial membrane 
suspensions using [^H]PRZ and [^H]RAU were summarized in Tables 1 and 2, 
respectively. [^H]PRZ and [^H]RAU bound to porcine myometrial membranes with high 
affinity and in a saturable manner (Figs. 3A and 4A). The values for both o-ARs 
were not changed significantly among all the tested groups (Tables 1 and 2). The 
densities of oi-ARs in all groups were low and were 1 - 3% of total ct-ARs. The 
was between 7.5 ±1.6 and 23.6 ± 2.1 fmol/mg membrane protein. The rank order 
of the was L = EPG > LPG > MPG > PPT > F. 
In contrast, saturation binding experiments with [^H]RAU revealed the presence 
of a high density of c72'ARs as their values were greater than those of [^HIPRZ m 
all groups (Table 2). Generally, the values of [^HjRA'J during pregnancy, except in 
prepartum period, were greater than that in the luteal phase. The B-^^ value of 
Fig. 1. A. Time course for association (•) and dissociation (•) of specific [^H]PRZ 
binding to porcine longitudinal myometrium in the luteal phase of the estrous 
cycle. 200 /vi of membrane protein suspensions (1 mg/ml) were incubated 
with the final concentration of 0.1 nM (^H]PRZ at 30°C for the indicated 
times. After equilibrium was reached, unlabelled phentolamine (10'® M) was 
added (arrow) to initiate radioligand dissociation. The specific binding, which 
was calculated as total binding minus nonspecific binding determining with 
10'® M phentolamine. Data points are expressed as mean ± SE (n = 4). 
B. Natural log pseudo first-order kinetic plot of association data where B and 
are specific [^H]PRZ binding at time point shown and at equilibrium, 
respectively. The slope, was determined by the linear regression analysis, 
equals to the observed association rate constant which was 0.138 ± 
0.016 min"' (correlation coefficient, r, = 97.9 ± 0.9%). Each point is the 
mean of four experiments each performed in duplicate. 
C. Natural log first-order kinetic plot of (^H) PRZ dissociation curve. The 
slope, was determined by linear regression analysis, equals to the dissociation 
rate constant (/r.,), which was 0.080 ± 0.008 min ' (r = 99.4 ± 0.2%). The 
second-order association rate constant (^+i), was calculated from k= (k._^ -
where L is the concentration of (^H]PRZ in the assay (0.1 nM), was 
0.558 ± 0.009 nM * min '. The kinetic equals to k.Jk^., which was 1 62 
± 36 pM. Points are means of four experiments. 
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Fig. 2. A. Time course for association (•) and dissociation {•) of specific [^H]RAU 
binding to porcine longitudinal myometrium in the luteal phase of the estrous 
cycle. 200 //I of membrane protein suspensions (60 /yg/ml) were incubated 
with the final concentration of 0.5 nM (^H]RAU at 22°C for the indicated 
times. After equilibrium was reached, unlabelled phentolamine dO'® M) was 
added (arrow) to initiate radioligand dissociation. The specific binding, which 
was calculated as total binding minus nonspecific binding determining with 
10'® M phentolamine. Data points are expressed as mean ± SE (n = 4). 
B. Natural log pseudo first-order kinetic plot of association data where B and 
are specific [^H]RAU binding at time point shown and at equilibrium, 
respectively. The slope, was determined by the linear regression analysis, 
equals to the observed association rate constant which was 0.192 ± 
0.012 min'^ (correlation coefficient, r, = 99.8 ± 0.1%). Each point is the 
mean of four experiments. 
C. Natural log first-order kinetic plot of [^H]RAU dissociation curve. The 
slope, was determined by linear regression analysis, equals to dissociation rate 
constant (/:.,), which was 0.057 ± 0.004 min ' [r = 9S.2 ± O.S%). The 
second-order association rate constant (/r^.,), was calculated from A-,, = -
A'.il/IL], where L is the concentration of [^H]RAU in the assay (0.5 nM), was 
0.269 ± 0.031 nM * min"'. The kinetic Kq equals to k.^lk^^, which was 228 
± 42 pM. Points are means of four experiments with each performed in 
duplicate. 
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Table 1. Specific binding of [^H]PRZ binding to porcine longitudinal myometrium in the 
estrous cycle and during pregnancy 
[^H]PRZ' 
Stage fmol/mg protein pM % % 
F 7.5 ± 1.6 33.5 + 11.1 95.0 + 3.0 1 .07 0.03 95.1 2.3 
L 23.6 2 1 a.b.c 30.9 2.3 99.0 0.3 1. 13 ± 0.05 99.4 ± 0.3 
EPG 22.0 ± 1.3'" 21.5 ± 0.8 98.5 ± 1.0 1 .00 ± 0.08 98.6 ± 0.7 
MPG 15.6 ± 3.4' 23.2 3.2 99.5 ± 0.1 1 .13 ± 0.03 99.5 ± 0.2 
LPG 20.0 •4- 3.9' 24.6 ± 7.1 99.5 ± 0.5 1 .11 ± 0.06 99.5 ± 0.5 
PPT 1 1.3 ± 1.1 31.1 ± 7.4 98.8 ± 0.7 0.99 ± 0.05 98.6 ± 1.0 
"Values shown were obtained from Rosenthal plot analysis and are mean ± SE 
{n = 4). 
"Correlation coefficient for the slope of Rosenthal plot. 
'"Correlation coefficient for the slope (Hill coefficient = of Hill plot. 
""P < 0.05, comparing with the follicular phase of the estrous cycle (F). 
''P < 0.05, comparing with prepartum period (PPT). 
"P < 0.05, comparing with mid-pregnancy (MPG). 
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Table 2. Specific binding of [^H]RAU binding to porcine longitudinal myometrium in the 
estrous cycle and during pregnancy 
[^H]RAU' 
^max r Dyf r 
Stage fmol/mg protein nM % % 
F 265 4- 50 4.6 1.0 97.5 + 1.4 1.01 -u 0.02 98.9 ± 0.6 
L 1,568 + 135^ 5.6 + 0.7 99.0 ± 0.8 1.00 ± 0.03 98.8 -i- 0.5 
EPG 2,426 430''''-'= 6.9 + 0.5 97.7 ± 1.0 1.14 ± 0.04 99.6 ± 0.2 
MPG 1,999 ± 318^ 5.6 ± 1.2 98.1 ± 0.7 1.06 ± 0.01 99.3 ± 0.3 
LPG 2,049 ± 13r 5.6 0.7 98.0 ± 0.7 1.08 ± 0.05 99.0 ± 0.4 
VLPG 2,392 ± 34ia ,b,c 6.8 ± 1.2 98.9 4- 0.6 1.07 ± 0.05 99.5 + 0.3 
PPT 1,507 ± 236" 6.6 ± 1.7 97.9 ± 1.1 1.05 ± 0.02 99.4 i 0.2 
'Values shown were obtained from Rosenthal plot analysis and are mean ± SE 
(n = 4). 
"Correlation coefficient for the slope of Rosenthal plot. 
'"Correlation coefficient for the slope (Hill coefficient = /?„) of Hill plot. 
< 0.05, comparing with the follicular phase (F) of the estrous cycle. 
"P < 0.05, comparing with the luteal phase (L) of the estrous cycle. 
T < 0.05, comparing with prepartum period (PPT). 
Fig. 3. A. Saturation binding curve of [^H]PRZ in porcine myometrium in the luteal 
phase of the estrous cycle. 200 /yl of membrane protein suspensions (1 
mg/ml) were incubated with [^H]PRZ at a final concentration of 0.02 - 1.0 nM 
at 30°C for 40 min and then filtered to separate bound from free radioligand. 
The values given are those of specific binding, which were calculated as total 
binding minus nonspecific binding determining with 10^ M phentolamine. The 
points are expressed as mean ± SE (n = 4). 
B. The Rosenthal plot of specific [^H]PRZ binding data from A. Line of best fit 
was calculated by linear regression and given values for and of 23.6 ± 
2.1 fmol/mg protein and 30.9 ± 2.3 pM (correlation coefficient, r, = 99.0 ± 
0.3%), respectively. This transformation yields a straight line, indicating the 
existence of a single class of binding sites. Each point is the mean of four 
experiments each performed in duplicate. The and values of all 
experiments are shown in Table 1. 
C. Hill plot of specific [^H]PRZ binding to porcine myometrium. The slope of 
the plot (or Hill coefficient, n„), which was determined by linear regression, 
equaled to 1.00 (correlation coefficient, r, - 99.9%). Each point represents 
the mean of duplicate determinations from a representative experiment in the 
luteal phase of the estrous cycle. The and r values of all experiments are 
shown in Table 1. 

Fig. 4. A. Saturation binding curve of [^H]RAU in porcine myometrium in the luteal 
cycle of the estrous cycle. 200 //I of membrane protein suspensions (60 
;yg/ml) were incubated with [^H]RAU at a final concentration of 0.05 - 2.0 nM 
at 22°C for 30 min and then filtered to separate bound from free radioligand. 
The values given are those specific binding, which were calculated as total 
binding minus nonspecific binding determining with 10^ M phentolamine. The 
points are expressed as mean ± SE (n = 4). 
B. The Rosenthal plot of specific (^H]RAU binding data from A. Line of best 
fit was calculated by linear regression and given values for and of 
1,568 ±135 fmol/mg protein and 5.6 ± 0.7 nM (correlation coefficient, r, 
99.0 ± 0.8%), respectively. This transformation yields a straight line, 
indicating the existence of a single class of binding sites. Each point is the 
mean of four experiments each performed in duplicate. The and Kq values 
of all experiments are shown in Table 2. 
C. Hill plot of specific [^H]RAU binding to porcine myometrium. The slope of 
the plot (or Hill coefficient, n^^), which was determined by linear regression, 
equaled to 0.93 (correlation coefficient, r, = 99.0%). Each point represents 
the mean of duplicate determinations from a representative experiment in the 
luteal phase of the estrous cycle. The and rvalues of all experiments are 
shown in Table 2. 
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[^H]RAU in prepartum period decreased to 60% comparing with the samples collected 
from very late gestation period (> 100 days) (Table 2). The follicular phase had the 
smallest value of I^H]RAU among all groups studied. 
Linear transformation of the saturation data according to Rosenthal plot analysis 
yields a straight line (Figs. 3B and 4B), indicating that [^H]PRZ or (^H]RAU bound to a 
single class of receptors over the concentration range used (corresponding coefficient, 
r, = 99%). Furthermore, Hill plots of the saturation data with [^H]PRZ and [^H]RAU 
were linear with the average Hill coefficient (/?„) of 0.99 - 1.13 (r = 95.1 - 99.5%) and 
1.00 - 1.14 [r = 98.8 - 99.6%), respectively, for both radioligands, indicating no 
evidence of cooperativity or multiple receptors of different affinities in all tested groups 
(Legrand eta/., 1993) (Figs. 3C and 4C and Tables 1 and 2). 
Competition studies of f^HIRAU bindings 
The specificity of [^H]RAU binding was determined by competition binding 
experiments with selective agonist or antagonists. The relative rank order of affinity 
for competing agents as expressed by K, values was; RX 821002 > yohimbine > 
oxymetazoline > idazoxan > WB 4101 > PRZ (Table 3). From the cr-AR antagonists 
tested, the Oj-seiective drug, such as yohimbine has an approximativeiy 630-fold higher 
affinity than the ct,-selective drug PRZ. These results clearly demonstrated the a.-AR 
specificity of the [^H]RAU binding sites in porcine myometrial membrane. All 
adrenergic compounds used in this study interacted at the [^H]RAU binding site in a 
homogenous manner, with competition curves fitting best the one-site model (Figs. 5 
and 6) and Hill coefficients (Oh) close to 1.0 (Table 3). 
To provide a more definitive characterization of o^-AR subtypes in porcine 
myometrium, the affinities of these adrenergic drugs were compared with their 
affinities {K,) for the tissues of know." aj-AR subtypes (Table 4). The data of porcine 
myometrium were close to those of the cells in which only Oja-ARs are found, e.g., 
Fig. 5. Inhibition of specific [^H]RAU binding by Oj-AR compounds. Porcine 
longitudinal myometriai membrane suspensions in the luteal phase of estrous 
cycle were incubated with [^H]RAU at a final concentration of 0.5 nM and 
various concentrations, as indicated, of yohimbine (•), RX 821002 (•), WB 
4101 (v), idazoxan (•), oxymetazoline (O) and prazosin (•) at 22°C for 30 
min. For each concentration of adrenergic agent, [^H]RAU binding is 
expressed as a percentage of specific binding in the absence of any agent 
(maximal binding). The data points are expressed as mean ± SE (n = 4). 
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Fig. 6. Hill plots of the inhibition of specific [^H]RAU binding by O2-AR compounds, 
including yohimbine (O), RX 821002 (•), WB 4101 (v), idazoxan {•), 
oxymetazoline (•) and prazosin (•). Points are means of four experiments 
each performed in duplicate. The slopes of the plot, were determined by the 
linear regression, equal to Hill coefficients (^7^). The /?„ and r (correlation 
coefficient) for all compounds are shown in Table 3. 
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Table 3. Inhibition of specific [^H]RAU binding to porcine myometrial membranes by 
adrenergic agonist or antagonists^ 
K, (nM) /7h (%) 
Agonist 
Oxymetazoline (CTsa) 1.15 ± 0.01 0.91 ± 0.02 99.5 = 0.2 
Antagonist 
RX 821002 (QTJ;,) 0.20 + 0.02 1.00 0.02 99.5 ± 0.3 
Yohimbine (02) 0.48 ± 0.05 0.99 -r- 0.02 99.9 ± 0.0 
Idazoxan (CTj) 1.49 ± 0.10 0.91 ± 0.04 99.8 0.1 
WB 4101 (ajJ 2.14 + 0.23 1.02 0.04 99.6 4- 0.2 
Prazosin (ajg) 302 25 0.93 ± 0.03 99.8 ± 0.1 
^The values of inhibition constants (K^, Hill coefficients (/?„) and correlation coefficients 
[r] are expressed as mean ± SE (n = 4). 
"Correlation coefficient for the slope of Hill plot (n^). 
Table 4. Inhibition constant (/C;) of [^H]RAU on various tissues by Oj'Adrenergic compounds 
Yohimbine Oxymetazoline Idazoxan WB4101 Prazosin 
Tissue/Cell line Type 02 02^ 02 O2B 
Porcine myometrium a'2A 0.48 ± 0.05 1.15 ± 0.01 1.49 ± 0.10 2.14 ± 0.23 302 ± 25 
HT29 cells"" 0.65 ± 0.18 0.79 ±0.15 1.90 ± 0.03 1.20 ± 0.39 316 ±19 
Human platelet'"'' 0.85 ± 0.09 0.63 n. d. 3.52 ± 0.20 339 
NG108-15 cells" 0.67 ± 0.04 38 ± 9 3.90 ± 0.20 6.40 ± 0.40 3.7 ± 0.7 
Neonatal rat lung"" 1.00 ±0.10 71 ± 8 4.70 ± 0.20 8.70 ± 2.60 5.4 ± 0.5 
OK cells" 02C 0.19 ± 0.04 31 ± 3 0.56 ± 0.02 0.27 ± 0.01 15 ±3 
Opossum kidney" 0.40 ± 0.15 73 ± 12 2.40 ± 0.10 1.60 ± 0.50 36 ± 3 
Bovine pineal gland" 020 3.60 ± 0.60 1.45 ± 0.32 n. d. 7.60 ± 0.80 106 ±10 
Rat submaxillary gland' 020 n. d. 8.71 5.62 60.26 457 
Values are expressed as mean ± SE if possible. The data of porcine myometrium are shown in mean ± SE (n =4). 
n. d. not determined. Data were obtained from Blaxall et a!., 1991; Bylund et al., 1988; Cheung et a!., 1982; 
MacKinnon et al., 1 994; Simonneaux et a!., 1 991; Michel et a/., 1 989. 
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HT29 cells (a human colonic adenocarcinoma ceil line) and human platelets. When 
comparing the /C, ratios of various drugs in porcine myometrium with known Oj-AR 
subtype tissues and cell lines, these ratios were close to the subtype expressed by 
HT29 cells and human platelets, and distinct from the Ojb subtype expressed by 
NG108-1 5 ceils (a neuroblastoma-glioma cell line) and the neonatal rat lung, the a-^c 
subtype expressed by OK cells (an opossum kidney cell line) and the opossum kidney, 
and the 020 subtype expressed in the bovine pineal gland and rat submaxillary gland 
(Table 5). Moreover, the excellent correlations of drug potencies, which were 
expressed as p/C, (= -log K) values, were seen between porcine myometrium and the 
tissues (i.e., HT cells and human platelet) containing Oja subtypes (Fig. 7 and Table 6). 
in contrast, the correlations were poor between porcine myometrium and either ar^, a-c 
or a^D subtype tissues (Fig. 8 and Table 6). 
Discussion 
The results of the present study identified and characterized porcine longitudinal 
myometrial a, - and Oj-ARs using I^HIPRZ and (^H]RAU in the estrous cycle and during 
pregnancy. The results also provided evidence that the a-AR-mediated myometrial 
contractility in sows was correlated with the quantities of myometrial cr-ARs, in which 
Oj-ARs were the major a-ARs and predominantly mediated catecholamine-induced 
myometrial contractility (Ko eta!., 1990a; Yang and Hsu, 1995a and 1995b). In 
addition, the density of a^-ARs in porcine myometrium changed in the estrous cycle 
and pregnancy, while the o,-ARs remained at a low concentration. Moreover, from the 
competition binding experiments we suggested that the Oj-AR in the porcine 
myometrium is the ajA-subtype. 
Our results of kinetic, saturation and competition experiments clearly indicated 
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Table 5. Comparison of K, value ratios for various Oj-AR subtypes 
Tissue/Cell lines Type Prazosin/ 
Oxymetazoline 
Prazosin/ 
WB 4101 
Oxymetazoline/ 
WB 4101 
Porcine myometrium cr2A 263 150 0.54 
HT29 cells' ^2 A 400 260 0.66 
Human platelet^ <^2A 330 330 1.01 
NG108-15 cells" ^23 0.10 0.58 5.90 
Neonatal rat lung' OzB 0.08 0.62 8.20 
OK cells' <^2C 0.50 56 260 
Opossum kidney' ^2C 0.49 22 46 
Bovine pineal gland'' ^20 73 13.9 0.19 
Rat submaxillary gland'' ^20 52.5 7.58 0.14 
value ratios were obtained from Blaxall et a!., 1991. 
"/C, value ratios were calculated from the data in Simonneaux et aL, 1991. 
Fig. 7. Correlation between adrenergic drug affinity estimates (p/C, = -log K,, in which 
K, values from Tables 3 and 4) obtained for the gTj-ARs of porcine myometrium 
and OjA-subtype tissues (A, HT29 ceils; B, human platelets) labelled with 
(^H]RAU. The drugs used were yohimbine (O), oxymetazoline (•), idazoxan 
[A), WB 4101 (a) and prazosin (a). Correlation coefficients and slopes of the 
correlation lines are summarized in Table 6. 
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Table 6. Correlations between subtype in porcine myonnetrium and other 
known cTj-AR subtype tissues and cell lines 
Slope r (%} 
Porcine myometrium 
vs. HT29 cell (OjJ 0.98 98.4 
vs. human platelet (Osa) 0.99 98.3 
vs. NG108-15 cell (Ojg) 0.02 3.3 
vs. rat neonatal lung (£725) 0.04 6.6 
vs. OK ceil (02c) 0.46 44.4 
vs. opossum kidney (Ojc) 0.46 53.7 
vs. bovine pineal gland (ctjo) 0.60 93.6 
vs. rat submaxillary gland (Ojo) 0.70 90.1 
Values are correlation coefficients (r) and slopes from regression analysis of the p/C, 
[- -log K,) values for the 4-5 drugs in Table 4. The correlation plots between porcine 
myometrium and individual known a^-AR subtype cell lines and tissues are shown in 
Figs. 7 and 8. 
Fig. 8. Correlation between adrenergic drug affinity estimates (p/C,, = -log in which 
K, values from Tables 3 and 4) obtained for the aj-ARs of porcine myometrium 
and of various tissues labelled with [^H]RAU, including rat neonatal lung (A; 020 
subtype), NG108-15 cells (B; O2B subtype), OK cells (C; Ojc subtype), opossum 
kidney (D; ajc subtype), bovine pineal gland (E; a^o subtype) and rat 
submaxillary gland (F; subtype). The drugs used were yohimbine (O), 
oxymetazoline (•), idazoxan (A), WB 4101 (a) and prazosin {•). Correlation 
coefficients and slopes of the correlation lines are summarized in Table 6. 
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the a," and a2-AR specificity of the [^H]PRZ and [^H]RAU binding sites, respectively, in 
porcine myometriai membrane. The presence of these o-ARs has been previously 
suggested in porcine myometrium using [^H]dihydroergocryptine (DHE) (Rexroad and 
Guthrie, 1983). However, this ligand has been shown to bind with almost equal 
affinity to both o,- and aj-ARs, which does not distinguish these two subtypes 
(Williams et a!., 1976). As shown in our results, and a2-ARs were directly 
characterized in porcine myometrium with [^H]PRZ and [^H]RAU, the specific a- and 
cr2-AR radioligands, respectively, which are superior to [^HIDHE. In this context, it is 
suggested that both [^H]PRZ and [^H]RAU are useful in the study on porcine 
myometriai a, - and Oj-ARs, respectively. 
The concentration of (7,-ARs in porcine myometrium was quite low, and only 
accounted for 1 - 3% of total o-ARs in all reproductive stages tested. The low 
percentage of ai-ARs was in agreement with the data in ewes (Vass-Lopez et a!., 
1990b), but was remarkably less than that in humans (Bottari et a/., 1985), rats 
(Maltier and Legrand, 1985), rabbits (Riemer eta!., 1987), guinea pigs (Arkinstall and 
Jones, 1988 and 1989) and pigs (Taneike et a!., 1995). The results were not 
consistent with the data that a,-AR density did not change in the reproductive stages 
or following ovarian steroid treatments in humans (Bottari et a!., 1985), rabbits (Riemer 
et a!., 1987) and ewes (Vass-Lopez eta!., 1990b), nor with guinea pigs (Arkinstall and 
Jones, 1989) in which the concentrations increase at term. The porcine myometriai a,-
AR concentrations in the luteal phase and in the reproductive stages during pregnancy, 
except in the prepartum period, were similar, and were greater than those in the 
follicular phase and prepartum period, but the percentages in total myometriai a-ARs 
remained low. These findings of extremely low concentrations of a,-ARs in porcine 
myometrium provide the evidence to support our previous findings (Yang and Hsu, 
1995a and 1995b) that the epinephrine- and norepinephrine-induced increase in 
142 
myometrial contractility is minimally mediated by ai-ARs. In our results, the density of 
myometrial a,-ARs in the follicular phase is lower than that in other report (Taneike et 
a!., 1995). The reason for the discrepancy of the results is not clear. 
Although previous study (Taneike eta!., 1995) has found that Oj-ARs are 
present in porcine myometrium using [^HIRAU, the selective Oj-AR radioligand, the 
results are limited to the follicular phase in which the density of Oj-AR is the lowest in 
the reproductive stages we studied. In the present study, we demonstrated that the 
densities of porcine myometrial Oj-ARs changed in reproductive stages, which were in 
agreement with the results obtained from ewes (Vass-Lopez et a!., 1990a and 1990b), 
humans (Bottari et a!., 1985) and guinea pigs (Arkinstall and Jones, 1988). Generally, 
the Oj-AR concentration in porcine myometrium in the luteal phase and pregnancy, in 
which plasma progesterone concentration is high (Thilander and Rodriguez, 1989a and 
1989b), is greater than that in the follicular phase, in which the myometrium is 
exposed to a low progesterone environment (Thilander and Rodriguez, 1989a and 
1 990). These results were consistent with the results in ewes (Vass-Lopez et a/., 
1990a and 1990b), guinea pigs (Arkinstall and Jones, 1988) and pigs (Taneike et a!., 
1995), but were in contrast to humans (Bottari eta!., 1983c and 1985) and rabbits 
(Hoffman eta!., 1981; Jacobson eta!., 1987; Riemere^a/., 1987), in which a;-AR 
concentrations increase in the estrogen-dominated environments. 
The present study confirmed that the dominant o^-ARs in porcine myometrium 
mediate catecholamine-induced myometrial contractility (Yang and Hsu, 1995a and 
1995b). The concentration of myometrial a2-ARs in the luteal phase is lower than that 
in the pregnancy, except in the prepartum period in which a^-AR density was higher 
than that in luteal phase. However, the potency of natural catecholamines to induce 
myometrial contractility in the presence of propranolol in vitro, which is mediated by 
ARs, is not significantly different among these reproductive stages (Yang and Hsu, 
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1995b). The myometrial Oj-AR concentrations in pregnancy, which are greater than 
those in the estrous cycle, are also seen in guinea pigs (Arkinstall and Jones, 1988) 
and ewes (Vass-Lopez et a!., 1990b). The physiological significance regarding high 
myometrial a2-AR population during pregnancy is not clear; however, at least, o.-ARs 
mediate an increase in porcine longitudinal myometrial contractility during pregnancy 
(Yang and Hsu, 1995b). The uterus during pregnancy is to provide a quiescent state to 
allow the fetus to grow and develop until the delivery at term, the stability of the 
uterus is related to the inhibitory ;S-AR action on myometrium (Wray. 1993). 
Therefore, the increased myometrial Oj-ARs in pregnancy may have additional 
physiological roles. It is possible that the aj-ARs regulate some aspects of cellular 
metabolism important for uterine function, and that the ovarian steroid-induced 
changes in aj-AR density may mediate changes in the metabolic activity of the uterus 
during pregnancy (Ruffolo and Hieble, 1994). However, no studies have yet been 
performed to investigate the effect of Oj-AR activation on uterine metabolic function. 
It is also likely that Oj-ARs are to counterbalance the /?2-AR-mediated myometrial 
relaxation. This could be important at terms, because without the participation of a^-
ARs, there could be excessive myometrial relaxation, which may interfere with 
parturition process. 
The concentration of myometrial CT j'ARs in prepartum period was similar to that 
in the luteal phase. However, its catechoiamine-induced myometrial contractility is less 
than that in the luteal phase (Yang and Hsu, 1995b). Therefore, it is possible that 
changes in signal transduction system during prepartum period lead to a lower 
response to cTj-AR stimulations than luteal phase. 
The myometrial Oj'ARs in the follicular phase, in which the tissues are exposed 
to a low progesterone environme.nt, are only 11 - 17% those of other reproductive 
stages. This reduction in myometrial a^-ARs is consistently accompanied by a smaller 
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increase in Oj^AR-mediated porcine myometrial contractility than other reproductive 
stages (Yang and Hsu, 1995b). From our findings, it is suggested that progesterone 
may play a role in regulation of the Oj-AR density in porcine myometrium. 
Estrogens may influence the density of Oj-ARs because they decrease the a.-
ARs in rabbit platelets (Mishra et a!., 1985) and female rat hypothalamus (Karkanias 
and Etgen, 1994). On the contrary, the concentration of Oj'ARs increases in human 
and rabbit myometrium (Jacobson etaL, 1987), but does not change in ovine 
myometrium (Vass-Lopez etaL, 1990a and 1990b) nor in female rabbit brain, spleen 
and kidney (Mishra etaL, 1985). In porcine myometrium estrogens may not influence 
the density of aj-ARs, because we found that the as-AR concentration in prepartum 
period was still 5-fold as that in the follicular phase even the plasma concentrations of 
estrogens in the prepartum period were supposed to be 7 fold as high as in the 
follicular phase (Thilander and rodriguez, 1989a and 1990). Therefore, further studies 
using ovariectomized animals with or without supplementation of steroids will provide 
answers to this question. 
During the pregnancy, the density of Oj-ARs in the prepartum period was lower 
than that in other stages of pregnancy, in which the plasma concentrations of 
progesterone have started to decrease (Thilander and Rodriguez, 1990). The 
diminished myometrial Oi'AR receptor density also occurs in guinea pigs at term 
(Arkinstail and Jones, 1988), and is associated with pregnancy-related myometrial 
denervation (Thorbert, 1978; Arkinstail and Jones, 1988). In sows, the adrenergic 
innervation of the uterus in very late pregnancy and at parturition is scanty, compared 
to cycling animals and early to mid-pregnancy (Thilander, 1989). However, i t  has not 
been demonstrated that myometrial Oj-AR receptor density correlates with the 
structural changes of the adrenergic nerves in this species. Nevertheless, based on our 
results, at least in part, the decreased density of CTj-ARs in this stage is attributed to 
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the tissues that are exposed to a lower progesterone environment (Thilander and 
Rodriguez, 1990). 
The pharmacological characteristics, as expressed in K values of o,-AR 
competing drugs, of porcine myometrial a^-ARs are identical to those of the Oja-AR 
subtype as defined by HT29 cells (Bylund et al., 1988) and human platelets (Cheung et 
a/.. 1 982). It is different from the 023 subtype expressed in NG108-1 5 cells (Bylund et 
a/., 1988) and neonatal rat lungs (Bylund et al., 1988), the o^c subtype expressed in 
OK cells (Blaxall et a/., 1991) and opossum kidney (Blaxall et a/., 1991), and the a:c 
subtype expressed in the bovine pineal gland (Simonneaux et a!., 1991) and rat 
submaxillary gland (Limberger ef a/., 1992). 
The ratios of /<", values for PRZ, oxymetazoline and WB 4101 in competition with 
[^H]RAU can be used as an indicator for classification of Oj-AR subtypes (Blaxall et a!., 
1 991). The ratio of K, values in porcine myometrium was in the same range as in 
HT29 cells and human platelets, which express only Oja-AR subtype, and were 
remarkably different from those in other tissues which have expressed only cr^B' or 
OjD subtype. Furthermore, the correlation of p/C, values between the porcine myometrial 
Oj-ARs and a^A-AR prototype tissues, HT29 cells and human platelets, was high with 
correlation coefficients being 98.4 and 98.3%, respectively. In contrast, the 
correlations between porcine m-, metrial Oj-ARs and 02^-, or ajc-prototype tissues were 
poor, and correlations of porcine myometrial Oj-ARs with ajo-AR prototype tissues were 
lower than that with CTj^-AR. However, considering the pharmacological characteristics 
with the corresponding K, ratios, the a^-ARs in the porcine myometrium were distinct 
from Ojo subtype. For instance, the K, ratio of PRZ and oxymetazoline for porcine 
myometrial Cj'AFis is 4 - 5 fold of known a2D-prototype tissues, bovine pineal gland and 
rat submaxillary gland. 
Our results ctja is the predominant subtype in porcine myometrium were 
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different from that in the rat (Legrand et al., 1993). From the competition studies, 
both oxymetazoiine, the Oja'AR agonist and PRZ, the Ojb^AR antagonist have high 
affinities for myometrial Oj-AR of the rat. Therefore, it is suggest that both and 
a2B-ARs are present in the murine myometrium. However, porcine myometrial aj-ARs 
had high affinities with CTja-AR agents, e. g. oxymetazoiine, RX 821002 and WB 4101, 
but had low affinities with PRZ, the a2B-AR antagonist. 
Based on our findings, porcine longitudinal myometrium had a higher density of 
Oj-ARs than that in humans (Bottari etaL, 1985), ewes (Vass-Lopez et a!., 1990b), 
guinea pigs (Arkinstall and Jones, 1988), rats (Maltier and Legrand, 1985) and rabbits 
(Riemer et a!., 1987). Hence, porcine longitudinal myometrium is a suitable model for 
the mechanistic studies of Os^-ARs, particularly pertaining to those in smooth muscles. 
In conclusion, the present study suggested that a,- and Oj-ARs are present in 
the porcine longitudinal myometrium in the estrous cycle and pregnancy. gtj-AR is the 
major o-AR in porcine myometrium and its concentrations vary among the reproductive 
stages, its density is high in progesterone-dominated stages, such as the luteal phase 
and pregnancy, and is low in estrogen-dominated stages, such as the follicular phase. 
In contrast, a,-ARs are in low concentrations throughout the reproductive stages and 
account for only 1 - 3% of total porcine myometrial a-ARs. Furthermore, based on the 
competition binding studies we suggest that porcine myometrial a^-AR is 
predominantly the o^a subtype. 
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EFFECTS OF WB 4101 AND PRAZOSIN ON EPINEPHRINE-INDUCED PORCINE 
MYOMETRIAL CONTRACTILITY: EVIDENCE FOR PARTICIPATION OF o,-
ADRENOCEPTORS 
A paper submitted to European Journal of Pharmacology. 
Chih-Huan Yang and Walter H. Hsu. 
Abstract 
The effect of epinephrine on myometrial contractility in vitro was studied using 
porcine uterine strips of the longitudinal layer in the luteal phase of the estrous cycle. 
In the presence of 10 ® M propranolol, epinephrine (10 ® - 3 x 10'^ M) caused a dose-
dependent increase in myometrial contractility. The OjA-adrenoceptor antagonist, WB 
4101 (3 X 10 ®, 10'^, 3 X 10'^ M), antagonized the effect of epinephrine in a dose-
dependent manner. In contrast, the o,- and c/js-adrenoceptor antagonist, prazosin (10-
and 3 X 10® M) did not block the epinephrine-induced increases in contractility. 
Comparing the affinity of aj-adrenergic antagonists in porcine myometrium, there was 
an excellent correlation between values from function studies and K values from the 
radioligand binding studies (correlation coefficient = 100%, slope = 1.01). Thus, the 
functional data were consistent with the radioligand binding data and supported the 
existence and definition of OjA-adrenoceptor subtype in porcine myometrium. These 
results suggested that epinephrine-induced increase in myometrial contractility in the 
luteal phase of the estrous cycle in the sow is mediated by ajA-adrenoceptors. 
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Introduction 
Natural catecholamine-induced porcine myometrial contractility in 
vitro is predominantly mediated by oj-adrenoceptors (ARs) (Yang and Hsu, 1995a and 
1995b). From [^H]prazosin and [^H]rauwolscine binding studies, both a,- and a^-ARs 
are present in the porcine myometrium and most of the ARs are Oj-ARs (Yang and Hsu, 
1995c). We also have suggested that porcine myometrial 02-AR is the 02^ subtype 
because from the competition binding studies the drug potencies in porcine 
myometrium are correlated highly with the known OzA-prototype tissues, the human 
platelet (Bylund, 1985) and the HT29 cell, a human colonic adenocarcinoma cell line 
(Bylund etaL, 1988), but poorly with the known <723-, Osc", and ojo-prototype tissues 
(Yang and Hsu, 1995c). 
However, receptors can not be identified solely on the basis of binding studies 
(Bylund and Ray-Prenger, 1989). For instances, although WB 4101 is a potent ct^a-AR 
antagonist (Ruffolo and Heible, 1994), in which it has high affinity for Oj-ARs of 
porcine myometrium (Yang and Hsu, 1995c), it also has high affinity for Ojc-AR 
tissues, such as the OK ceil, an opossum kidney cell line (Murphy and Bylund, 1988) 
and opossum kidney (Blaxall etaL, 1991). Therefore, the present study was 
undertaken to determine if the pharmacological characteristics observed in binding 
studies were also observed in functional studies using myometrial contractility in the 
porcine longitudinal myometrium. If so, how close they were correlated with each 
other. 
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Materials and Methods 
Tissue preparation 
The uterine specimens were collected from a local abattoir. Only the niid-
portion of the uterine horns was used in the experiment. The specimens were 
determined to be in the luteal phase based on the presence of light red corpora lutea on 
the ovaries, and the absence of embryos (Arthur et a!.. 1989). Tissues were stored in 
ice-cold Tyrode's solution (137 mM NaCI, 2 mM KCI, 1 mM CaCi,, 0.4 mM MgCI-, 1 1 
mM dextrose, and 12 mM NaHCOj; pH 7.4) and transported to the laboratory. Upon 
arrival, the endometrium was removed from the uterus; the myometrium was stored in 
ice-cold Tyrode's solution aerated with 95% 02-5% CO^ and was used for experiments 
within 30 h. There were no changes in responsiveness to contractants during this 
period. 
The methods for studying porcine myometrial contractility were as previously 
described (Yang and Hsu, 1995a and 1995b). In brief, the longitudinal uterine strips 
(10x2 mm^) were suspended vertically in a 10-ml organ bath containing Tyrode's 
solution at 37°C and aerated with 95% 02-5% COj. The contractions were recorded 
isometrically on a multiple-channel recorder (R411, Beckman Instruments Inc., Schiller 
Park, IL) through a transducer (Grass FT03, Grass Instrument Co., Quincy, MA). The 
strips were equilibrated under a 2-g tension for 20-25 min before being exposed to 10 ' 
M carbachol (CARB) twice for 3 min each to determine their responsiveness to the 
contractant. Two of three-minute exposures to CARB separated by a 1 5 min interval 
were performed with four of 10-ml washes with Tyrode's solution used to remove 
CARB after the stimulation. The quiescent state usually lasted > 25 mm. The basal 
resting tension was readjusted to 2 g before the pretreatrr.ent drug was added. In the 
following experiments, epinephrine (EPI) was added at a 10-min interval in cumulative 
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doses to attain a dose-response relationship. 
Effect of WB 4101 and prazosin on EPI-induced mvometrial contractility 
The o,- and ctja-AR antagonist WB 4101 (3 x 10 ®, 10'^ or 3 x 10^ M) or the a 
and ajB-AR antagonist prazosin (PRZ) (10 ®, 3 x 10'^ or 10 ® M) was added with 10'- M 
propranolol (PROP) which inhibits y?-AR-mediated relaxation (Yang and Hsu, 1995a and 
1995b), to the organ bath for 10 min. After pretreatment with the antagonists for 10 
min, EPI was given in cumulative doses (3 x 10 ® - 10 ® M). The control group did not 
receive an antagonist. 
The 10-min pretreatment for a- and 0-AR antagonists was chosen, because in 
the preliminary experiment, a- and y?-AR antagonisms by yohimbine and PROP reached 
maximum in 10 min, respectively (n = 4 uteri) (Yang and Hsu, 1995a). 
Different strips from the same uterus were randomly assigned to all treatment 
groups in one trial and each uterus was used for one trial only. 
Assessment of the contractile response 
The determinations of the contractile response were as previously described 
(Yang and Hsu, 1995a). Briefly, the contractile response of epinephrine was assessed 
by the area under the contraction curve (AUCC) and was determined with the use of a 
scanning program (SigmaScan, Jandel, Corte Madrera, CA). The values were 
expressed as a percentage of response to a 10 ° M CARB treatment for 10 min. In 
pilot studies we noticed that many tissue strips lost contractions after a 3-min but not 
a 10-min stimulation by 10'® M CARB after several washouts with Tyrode's solution. 
To transform the data for the 3-min CARB treatment to those for the 10-min treatment, 
an independent study was performed to obtain a regression line (Yang and Hsu, 
1995a): 
Y (10 min) = 2.95 * X (3 min) 1.32 (n = 39). 
In this study, the AUCC produced by the second 3-min 10'^ M CARB 
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stimulation, was transfornned to a 10-min area using the above formula and this 10-min 
area was defined as the 100% 10® M CARB contractile response. The contractile 
response of the tissue strip was calculated from the AUCC produced by the agonist EPI 
10 min over each cumulative dose and was expressed as a percentage of the response 
to 10 ® M CARB. 
Drugs 
The following drugs were used: carbachol chloride, (-)epinephrine bitartrate, and 
propranolol HCI (Sigma Chemical Co., St. Louis, MO); prazosin HCI (Pfizer Inc., Groton, 
CT), and WB 4101 HCI (Research Biochemicals Inc., Natick, MA). Drugs were 
dissolved in distilled water, except for epinephrine, which was dissolved in 0.1% (W/V) 
ascorbic acid in 0.9% NaCI, and prazosin HCI, which was dissolved in 2% lactic acid to 
achieve a concentration of 1 mM. Drug-containing solutions were prepared by 
appropriate dilutions of the stock solutions, which were stored at -20°C. 
Data analyses 
The dose-response curves were produced by a cumulative application of EPI 
one-half log increments (van Rossum, 1963). The data were expressed as pDj (-log 
ECso). 
Dissociation constants (Kg) of prazosin and WB 4101 against EPI were 
determined using the equation: = [B]/(CR - 1), where B is the concentration of the 
antagonist (Furchgott, 1972). The responses to 3 x 10 ® M PRZ and 3 x 10 ® M WB 
4101 were used for these calculations, respectively. The concentration ratio (CR) 
equals to ECjo'/ECso, in which EC50 and EC50' values are the values for the agonist in 
the absence and presence of the antagonist, respectively. The dissociation constant of 
the antagonist was expressed as p/Cg. In PRZ antagonism experiments, the contractile 
response was compared with the control group at the corresponding dose of the 
agonist. 
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Data were expressed as mean ± SE and analyzed by analysis of variance 
(ANOVA). The conservative F value was used to establish significance for the 
treatment effect. The least-significant difference test as used to determine the 
difference between means of end points for which the ANOVA indicated a significant 
(P < 0.05) F ratio. 
Results 
Epinephrine (EPI) (10 ® - 3 x 10"^ M) in the presence of lO '" M PROP produced a 
dose-dependent increase in myometrial contractility in the luteal phase of the estrous 
cycle (Fig. 1). Higher doses of EPI decreased the contractility progressively. The pD, 
value was 7.95 ± 0.23 (n = 5), which was not significantly different from that of the 
previous study (7.81 ± 0.07, n = 6) (Yang and Hsu, 1995a). 
The Oja-AR antagonist, WB 4101, blocked the effects of EPI in a dose 
dependent  manner (Fig. 1A). The p/Cg value for WB 4101 against EPI (7.76 ± 0.14, n 
= 5) was not significantly different from the previous study for yohimbine against the 
same agonist (8.42 ± 0.14, n = 6), but was significantly different from PRZ against 
EPI (5.65 ± 0.06, n = 5) in this study. 
The a," and O jb-AR antagonist, PRZ, at 10 ® or 3 x 10® M, failed to antagonize 
the effect of EPI on myometrial contractility (Fig. IB). However, at 10" iVl, it inhibited 
the effect of EPI (10"' and 3 x 10"^ M) (Fig. IB). 
In order to assess the agreement between the functional studies and radioligand 
binding studies in a more quantitative manner (Table 1), correlation analysis was 
performed between the values from myometrial contracti l i ty studies (Yang and Hsu, 
1995a and present study) and the K. values from [^H]rauwolscin8 binding studies (Yang 
and Hsu, 1995c). As shown in Fig. 2 the correlation coefficient (r) of the KQ values 
Fig. 1. Effect of WB 4101 (A) and prazosin (B) on epinephrine-induced increases in 
myometria! contractility. Data are expressed as mean ± SE (n = 5). All 
strips had been pretreated with 10® M propranolol for 10 min before the first 
dose of the agonist was applied. Effects are shown in the absence (C) and 
(A) in the presence of WB 4101, 3 x 10 ® M, •; 10'^ M, A; 3 X 10^ M, A , or 
(B) in the presence of prazosin, 10® M, •; 3 x 10® M, a; 10^ M, 
'P < 0.05, compared with the control group at the corresponding agonist 
dose. 
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Table 1. Comparison of values from functional studies with K, values from receptor 
binding studies 
Porcine myometrium 
Antagonist Kg"" (nM) K," (nM) 
Yohimbine 3.80 ± 0.06 (6) 0.48 ± 0.05 (4) 
WB4101 17.38 ± 0.31 (5) 2.14 ± 0.26 (4) 
Prazosin 2,239 ± 24 (5) 302 ± 25 (4) 
values of yohimbine were transferred from p/Cg values in Yang and Hsu (1995a). 
X values of binding data were taken from Yang and Hsu (1995c). 
Parentheses indicate the number of observations. 
Fig. 2. Correlation of antagonist affinities from functional (/Cg) and binding (K) studies 
for porcine myometrium. Data for correlations were taken from Table 1. The 
data were best described by the expression Y = 1.0125 *X + (-9.1461) 
(correlation coefficient,= 100% and slope = 1.01). 
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with the K, values v»/as 1.00 (slope = 1.01), indicating an excellent agreement 
between the functional and binding assays. 
Discussion 
The results of the present study suggest that the EPI-induced contractility of 
porcine longitudinal myometrium is mediated predominately by o^a-ARs, and minimally 
by a,- and ajs-ARs in the luteal phase of the estrous cycle. These findings are 
consistent with those of the radioligand binding studies that the a,-AR in the porcine 
myometrium is the a2A-AR subtype (Yang and Hsu, 1995c). These results confirm and 
extend the previous report that the Oja-ARs present in the porcine myometrium mediate 
excitatory contractions (Yang and Hsu, 1995a). 
In the presence of PROP, EPI induced an increase in myometrial contractility in a 
dose-dependent manner. Its pDj value was consistent with the results from the same 
treatment of the previous study (Yang and Hsu, 1995a). In response to higher doses 
of EPI the myometrial contractility decreased because more /?2-ARs had been activated 
by the agonist (Yang and Hsu, 1995a). 
In the presence of PROP, the aj^-AR antagonist WB 4101 competitively 
antagonized the EPI-induced increase in myometrial contractility in a dose-dependent 
manner. However, the (7,- and CTjb-AR antagonist, PRZ, failed to do so, except that at 
an excessively high concentration (10 ® M), it antagonized the effect of EPI (10 ' and 3 
X 10 ' M) (P < 0.05). 
Since the p/Cg value of WB 4101 against EPI was not significantly different from 
the value of yohimbine against EPI (Yang and Hsu, 1995a), it indicated that both have 
high affinities for the porcine myometrial £72-ARs, which mediated myometrial 
contractions, whereas PRZ has a lower affinity. These results indicated a high 
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correlation between the functional and binding assays (Yang and Hsu, 1995a, 1995b 
and 1995c). 
The antagonism by WB 4101 at 3 x 10"' M appeared to be a noncompetitive 
manner when high concentrations of EPI (> 10 ® M) did not overcome its inhibitory 
action (Bourne and Robert, 1995). The similar noncompetitive antagonism was seen 
when the uterine strip was pretreated with 3 x 10'^ M yohimbine, which was attributed 
to the mediated relaxation because the higher dose of PROP (10^ M) further 
reversed the decreased contractility (Yang and Hsu, 1995a). 
Prazosin (PRZ) is a selective c7,-and Ojg-AR antagonist (Bylund and U'Prichard, 
1983; Bylund et al., 1988). Although PRZ at 10"® M blocked the contractile effect of 
EPI in porcine myometriai strips, it would not suggest that Oi-ARs mediate the effect of 
EPI since the lower doses (10'® and 3 x 10"® M) used in this study failed to antagonize 
the effect of EPI. PRZ at 10'^ M may have a2-AR antagonistic effects (Van Zwieten 
and Timmermans, 1983; Ko etal., 1990). In addition, we have observed high 
concentrations of the a^-AR agonist methoxamine (10"® - 10 "^ M) caused porcine 
myometriai contractions. PRZ at much lower concentrations (10"® - 10"' M) partially 
antagonized methoxamine's actions (Yang and Hsu, unpublished observation). 
Moreover, PRZ at a lower concentration (10'® M) blocks OtAR in other tissues, such as 
ovine umbilical veins (Zhang and Dyer, 1991). Because PRZ inhibited EPI-induced 
myometriai contractions much less than WB 4101, these results suggested that the 
EPI-induced increase in myometriai contractility was mediated predominantly by 0,^-. 
and minimally by Ojb-ARs. These results were in agreement with those of the 
radioligand binding studies in which PRZ does not displace [^HJrauwolscine in porcine 
myometriai membrane until 10"® M, whereas WB 4101 starts to displace at 10"'" M 
(Yang and Hsu, 1995c). 
WB 4101 is a selective a-^c^-AR antagonist (Niddam et a/., 1 990), and it is also 
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selective for Ojc-ARs in OK cells and opossum kidneys (Bylund, 1992). Although the 
high affinity of WB 4101 for porcine myometrial Oj-ARs (Yang and Hsu, 1995c) is 
close to the data for Ojc-AR prototype tissues (Murphy and Bylund, 1988; Blaxall et ai., 
1991), the high affinity of oxymetazoline, an qtja-AR agonist (Bylund et a!.. 1988), only 
occurred in porcine myometrium (Yang and Hsu, 1995c), but not in Ojc-AR prototype 
tissues (Blaxall et aL. 1991). In addition to the comparison of selective Oj-AR subtype 
agents, good correlations of porcine myometrium are only obtained with a^^^-AR 
prototype tissues, but not with Ojb-, Osc"- or ajo* prototype tissues (Yang and Hsu, 
1995c). Therefore, our findings provided evidence that WB 4101 expresses the CTja^AR 
selectivity in porcine myometrium. 
We also compared the affinities of three Oj-AR antagonists, including PRZ, WB 
4101 and yohimbine, in porcine myometrium using both the function [K^ value) (Yang 
and Hsu, 1995a and present study) and the radioligand binding (/C, value) techniques 
(Yang and Hsu, 1995c). There was an excellent correlation between values and K 
values. Hence, the functional data are consistent with the radioligand binding data 
which further support the existence and definition of Oja'AR subtype in porcine 
myometrium. 
Although the and AC, values were highly correlated, the values were 
significantly higher than the /C, values. For examples, the value for WB 4101 is 8-
fold greater than the K, value. The affinity difference of antagonists was probably 
caused by different assay conditions in functional and radioligand binding studies 
(Bylund and Ray-Prenger, 1989). The assay conditions used for the radioligand binding 
studies in myometrial membrane proteins are the results of efforts to optimize the 
binding in terms of high affinity and low nonspecific binding of [^HJrauwolscine (Yang 
and Hsu, 1995c). In contrast, the studies on myometrial contractility in vitro were 
performed under conditions that were comparable to the isolated organ bath system. 
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In addition, the drug penetration through the tissue mass could be a factor in the 
isolated organ system. 
The density of Oj^-ARs in porcine longitudinal myometrium is higher than that in 
other 0'2a-AR prototype tissues, e.g. HT cells and human platelets (Bylund et a!.. 1988). 
Moreover, this specimen is readily available and provides a large amount of O j a^ARs. 
Therefore, porcine myometrium should be a good tissue model for the study of 0;^-
ARs.  
In summary, the present work suggested that but not a^g-ARs, mediate 
EPi-induced increases in porcine myometrial contractility in the luteal phase of the 
estrous cycle. Furthermore, there is an excellent agreement between values for o-
AR antagonists determined by functional assays in porcine myometrial strips and the K, 
values determined from radioligand binding assays in porcine myometrial membrane. 
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EFFECTS OF YOHIMBINE AND PRAZOSIN ON METHOXAMINE-INDUCED INCREASE IN 
PORCINE MYOMETRIAL CONTRACTILITY IN VITRO 
A paper submitted to Life Science, Pharmacological Letters. 
Chih-Huan Yang and Walter H. Hsu 
Abstract 
Oj-Adrenoceptors are major a-adrenoceptors in porcine myometrium and mediate 
catecholamine-induced increase in myometrial contractility. However, the activity of 
porcine myometrial o,-adrenoceptors on contractions is not clear. Hence, the objective 
of the study was to investigate if there is a,-adrenergic effect on porcine myometrial 
contractility in vitro using uterine strips of the longitudinal layer in the luteal phase of 
the estrous cycle. Methoxamine, the a,-adrenoceptor agonist, at high concentrations 
of 10", 3 X 10"^ M and 10'"^ M, caused a dose-dependent increase in myometrial 
contractility. Both the a,-adrenoceptor antagonist, prazosin (10®, 3 x 10 ®, 10 " M) and 
the oj-adrenoceptor antagonist, yohimbine (10®, 3 x 10® M) inhibited the 
methoxamine-induced increases in myometrial contractility. However, after the 
application of 10" M methoxamine, when myometrium was greatly contracted, 
yohimbine (3 x 10'^ M) abolished the contractions, but prazosin (10 ' M) only slightly 
reduced the contractions. These results suggest that both o,- and 0;-adrenoceptors 
mediate the methoxamine-induced increase in porcine myometrial contractility, with a^-
adrenoceptors mediating greater of this effect than a,-adrenoceptors. These findings 
are attributed to the fact that with regards to o-adrenoceptor subtypes, porcine 
myometrium contains predominantly aj-adrenoceptors. 
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Introduction 
Our previous reports have demonstrated that natural catecholamine-induced 
porcine myometrial contractility is mediated by OjA-adrenoceptors (ARs), but not by a,-
ARs (Yang and Hsu, 1995a, 1995b & 1995c), despite the fact that a - and a^-AR 
subtypes account for 1 - 3 and > 97% of cr-ARs, respectively (Yang and Hsu, 1995c). 
The present study was undertaken to determine if the Oi-AR agonist 
methoxamine has any stimulatory effect on myometrial contractility. We hypothesized 
that if methoxamine increased myometrial contractions, this effect should be blocked 
by 02-. but not a,-AR antagonists. 
Materials and Methods 
Tissue preparation 
Porcine uteri were collected from a local packing plant. Only the mid-portion of 
the uterine horns was used in the experiment. The uteri were determined as in the 
luteal phase based on the presence of light red corpora lutea on the ovaries, and the 
absence of embryos (Arthur et al., 1989). The tissues were stored in ice-cold Tyrode's 
solution (137 mM NaCI, 2 mM KCI, 1 mM CaClj, 0.4 mM MgClj, 1 1 mM dextrose, and 
12 mM NaHCOs; pH 7.4) and transported to the laboratory. Upon arrival, the 
endometrium was removed from the uterus; the myometrium was stored in ice-cold 
Tyrode's solution aerated with 95% 0,-5% CO, and was used for experiments withm 
30 h. There were no changes in responsiveness to contractants during this period. 
The methods for studying porcine myometrial contractility were as previously 
described (Yang and Hsu, 1995a and 1995b). in brief, the iongitudinal uterine strips 
(10x2 mm^) were suspended vertically in a 10-ml organ bath containing Tyrode's 
171 
solution maintained at 37°C and were aerated with 95% 02-5% CO^- The 
contractions were recorded isometrically on a multiple-channel recorder (R41 1, 
Beckman Instruments Inc., Schiller Park, IL) through a transducer {Grass FT03, Grass 
Instrument Co., Quincy, MA). The strips were equilibrated under a 2-g tension for 20-
25 min before being exposed to 10 ® M carbachol (CARB) twice for 3 min each to 
determine their responsiveness to the contractant. Four washes with 10 ml of 
Tyrode's solution each were used to remove CARB after its 3-min stimulations. The 
interval between the two CARB stimulations was 15 min. Usually the strips lost 
contractions within 15 min after the washout of CARB, and this quiescent state usually 
lasted > 25 min. The basal resting tension was readjusted to 2 g before the 
pretreatment drug was added. In the following experiments, methoxamine was added 
at a 10-min interval in cumulative doses to attain a dose-response relationship. 
Effect of prazosin and yohimbine on methoxamine-induced mvometrial contractility 
The a,-AR antagonist prazosin (PRZ) (10®, 3 x 10® or 10^ M) or the cr^-AR 
antagonist yohimbine (YOH) (3 x 10'®, 10 ® or 3 x 10 ® M) was added to the organ bath 
for 10 min. After 10-min of pretreatment with the antagonists, methoxamine was 
given in cumulative doses {10 ® - lO"* M). Control received only methoxamine without 
an a-AR antagonist. 
The 10-min pretreatment for a-AR antagonist was chosen, because in the 
preliminary experiment, cr-AR antagonism by YOH reached maximum in 10 min, 
respectively (Yang and Hsu, 1995a). 
Different strips from the same uterus were randomly assigned to ail treatment 
groups in one trial of experiment, and each uterus was used for one trial only. 
Assessment of the contractile response 
The determinations of the contractiie response were as previously described 
(Yang and Hsu, 1995a). Briefly, the contractile response of methoxamine was 
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assessed by the area under the contraction vurve (AUCC) and was determined with the 
use of a scanning program (SigmaScan, Jandel, Corte Madrera, CA). The values were 
expressed as a percentage of response to a 10 ® M CARB treatment for 10 min. In 
pilot studies we noticed that many tissue strips lost contractions after a 3-min but not 
a 10-min stimulation by 10 ® M CARB after several Tyrode's solution washouts. To 
transform the data for the 3-min CARB treatment to those for the 10-min treatment, an 
independent study was performed to attain a regression line (Yang and Hsu, 1 995a): 
Y (10 min) = 2.95 * X (3 min) -h 1.32 (n = 39). 
In this study, its area under the AUCC, produced by the second 3-min 10 ' M 
CARB stimulation, was transformed to a 10-min area using the above formula and this 
10-min area was defined as the 100% 10 ® M CARB contractile response. The 
contractile response of the tissue strip was calculated from the AUCC produced by 
agonist methoxamine over 10 min at each cumulative dose and was expressed as a 
percentage of the response to 10 ® M CARB. 
Dfuq 
The following drugs were used: carbachoi chloride and yohimbine HCI (Sigma 
Chemical Co., St. Louis, MO); methoxamine HCI (Burroughs Wellcome Co., Research 
Triangle Park, NJ), and prazosin HCI (Pfizer Inc., Groton, CT). Drugs were dissolved in 
distilled water, except for prazosin HCI, which was dissolved in 2% lactic acid to 
achieve a concentration of 1 mM. Drug-containing solutions were prepared by 
appropriate dilutions of the stock solutions, which were stored at -20°C. 
Data analyses 
The dose-response curves were produced by cumulative application of 
methoxamine in approximately one-half log increments (van Rossum, 1963). The data 
ware expressed as pDj '-log EC52) and v^ere expressed as mean ± SE. In PRZ and 
YOH antagonism experiments, the contractile response was compared with the control 
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group at the correponding dose of the agonist. Data were expressed as mean ± SE 
and analyzed by analysis of variance (ANOVA). the conservative F value was used to 
establish significance for the treatment effect. The least-significant difference test as 
used to determine the difference between means of end points for which the ANOVA 
indicated a significant (P < 0.05) F ratio. 
Results 
Methoxamine, the selective a,-adrenoceptor agonist, at high concentrations of 
10'® - 10"* M, caused a dose-dependent increase in myometrial contractility (Fig. 1). 
The pDj value of methoxamine was 4.95 ± 0.07 (n = 5). Both the a.-AR antagonist, 
PRZ (10 ®, 3 X 10®, 10' M) {Fig. 1A) and the O2-AR antagonist, YOH (3 x 10 ®, 10 ', 3 
X 10® M) (Fig. IB) inhibited significantly the methoxamine-induced increases in 
myometrial contracti l i ty. However, after the administration of methoxamine while the 
muscle was contracted, the addit ion of 3 x 10'^ M YOH (Fig. 2A) greatly reversed, but 
10 ® M prazosin (Fig. 2B) only slightly reduced the effect of methoxamine. 
Discussion 
The results of the present study suggested that methoxamine-induced 
contracti l i ty of porcine longitudinal myometrium is mediated by both a.- and a^-ARs in 
the luteal phase of the estrous cycle because both PRZ and YOH inhibit the effect of 
methoxamine. These findings provided the evidence and extended the results of our 
previous studies in which o.-ARs in porcine myometrium mediate minimal contracti le 
activity (Yang and Hsu, 1995a, 1995b, 1995c & 1995d). Furthermore, the results 
also showed that methoxamine, the selective Oi-AR agonist had agonistic activity at 
Fig. 1. Effect of prazosin (A) and yohimbine (B) on methoxamine-induced increases in 
myometrial contractility. Data are expressed as mean ± SE (n := 5). Effects 
are shown in the absence (O) and (A) in the presence of prazosin, 10'® M, •; 
3 X 10® M, A; 10'^ M, or (B) in the presence of yohimbine, 3 x 10"^ M, •; 
10® M, A; 3 X 10® M, a. 
'P < 0.05, compared with the control group at the corresponding agonist 
dose. 
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A. Prazosin 
-7 - 6  -o 
B. Yohimbine 
70 r 
Log [Ml Methoxcmine 
Fig. 2. Representative tracings of the uterine contractile response for methoxamine. 
The contractile responses at lO""* M methoxamine (A and C) were obtained 
from cumulative doses (3 x 10® - 10"^ M) in the absence of a-adrenoceptor 
antagonist. The methoxamine-induced myometrial contractility was greatly 
reversed by 3 x 10"^ M yohimbine (B), but was slightly reduced by 10 ® M 
prazosin (D). Data shown are the representative of three experiments. 
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c. 
10"* M Methoxamine 
D. 
10'® M Prazosin 
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porcine myometriai Oj-ARs. 
In our previous studies PRZ, the Gr,-AR antagonist, at 10 ® M in the presence of 
PROP failed to antagonize the effect of epinephrine and norepinephrine on the porcine 
myometriai contractility. The potency of natural catecholamines on myometriai 
contractility is not changed by the effect of an cr,-AR antagonist PRZ. We suggest that 
Oi-ARs in porcine myometrium have minima! function to mediate contracti l i ty (Yang and 
Hsu, 1995a). Results from the studies of radioligand binding assays indicated that a.-
AR density is only 1 - 3% of total a-ARs in porcine myometrium, and PRZ has very low 
affinity to displace [^H]rauwolscine, a specific a^-AR antagonist, from binding sites 
(Yang and Hsu, 1995c). 
The present findings that the low potency of methoxamine, which was 
compared with that of epinephrine and norepinephrine to induce myometriai 
contractility (Yang and Hsu,1995a), at least in part, supported that ai-ARs mediate 
minimal response on myometriai contracti l i ty because the contracti l i ty was inhibited by 
PRZ. 
However, methoxamine has activity at Oj-ARs, in addition to potent activity at 
a,-ARs (Nichols and Ruffolo, 1991). It was reasonable to expect that it activated both 
or,- and Oj-ARs in high concentrations which induced myometriai contractions in this 
study. Our results that both PRZ and YOH at lower concentrations inhibited the effect 
of methoxamine supported this contention. Under the stimulation with a highest 
concentration (10"^ M> of methoxamine in this study, the myometriai contractions were 
mediated predominantly by c/j-ARs because it was abolished by YOH, but not by PRZ. 
The inabil i ty of PRZ at 10 ® M to reverse the effect of methoxamine was probably due 
to the extremely low a,-AR density in porcine myometrium which might have been fully 
activated at < 10"' M methoxamine. in conclusion, our results suggest that both a -
and Oj-ARs mediate the methoxamine-induced myometriai contractions, with a.-ARs 
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mediating greater of this effect than Oi-ARs did. These findings are attributed to the 
fact that with regards to g-AR subtypes, porcine myometrium contains predominantly 
oj-adrenoceptors. 
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GENERAL DISCUSSION 
The classification of a-ARs in this study was undertaken by both functional and 
radioligand binding studies. The functional study is based on the receptor occupation 
theory where it is assunned that the occupation of a receptor by a drug leads to a 
stimulus and a subsequent response (Kenakin, 1984). The radioligand binding study 
identifies the specific receptors, determines the density of the receptors in the tissues, 
and characterizes the subtype of the receptors (William and Lefknowitz, 1978a). 
In the functional study, myometrial contractility in vitro was used to test the 
potency of catecholamines (CATs) on o-AR subtype-mediated activity and to 
distinguish the affinity of specific a-AR antagonists against a-AR agonists on porcine 
myometrium. In this species, Oj-ARs, specifically Oja-ARs, predominantly mediated the 
natural CAT-induced increase in myometrial contractility. In addition, the natural CAT-
induced relaxation through j5-AR-mediated action was also detected. In the radioligand 
binding study, otja-AR was the dominant a-AR in the porcine myometrium throughout 
the estrous cycle and during pregnancy. a,-ARs were present in small amounts (1 -3% 
of a-ARs), which minimally mediated myometrial contractility. 
The presence of a heterogenous population of receptors serving antagonistic 
responses with respect to each other can subtract the effects mediated by the 
respective receptors (Kenakin, 1984). In this study the effect of the /?-AR-mediated 
relaxation on Oj-AR-mediated contractions in porcine myometrium provided a good 
example. The most common method used to detect and eliminate this problem is by 
using selective antagonists of the interfering receptor population (Kenakin, 1984). In 
our results, the a2-AR responses on porcine myometrial contracti l i ty were strikingly 
potentiated when the relaxant /?-ARs were blocked by PROP in all reproductive stages 
tested, except in the follicular phase. In the follicular phase, the spontaneous 
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contractions were present throughout the experiment. In the absence of PROP, the 
spontaneous contractions were decreased progressively by the natural CATs, and this 
was attributed to the activation of myonnetrial ff-ARs. In the presence of PROP, neither 
EPi nor NE caused a dose-dependent increase in myometriai contractility in this phase. 
The lack of agonistic activity of the natural CATs is due partially to the low 
concentration of Oj-ARs in the porcine myometrium because oxytocin induced a dose-
dependent myometriai contractility in this phase (Yu and Hsu, 1993). 
In the presence of PROP, EPI was more potent than NE in inducing an increase 
in myometriai contractility in the luteal phase of the estrous cycle and various stages of 
pregnancy. Differences in relative potency between agonists may result from 
differences in their relative affinity for receptors and/or their relative efficacy (Kenakin, 
1984). 
The efficiency of the stimulus response mechanisms in different tissues may 
vary. Two factors can affect the efficiency of the stimulus response mechanism in a 
tissue: 1) the number of receptors in the tissue, 2) the second messenger system 
which translates receptor stimulus into a cellular response (Kenakin, 1984). The 
second messenger system often performs as an amplifier in biological system (Ariens 
and Simonis, 1976; Goldberg, 1975). In general, the density of porcine myometriai a--
ARs in pregnancy was greater than that in the luteal phase. However its CAT-induced 
myometriai contractility was less than that in the luteal phase. Therefore, it is possible 
that changes in the signal transduction system during pregnancy may lead to a lower 
response to Oj-AR stimulation than in the luteal phase. In addition, as the pregnancy 
progresses in the sow, the thickness of the longitudinal myometrium decreases 
progressively (Thilander and Rodriguez, 1989b and 1990). It is possible that the 
decreased thickness of myometriai strips provides fewer c^-ARs, then lowers the 
contractile response to CATs in vitro study. 
183 
Selective agonism can provide useful information about the presence or absence 
of certain receptors in a given tissue, if a selective agonist produces a response in a 
tissue, a distinction should be made between selectivity and specificity (Kenakin, 
1984). In the present study, both EPI and NE caused a dose-dependent increase in 
myometrial contractility. The effect of the natural catecholamine was effectively 
antagonized by YOH and WB 4101, the Oj-ZajA-AR antagonist, but not by PRZ, an o -
and O2S-AR antagonist, indicating that the contraction was mediated by the o.-ARs, 
specifically O ja-ARs. This finding was consistent with that in radioligand binding 
assays in which the a'2'Subtype was found to be the dominant o-ARs in the porcine 
myometrium and the affinity of the 02-/a2A-AR drugs to compete [^H]rauwolscine 
binding was greater than that of PRZ, the a,-/a'2B-AR drug. 
On the other hand, if a tissue does not respond to a selective agonist, it could 
mean either that the receptor is not present or that the stimulus-response mechanism 
of the cell produces insufficient amplification of the receptor stimulus to generate a 
response. In this study, the weak agonist activity of methoxamine, the o.-AR agonist 
in the porcine myometrium could be due to the low concentration of a,-ARs. 
For the most part, the definitive classification of the major drug receptor types 
and subtypes has been accomplished by using selective competitive antagonists. In 
general, antagonists are more selective for receptor subtypes than the agonists 
(Kenakin, 1984). The potency of a competit ive antagonist depends on its equil ibrium 
dissociation constant (ATg) for the drug receptor. Since competit ive antagonists possess 
no intrinsic efficacy, the interaction of a competit ive antagonist with a drug receptor is 
a strictly chemical process. The rate of onset and offset of the antagonist with the 
drug receptor is controlled only by the molecular forces. Therefore, the Kg values are 
independent of receptor function, location, and animal species. A similar value for a 
specific competit ive antagonist against different agonists provides strong evidence that 
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these agonists act on the same type of receptors. 
In this study, either the values of YOH vs. EPI and NE in the tissues of the 
same reproductive stage, or the values of YOH vs. EPI or NE in the various 
reproductive stages were not significantly different, indicating that the natural CATs, 
EPI and NE, acted on the same type of o-AR, i.e., Oj-AR. On the other hand, if an 
agonist-induced response is not antagonized by a specific competitive antagonist, it 
can be concluded that the respective receptor is not present. In this study, the low 
concentration of a,-ARs in porcine myometrium provides evidence that explams why 
potent and selective a,-AR antagonist, PRZ, even at high concentrations failed to block 
the natural CATs-induced porcine myometrial contractility. 
Since the ultimate goal of a-AR binding studies is to gain insight into the 
molecular mechanism by which adrenergic agonists elicit physiological response, it is 
imperative that binding data be related to data from physiological response 
measurements (Williams and Lefkowitz, 1978b). In these studies, the affinities of 
three Oj-AR antagonists, including PRZ, WB 4101 and YOH, in porcine myometrium 
were compared between the function (/Cg values) and radioligand binding {K values) 
experiments. The excellent correlation between the results of these two studies 
supports the contention that the binding sites are indeed the physiologically active a--
ARs through which CATs and antagonists act. 
From these in vitro studies we foumi that the o^'ARs in porcine myometrium 
mediated natural CAT-induced myometrial contractions but their physiological function 
in the uterus is sti l l  not clear. Considering the contraction which is mediated by a--ARs 
in vivo, the action of ^-ARs, especially/Jj-ARs, on myometrial contracti l i ty can not be 
neglected. /S-ARs are present in the porcine myometrium (Yang and Hsu, unpublished 
results) and mediate uterine relaxation in this study. 
In the absence of PROP, both EPI and NE decreased myometrial contractility 
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progressively in the follicular phase but induced contractions when high concentrations 
(> 3 X 10'^ M) of EPI and NE were applied in all reproductive stages. These results 
implicate that at low concentrations of natural CATs /^-inhibitory action is greater than 
that of (7-excitatory action in controlling myometrial contractility. 
In physiological condition, the action of natural CATs on uterine motility may be 
similar to that in the in vitro study without /?-AR antagonism, i.e., natural CATs 
activate a- and ;S-ARs simultaneously. Therefore, if natural CATs in the body can 
induce myometrial contractions, their concentrations should be at least as high as > 3 
X 10"^ M to overcome the /S-AR-mediated relaxations. Plasma EPI and NE 
concentrations increase during labor in women {Lederman et a!., 1977 and 1978) and 
sheep (Eliot, et a!., 1981), but the concentrations may not increase so high as to cause 
uterine contraction (NE: 1 ng/ml plasma = 3 x 10 ® M in sheep) (Eliot, et a!., 1 981). 
However, the potency of natural CATs to induce myometrial contraction in vitro may 
not reflect the same physiological response as in vivo because the assay conditions 
used for myometrial contractility in vitro were the results of efforts to optimize the 
isolated tissues in organ bath system. 
The plasma estrogen concentrations increase prior to parturition in many 
species, including sows (Ford eta!., 1984; Thilander and Rodriguez-Martinez, 1990). 
The high estrogen levels stimulate the formation of gap junctions in myometrium, 
enhance uterine contractility through stimulating prostaglandin production and increase 
myometrial oxytocin receptors to facilitate labor (Garfield, 1994). Therefore, the 
activity of myometrial Oj-ARs may interact with other hormones and autacoids, such as 
prostaglandin to increase myometrial contractions. Furthermore, since our results 
suggested that the action of Oj-ARs in porcine myometrium is excitatory, it is feasible 
to use an o^-AR agonist in combination with prostaglandin F;_. to facil itate delivery of 
the fetus or synchronize farrowing in preparturient sows (Ko et a!., 1989). 
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Moreover, it is likely that Oj-ARs counterbalance the ^Sj-AR-mediated myometrial 
relaxation. This could be important at term, because without the participation of cr,-
ARs, there could be excessive myometrial relaxation when animals are stressed, which 
may interfere with parturition process. Although it is postulated that Oj-ARs regulate 
some aspects of cellular metabolism important for uterine function, and that the 
ovarian steroid-induced changes in o^-AR density may involve the control of the 
metabolism of the uterus during the estrous cycle and pregnancy (Ruffolo and Hieble, 
1994), it is yet to be investigated. 
From the results of the present study, we suggest that the porcine myometrial 
G2-AR appears to be under the control of progesterone since its density is high in a 
progesterone-dominant environment, such as the luteal phase or pregnancy. In 
contrast, the density of Oj-ARs was low when myometrium was exposed to a low 
progesterone environment, such as the follicular phase. However, estrogens might not 
influence the density of porcine myometrial OJ-ARs because the OJ-AR concentration in 
prepartum period was still 5-fold greater than that in the follicular phase even through 
the plasma concentrations of estrogens in prepartum period was reported to be 7 fold 
higher than in the follicular phase (Thilander and Rodriguez, 1989a and 1990). 
Therefore, further research using ovariectomized pigs supplemented with steroids is 
needed to determine which sex steroids, or combinations, is responsible for the 
changes in Oj-AR density. 
We do not know why physiological changes in progesterone concentration 
would produce prominent changes in cr^^AR density in porcine myometrium. Steroia 
hormones are known to regulate the expression of various proteins through activation 
of gene transcription (Beato, 1989). The testosterone-enhanced cr^-AR expression n 
hamster fat cells is a result of the regulation of the synthesis and/or turnover of the a 
ARs (Saulnier-Blache eta!., 1992; Bouloumie eta!., 1994). Therefore, we hypothes ze 
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that progesterone may induce an increase in the density of porcine myometrial 
via enhanced transcription. Further studies are also needed to define the mechanisms 
involved in the regulation of CT^-AR expression by sex steroids in porcine myometrium. 
188 
GENERAL SUMMARY 
The adrenergic effect of natural catecholamines (CATs) epinephrine (EPI) and 
norepinephrine (NE) on contractility in vitro, and identification and characterization of a-
adrenoceptors (ARs) were studied in longitudinal myometrium of sows during the 
estrous cycle and pregnancy. The uterine strips in the follicular phase presented 
spontaneous contraction throughout the experiments, and the contractions were 
decreased by the action of EPI and NE in the absence of propranolol (PROP), the y?-AR 
antagonist, in the presence of 10 ® M PROP, neither EPI nor NE increased myometrial 
contractility in this phase. However, EPI or NE alone induced a dose-dependent 
increase in myometrial contractility in other reproductive stages. This effect was 
potentiated by pretreatment with 10 ® M PROP and the potency of EPI was greater than 
that of NE. The order of the potencies of EPI and NE was luteal phase (L) > late 
pregnancy (LPG) (days of gestation = 73 - 79) > mid-pregnancy (MPG) (days of 
gestation = 53 - 60) > early pregnancy (EPG) (days of gestation = 39 - 40) > 
prepartum period (PPT) (days of gestation = 111 - 113). These induced myometrial 
contractions were inhibited by both the Oj-AR antagonist yohimbine (YOH) (10 ® - 3 x 
10'^ M) and the ctja-AR antagonist WB 4101 (3 x 10 ® - 3 x 10'^ M) in a dose-
dependent manner, but not by prazosin (PRZ), the a,-AR antagonist even at the high 
concentrations up to 3 x 10 ® M. Although methoxamine, the a.-AR agonist, at high 
concentrations of 10'^ - 10"* M, also caused a dose-dependent increase in myometrial 
contracti l i ty, the induced increase was inhibited by both PRZ (10 ^  3 x 10 ^  10^ M) 
and YOH (10 ®, 3x10 ® M). Moreover, the effect of methoxamine at 10 " M, when the 
myometrium had been greatly contracted, was abolished by YOH (3 x 10^ M), but was 
only slightly reduced by PRZ (10 ® M). 
When uterine strips were pretreated with Ca^^-free Tyrode's solution or 10 " M 
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verapamil, a voltage-dependent Ca^"" channel (VDCC) blocker, the EPl- and NE- induced 
myometrial contractility was greatly decreased. This decreased contractility in Ca"*-
free medium was further inhibited by 10' M YOH, and to a lesser extent by 10^ M 
PRZ. Therefore, the results in functional studies suggested that Oj-, specifically 0;^-
ARs, mediated EPi- and NE-induced increase in myometrial contractility in sows, which 
was attributed primarily to an increase in Ca^"" influx through VDCC and at least in 
part, due to calcium release from intracellular stores. 
In radioligand binding studies, we used [^H]prazosin ([^HIPRZ) and 
[^H]rauwolscine ([^H]RAU) as specific ligands to identify a.- and a2-ARs, respectively, in 
porcine myometrium. Both ligands were saturable with high affinities to a,- and Oj-
ARs. They were rapidly reversed by 10"^ M phentoiamine, an o-AR antagonist. 
Saturation binding studies with (^H]RAU showed that the density of Oj-ARs was high 
comparing to the a,-ARs, and Oj-ARs accounted for at least 97% of total a-ARs in all 
reproductive stages. The equilibrium dissociation constants (/<"•) being 4.6 - 6.9 nM 
were not significantly changed among reproductive stages. The order of the maximum 
binding density (Smax) fmol/mg protein of Oj-ARs was EPG (2,426 ± 430) > very 
late pregnancy (VLPG) (days of gestation > 100) (2,392 ± 341) > LPG (2,049 ± 
131) = MPG (1,999 ± 318) > L (1,568 ± 135) = PPT (1,507 ± 236) > F (265 ± 
50). However, the density of a,-ARs remained low in all reproductive stages although 
the KQ values (21.5 - 33.5 pM) were not significantly different among the tested 
groups. The order of in fmol/mg protein of a,-ARs was L (23.6 ± 2.1) = EPG 
(22.0 ± 1.3) > LPG (20.0 ± 3.9) > MPG (15.6 ± 3.4) > = PPT (11,3 ± 1.1) > F 
(7.5 ± 1.6). From the competition binding studies in myometrial membranes from the 
luteal phase, the drug affinities, including idazoxan, oxymetazoline, PRZ, RX 821002, 
WB 4101 and YOH, were highly correlated between porcine mycmstrium and knovvn 
OjA-subtype cells, such as human platelets and HT29 cells. In contrast, correlations 
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were poor between porcine myometrium and other known o^-subtype tissues or cells, 
i.e., OjB (neonatal rat lung and NG18-105 cells), Oic (opossum kidney and OK cells), 
and ajD (bovine pineal gland and rat submaxillary gland). Moreover, when comparing 
the affinity of Oj-AR antagonists, including WB 4101, PRZ and YOH, in porcine 
myometrium, there was an excellent correlation (r = 100%, slope = 1.01) between 
dissociation constants from the contractility study and inhibition constants from the 
radioligand binding study. 
Therefore, from the above results we suggested that the Oja-AR is the major a-
AR in porcine myometrium, it mediates natural CAT-induced increase in myometrial 
contractility in vitro in cycling and pregnant sows. Our data also suggested that 
ovarian steroids, especially progesterone, play an important role in the regulation of 
porcine myometrial a-ARs, i.e., in a high-progesterone environment (in the luteal phase 
or during pregnancy), the density of o-ARs is increased. However, in a iow-
progesterone environment (in the follicular phase) the density of a-ARs is decreased. 
Oi-ARs are present in porcine myometrium in small amounts and mediate minimal 
response on myometrial contractions. We also suggested that the effect of natural 
CATs on myometrial contractility is primarily mediated by an increase in influx 
through VDCC, and in part, through Ca^^ release from intracellular stores. 
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